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ABSTRACT 
For the last few decades, the expences of pharmaceutical development and drug 
discovery have been constantly increasing whereas the amount of new 
pharmaceutical products reaching the market has been diminishing. The drug 
discovery methods today rely heavily on different screening technologies in the early 
discovery phase. High-throughput screening is usually the dominant approach along 
with different computational methods, but these methods lack the ability to monitor 
the interactions between drugs and cells in real-time.  The ability to measure drug-
cell interactions and cell responses during drug stimulation in real-time could 
provide complementary kinetic information to traditional methods already used in 
drug discovery. This time-resolved information should help to build a better 
mechanistic understanding of the effect of drug formulation design on the drug 
release actions, the drug delivery process and the efficacy of the drug, especially when 
it comes to new biological drugs and nanoparticle formulations.  
This dissertation addresses challenges in developing functional surfaces and 
analysis methods based on the surface plasmon resonance technique for 
pharmaceutical research purposes. The research in this thesis spans from traditional 
drug-protein interaction studies and preparation of cell model surfaces to interaction 
studies with living cells. An approach where proteins were immobilized in a hydrogel 
was used for studying the interaction kinetics between protein kinase C ε and both an 
activating and an inhibiting single-chain antibody. The affinities determined for the 
interactions were able to predict the level of activation or inhibition in subsequent 
cell culture assays.  
This thesis also presents two types of new analysis methods, i.e. label-enhanced 
and multi-wavelength surface plasmon resonance (SPR) methods were developed in 
order to improve the sensitivity of bioassays and accuracy for characterizing ultra-
thin films, respectively. The label-enhanced SPR method was shown to improve assay 
sensitivity up to 100-fold, whereas the multi-wavelength SPR analysis provided the 
means to characterize organic layers in the range from a few nanometers to hundreds 
of nanometers, i.e. layer thicknesses of relevance to biological membranes and 
hydrogels.   
New surface coating chemistries based on dextran and thiol-PEG were also 
developed in this thesis in order to enable the preparation of robust biomimetic 
membranes by vesicle spreading or adsorption.  The dextran-based and PEG-based 
coatings promoted supported lipid bilayer and adsorbed vesicle layer formation, 
respectively. The new analysis approaches developed in this thesis were further 
utilized in order to characterize the optical properties of the formed lipid layers on 
the dextran- and PEG-based coatings. Finally,  a new analytical approach for signal 
processing of the real-time and label-free SPR measurements performed together 
with living cells is introduced which provides the mean to differentiate between para- 
and transcellular cell absorption routes of drug molecules. 
This dissertation contributes to the pharmaceutical research field by introducing 
new measuring tools, improved in vitro biomimetic models and new approaches for 
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processing of the signal from label-free measurements in order to provide relevant 
real-time and complementary information to traditional drug development and 
discovery tools. This will hopefully benefit the pharmaceutical research field and 
possibly enable a more efficient development of new pharmaceuticals and therapies 
in the future.  
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1 INTRODUCTION 
The ultimate goal of drug discovery is to produce a safe and effective drug for a given 
condition. Though modern high-throughput synthesis methods can produce massive 
amounts of new compounds for evaluation as drug leads, and computational methods 
for predicting chemical and biochemical interactions have been improving 
tremendously during the last few decades, there is still a lot to learn how a chemical 
affects a real biological system. As an unknown chemical compound cannot be tested 
in a human, because it is ethically extremely unacceptable, there is always a need to 
go through a series of in vitro and in vivo models before finding a clinically 
acceptable drug lead.  
Biomimetic is a word used to describe that a human-made system is copying, 
imitating or adapting a natural biological system. Though most commonly used in 
describing for example new functional materials that mimic natural structures, like 
super hydrophobic surfaces created by mimicking lotus leaves, the term is often used 
for describing its other common use i.e. modelling biological systems through their 
components. The closest biomimetic model for the complete human physiology is an 
animal physiology, but using animals is both ethically questionable and expensive, so 
the amount of animal tests is kept as low as possible during drug development. 
Basically most tests performed during drug development could be called biomimetic 
tests, as for example the simple solubility tests utilizing model gastrointestinal fluids. 
The reason why these tests are biomimetic is that the prediction ability form in vitro 
tests to the in vivo situation of the given assay is usually the better the closer it 
mimics the real biological environment. An extremely good example of this is the 
parallel artificial membrane permeation assay (PAMPA) which predicts the 
gastrointestinal absorption of drugs in human much better than the octanol-water 
partitioning coefficient, especially for charged molecules [1]. However, the 
knowledge, understanding and the ability to manipulate biological compounds is still 
rather limited, making it either completely impossible or too difficult and expensive 
to fully model biological systems. Therefore, there is an increasing need for a better 
understanding of how to prepare and manipulate simplified biomimetic interfaces for 
the purpose of drug discovery and development. 
For a given drug development assay, it is always the interplay of simplicity, 
prediction ability towards the desired in vivo situation and cost which determines 
how useful it is in drug development. Taking into account the above, there is a clear 
demand for improved assays, especially as the complexity of new drug molecules and 
formulations that enters the market is increasing, formulations are more specific in 
their treatment profile compared to earlier ones, and the increased use of 
nanotechnology in drug formulations are pushing the limits  of the capabilities of 
current in vitro assays [2]. 
There are two interesting types of assays which are commonly utilized in drug 
development. The first ones include the cell monolayer assays that model biological 
interfaces and membranes, e.g. Caco-2 and MDCK II that are mainly used as small 
intestine models [3-7], but also as many other tissue models, such as blood-brain-
Introduction 
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barrier  [8,9], retinal epithelia [10] and epidermal [11] models. The second type of 
assays are different kind of supported lipid bilayers (SLBs) which can be used to 
model different biological membranes such as the cell wall [12] or the mitochondria 
membrane [13], or as a stabilizing environment for membrane proteins and receptors 
like G-protein coupled receptors (GPCRs) [14], as well as for passive drug permeation 
prediction like PAMPA [15]. So far, these measurements have mostly been used as 
static measurements which produce information in timescale of hours, such as drug 
or nanoparticle permeation of cell monolayers, and provide only limited information. 
Currently, the SLBs do not show enough biomimetic ability which limits their use as 
an in vitro platform in the drug development cycle for predicting the the final in vivo 
situation.  
This work focuses on developing biomimetic interfaces and combining these with 
real-time and label-free detection methods to create new types of platforms and 
complementary approaches to traditional in vitro assays for drug discovery and drug 
development. The protocols and synthesis for preparing biomimetic interfaces based 
on supported lipid bilayers (SLB) and living cell monolayers on sensor surfaces for 
surface sensitive detection techniques (i.e. SPR and QCM) were developed and 
optimized. The ultimate goal is to provide complementary platforms for the future 
that could improve the in vivo predictability of purely interaction-based assays like 
PAMPA and ELISA, and to provide complementary real-time information for current 
traditional static cell-based assays, such as the Caco-2 and MDCK-II monolayers. 
Hence, the immediate goals of this work were to create a new and simplified protocol 
for preparing biomimetic air-stable SLBs for an easier large-scale industrial 
adaptation, and to optimize the immobilization protocols of living cells on the sensor 
surfaces. These biomimetic interfaces in combination with surface-sensitive 
techniques are anticipated to provide powerful platforms, which can measure 
biochemical and biophysical interactions in real-time and in conditions that take into 
account the dynamic processes present in biological systems, thus increasing the 
amount of information available through traditional cell-based assays. Additionally, 
fundamental non-labelled signal analysis was addressed in detail in order to correlate 
the effect of biochemical and biophysical phenomena on the optical signal. This was 
achieved by studying a traditional biochemical affinity interaction, developing an 
analysis approach for characterizing thin and thick organic layers, and by utilizing a 
new hybrid method combining the benefits of both non-labelled and labelled optical 
detection.  
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Figure 1 An illustration of the different barriers that are present and need to be taken into account 
during the drug development process. Some general methodology and especially label-free 
tools have been highlighted for the different steps. The process is not always linear but 
commonly involves repetition of previous stages, as indicated by the bidirectional arrows. The 
focus of this dissertation is in the two middle sections dealing with in vitro biochemical and 
biophysical interaction measurement tools. 
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2 REVIEW OF THE LITERATURE 
2.1 SURFACE SENSITIVE DETECTION METHODS 
There are several surface sensitive detection techniques, which are based on either a 
mechanical, optical or electrical detection of compounds. A common factor for these 
methods is that they detect compounds in contact with a surface or within a few 
hundreds of nanometers from the surface in a label-free manner. The different 
methods have of course their own strengths and weaknesses that are related to the 
physical principles of the method in question, and the practical limitations of the 
instrumentation arising from the physics, engineering and economical aspects. A few 
examples of the most commonly used methods have been summarized in Table1, and 
a short description of each method follow.  
The surface-sensitive label-free methods are in practice able to measure in real-
time. While for example a mass spectrometer, UV-VIS and other spectrophotometric 
technologies are in a broader sense label-free, they are what is called sampling 
techniques. This means that a sample of buffer, supernatant or something else needs 
to be removed from the system under study, before it can be detected. The practical 
maximum sampling frequency for these instruments is in the order of minutes, and 
more commonly hours or days. The real-time label-free methods have a sampling rate 
of seconds or less. In practice this means that the label-free technologies can achieve 
measurements of kinetic phenomena in a totally different magnitude than sampling 
methods. 
A significant difference between the predominant drug research methods and the 
label-free methods is that most of the label-free detection methods are flow-through 
systems instead of cuvette-based, as a well plate is also in principle a form of cuvette. 
This means that all traditional methods such as PAMPA, Caco-2 cell permeation and 
microscopy methods are performed under static or semi-static conditions. Flow-
through systems have two advantages over the well plates: A dynamic flow shear on 
the surface that mimics physiological conditions [16], and constantly maintained sink 
conditions even with extremely low sample concentrations. The sink condition is an 
important factor to consider when designing an assay, because if the concentration 
gradient in the experiments is not constant, then the kinetics of the experiment are 
affected and become non-linear as a function of time. In a flow system, the 
concentration is constantly “replenished”, and therefore sink conditions is ensured 
during the whole experiment. 
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2.1.1 MECHANICAL METHODS 
Quartz crystal microbalance (QCM) and atomic force microscopy (AFM) are 
mechanical methods that can be used for characterizing layers on the nanoscale. A 
unique and common feature for these higher-end mechanical methods is the ability 
to measure viscoelastic properties of thin films.  
 AFM is in practice purely an imaging tool, and in most cases it produces 
information about surface structure and thickness. While AFM is an effective imaging 
method for dry samples, it is still an extremely challenging method for measuring 
samples in a liquid environment [32,33,18]. In interfacial research, AFM is often used 
to probe the membrane morphology on a substrate [17], or certain binding events 
with large constituents such as nanoparticles or large macromolecules [34]. 
QCM utilizes AT-cut single-crystalline quartz sensors for measuring bound mass 
on surfaces through changes in the resonance frequency of the crystal [35]. When 
several overtones are simultaneously being measured, the thickness and viscoelastic 
properties can be modelled for nanoscale layers (by assuming the density of the 
sample) [36,37]. QCMs are also sometimes used as biosensor tools, but the need to 
use the whole quartz sensor without damping it makes the flow systems relatively 
large, and therefore limits the usefulness of the method for kinetic biosensor 
measurements. The literature is quite rare and shows a clear difference in 
information quality when comparing the use of QCM as a biosensor tool to the most 
commonly used methods, i.e. the optical biosensors [20,38,39]. The QCM has 
established itself as a fairly standard tool in SLB work where the capability of 
monitoring viscoelasticity enables an easy determination of the morphology of the 
deposited lipid layer (i.e. bilayer or vesicle) [40,41]. Consequently, the QCM is 
commonly used for SLB related biochemical or biophysical interactions research. A 
notable feature to highlight for the QCM again is its capability of probing 
viscoelasticity of adsorbed layers, which also enables to detect the effect of drugs on 
the membrane viscoelasticity during drug partitioning into the membrane [42]. 
2.1.2 ELECTROCHEMICAL METHODS 
Electrochemical biosensors usually utilize the measurement of a change in an 
electrical property, such as potential (potentiometric), current (amperometric), 
conductivity of a medium (conductometry) or impedance (impedimetric) for 
determining a binding property [29].  Electrochemical biosensors are the most 
common type of biosensors for a simple reason – there are several clinically relevant 
quick tests based on electrochemical detection, the most common probably being the 
blood glucose level test [28]. However, electrochemical sensors are based on catalytic 
electron creating reactions and on electron counting (current measuring). Therefore,  
they are generally not suitable for monitoring biochemical or biophysical 
interactions, because most of these interactions do not create any electrons. A more 
general electrochemical biosensing technique is impedance spectroscopy, which 
measures the ability of ions to move close to the electrode [29]. Basically, the more 
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resistive barrier the ions find, the lower the ion mobility. This can be used to detect 
biochemical interactions quite easily. However, due to the timescale and other 
practical issues such as electrode structure and subsequent flow cell geometry, the 
impedance spectroscopy is more useful in quantitative analysis than in kinetic 
characterization. Impedance sensors and electrodes are quite simple, and can even be 
prepared by printing them on paper [43]. This makes them more versatile than the 
mechanical or optical biosensor methods, as well as more viable candidates for 
consumer point-of-care applications even though not so lucrative as research tools. 
 
2.1.3 OPTICAL METHODS 
Most of the surface-sensitive label-free methods are based on an optical interfacial 
property called the evanescent field [22]. The evanescent field is a weak 
electromagnetic field that is created into a dielectric interface under total internal 
reflection conditions (i.e. the light incident angle is larger than the critical angle). For 
practical measurement purposes, this phenomenon needs to be enhanced with some 
other means, like multiple reflections (e.g. waveguides sensors used in optical 
waveguide lightmode spectroscopy (OWLS) and dual polarization interferometry 
(DPI)), or free electron excitation on a dielectric-metal interface (e.g. surface plasmon 
resonance, SPR). In principle, the evanescent field methods detect the optical density 
(i.e. refractive index, RI) or a change in it, inside the evanescent field, which extends 
approximately ½ a wavelength of the incident light to the measurement medium. The 
most typical applications of these are different molecule-molecule interactions, where 
the kinetics and binding affinity are determined [38,39]. Application areas which 
have hundreds of publications utilizing these evanescent field based methods are 
different biomolecule screens, such as antibody [44], nucleotide [45] and drug 
screens [46]. More advanced and interesting emerging applications involve the use of 
different SLB assays for screening drugs or other biochemical or biophysical 
interactions with both liposomes [47] and lipid bilayers [21]. Another new emerging 
application, that is highly relevant for drug screening, is the use of living cells in 
combination with the evanescent field based methods for developing different label-
free cell assays, for example for studying cell response to drug stimulus [48]. 
The ellipsometer is another common optical nanoscale detection method. An 
ellipsometer does not utilize the evanescent field but measures the change in the 
polarization of light when it is reflected from a surface. Due to its physical limitations, 
ellipsometry is still mostly used for characterizing thin films in air or vacuum. This, 
because the light beam is passing through the media above the sample, which means 
that if ellipsometer is to be used for measuring sample layers in liquid media, then 
the sampling fluidics need to be approximately 1 000 times larger than with the 
evanescent field methods (i.e. mL vs. μL) [23]. Ellipsometry is most commonly 
utilized in hard material science for the characterization of inorganic coating 
properties, but there are also some applications in the biochemical materials and 
biochemical and physical interactions field particularly when combined with other 
methods such as QCM [49,50]. 
Review of the literature 
22 
As all the optical detection principles is in practice based on a change in the 
refractive index, the molecules that resemble the medium (e.g. sugars that have a RI 
close to that of water-based buffers) will be difficult to detect with these methods. 
Fortunately, most biological compounds like proteins, lipids and nucleic acids have a 
relatively high RI (i.e. within a range of 1.4 – 1.5) and can effectively be detected with 
all the optical detection methods.  
This thesis provides a more in-depth discussion of the SPR method in the next 
chapter, because the SPR method has been the dominant method in most 
biochemical and biophysical interaction research in the past. It was also selected as 
the main detection method in this thesis because of the versatility offered by the 
physical principles and optical configuration utilized in the method.  
2.2 ANALYSIS OF THE SPR SIGNAL 
One of the most interesting label-free technologies is the SPR technology, because 
of its versatility which is enabled by the simple fundamental physics of the method 
[22,51,52].  Surface plasmons are particle waves of the free electron plasma on a 
metal surface, which can be excited by p-polarized light under the resonance 
condition. The resonance condition depends on the dielectric properties of the 
surrounding medium, and the electrical properties of the metal. This resonance 
condition can be described mathematically by Maxwell equations for a multilayer 
optical system [27]. A general answer for a multilayered system linked to measurable 
or controllable variables can be solved easily by modern computer-based calculative 
methods. The Maxwell equations and the matrix formalism needed for analysing 
multilayer systems has been described several times in literature in detail 
[27,54,51,55], and there are also dedicated software packages available for this [56], 
and is not discussed in further detail in this thesis. 
The physics behind the SPR phenomenon enable a wide range of applications 
from a biosensor of  molecular interactions  [38,39] to measurements of organic and 
inorganic thin films [27,53]. However, the SPR method as such has been mostly used 
as a pure biochemical interaction analysis method [38,39], and a highly unexploited 
area of SPR is its use in other pharmaceutical research areas, such as monitoring 
drug, protein or nanoparticle interactions with cell surfaces and cells. Unfortunately 
there are some gaps in the knowledge hoe the optical signal in SPR is affected by 
biophysical and biological phenomena. The actual reason for this is mostly 
instrumentation-related – the market leader in SPR instruments focuses completely 
on screening biomolecular interactions and on biosensor applications, and most of 
the instrumentation on the market is specialized only for  that purpose, which has 
limited the development of the method for other application areas [52].  
Because of this, there is a lack of both theoretical and empirical knowledge of SPR 
in nanoscale layer characterization, which needs to be addressed before new 
applications of the method can be adopted more widely. Therefore, the basic 
theoretical principles of the optical physics of SPR and biochemical interaction 
kinetics will shortly be introduced below. This also contains some discussions on how 
the SPR can be more effectively used as a thin film characterization tool, and how to 
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correlate the optical signal detected by SPR with the behaviour and responses of 
living cells immobilized on an SPR sensor during drug stimulus.  
2.2.1 MULTIVARIABLE SPR ANALYSIS 
When solving the SPR results for thickness (d) and real refractive index (n), it 
becomes clear that there is no unique answer for the resonance condition wave vector 
ksp when a sample do not absorb light (i.e. complex part of the refractive index k = 0). 
In such a case, only a continuum answer can be found where the n and d are non-
separable and proportional to each other: 
(1) ??? ? ? ? ?. 
This of course makes the determination of layer thickness from SPR data 
dependent on the quality of the literature value of the refractive index, and vice versa. 
This is problematic especially in the case of ultrathin films, as they do not always 
follow the properties of bulk materials [57]. Two different solutions to this issue have 
been proposed so far: A measurement of the layers in two different media with a large 
difference in their refractive indeses (such as air and water) [27], or a measurement 
with two different optical conditions (such as the use of two different light 
wavelengths with angle-scanning SPR) [58-60]. 
The two-media method is quite effective, giving a large difference between the two 
continuums and has the ability to determine the layer thickness from the SPR 
spectrawith high precision [27]. A significant limiting factor for this method is, 
however, that the sample needs to be stable in both media, and it should also not 
swell or collapse in either media.  
The two-wavelength approach does not suffer from the same draw-back as the 
two-media method. However, the difference between the continuum solutions is 
much smaller than with the two-media method, and the results of the analysis are 
less precise [58-60]. The two-wavelenght method also requires an additional 
parameter to be used, i.e. the wavelength dependency of the refractive index. While 
this parameter is relatively constant between similar materials [61], there is still some 
variation in it which can cause a systematic error in the analysis. 
It is apparent that neither method is still sufficiently robust to fulfill all 
characterization needs that arise with biological interfaces, because of instability (in 
dual media analysis) or lack of reference values (dual wavelength analysis). Thus, 
there is a need for more advanced analysis methods that could bypass these 
limitations when determining d and n of sample layers. 
2.2.2 SPR SIGNAL IN CELL-INTERACTIONS 
Label-free techniques have been adapted recently into studying cell-interactions with 
various compounds and surfaces. Several techniques have been proposed for this, 
among them different evanescent field detection methods  including SPR [48]. 
However, a common feature of the  evanescent field detection methods is that the 
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penetration depth of the evanescent field is approximately ½ of a wavelength of the 
incident light, meaning that it in most cases have a maximum penetration depth of 
250-500 nm. This is much less than the cell thickness, and the sensitivity in the 
evanescent field also decays exponentially when moving away from the sensor surface 
[52,55]. This means that the evanescent field only probes the bottom part of the cell. 
There have been some attempts to improve this with near infrared SPR [62,63], but 
the scanning depth with near infrared SPR is still much less than the common cell 
diameter. 
Based on the penetration depth of the evanescent field, it is clear that direct 
binding interactions that happen on the cell surface cannot be detected. The logical 
and commonly accepted paradigm is that the cell responds to the binding stimulus 
indirectly by shifting around its mass and organelles, which consequently affects the 
evanescent field. Thus, the detected signal from the binding event is an indirect signal 
from the cell’s response [48]. As SPR is a widely used method for detecting binding of 
a mass to a surface, it is commonly assumed that the behaviour of the SPR signal 
always displays similar trends as seen with general molecule-molecule interaction: a 
shift in SPR angle (or intensity at fixed angle) equals a binding. However, the cells do 
not necessarily move the mass towards the surface, which can also lead to a negative 
SPR signal change during cell stimulus [64]. Even more complicating is, that the 
basic SPR theory has been developed for systems that do not absorb light at the 
incident light wavelength and do not take into account that the cell organelles are in 
the size range that causes scattering of light. The light absorbtion will also affect the 
optical permeability of the sensor, and will therefore cause other changes in the 
optical signal. Upon closer inspection of the literature, it is clear that this 
phenomenon is poorly studied. Because of this, it has not been possible to properly 
explain the complex SPR signal behaviour with cells by traditional signal analysis of 
SPR or other evanescent field techniques. The unexplained non-linearity of the signal 
and a poor correlation between studies by different groups implicate that the effect of 
the behaviour of living cells on the signal detected by SPR is still poorly understood.  
Therefore, there is a need to improve the theoretical understanding of how cells 
influence the SPR signal. It is also apparent from the current literature that there are 
no well established protocols for cell culturing onto sensor surfaces and for retaining 
cell viability for the SPR based cell assays. Thus, there is a clear need for optimizing 
the measurements conditions and cell culturing protocols for successful SPR 
biosensing with living cells. 
2.2.3 LABEL ENHANCED SPR 
SPR and other label-free methods are commonly seen as very attractive biosensing 
techniques because they do not utilize labels for detection and can detect analytes by 
their inherent properties. However, this also means that there is no selectivity in the 
detection with label-free methods. For example, a change in salt concentration, 
addititional compounds or temperature will interfere with the detected signal. Hence, 
the more sensitive the method, the more sensitive it is to these environmental effects. 
Another drawback of label-free methods is the sensitivity of detection: Commonly 
fluorescence- and radioactive-labelled detections are several decades more sensitive 
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than a label-free detection [65,66]. However, achieving such a sensitive labelled 
detection usually needs long signal gathering periods (minutes or more), meaning 
that the measurements are always static and not able to characterize dynamic 
processes [67]. 
Due to these reasons, hybrid technologies that combine label-free and labelled 
detection have been proposed. SPR fluorescence is an interesting example as it uses 
the SPR evanescent field for exciting the fluorescent molecule and measures the 
emitted fluorescence by an external photodetector. The drawback of it is of course the 
need of additional equipment, and possibly also a quenching effect of the plasmonic 
metal surface [52,68]. Several different nanoparticle-based labelling technologies 
have also been proposed [69-71]. While nanoparticle-based labelling technologies 
improve the molecular sensitivity they actually affect the kinetics of the detection 
significantly as the label is several times larger than the analyte. The use of a labelled 
analyte that absorbs light at the SPR wavelength has also been proposed briefly 
[72,73]. However, this approach has never been largely adapted for use in biosensing 
applications. 
The use of labeled compounds in combination with SPR detection can 
complement the currently used SPR analysis approaches in some areas, such as 
detection of small molecular analytes. Therefore, this rhesis also introduces a new 
visible-light dye-labelling method for SPR technology which improves the detection 
sensitivity of SPR and avoids the drawbacks of the current technology when detecting 
small molecular compounds. 
2.2.4 PRINCIPLES OF KINETIC ANALYSIS 
2.2.4.1 One-to-one interactions 
The most simple biochemical interactions are single-site binding reactions, such as 
simple protein-protein or protein-drug interactions. They can mathematically be 
described by a simple one-to-one kinetic model (i.e. one analyte, one binding site).  
(2) ? ? ???
???
??
?????  ,   
where A and B are the two interacting components (i.e. immobilized ligand and 
analyte in solution), AB is the complex formed when they react and ka and kd are on- 
and off-kinetic constants, respectively.  
When this kinetic model is derived for a regular chemical equilibrium the affinity 
of the binding at the equilibrium position can be calculated from any kind of signal 
from any instrument. If affinity is measured, the equation is treated as a chemical 
equilibrium, and the equilibrium constant is calculated at the state of equilibrium 
binding. Similarly, if the expression is treated as a chemical kinetic rate constant 
equation, we can solve for the kinetic parameters with differential equation against 
time. These methods are well known, and the reader should refer to previous 
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literature for details [74,52]. It is important to notice that the affinity is by definition 
related to the kinetic parameters (kd/ka = KD), and several different kinetic constants 
can produce exactly the same affinity.  
In practical experimental considerations, it is extremely important to take into 
account the minimum data requirements for calculating the affinity – wrong type of 
data might seemingly enable a calculation of kinetics and/or affinity, but ctually have 
no unique solution and might instead give a large error related to the values produced 
by the analysis [75]. 
It should also be noticed that the kinetics of an interaction govern the timescale in 
which it can actually be accurately measured [75]. This can complicate the analysis, 
especially in the cases of slow off-rates as it can slow down the whole experimental 
process and lower the throughput of the assay. This is unfortunate, as a slow off-rate 
is normally desirable for a drug in order for it to give a good therapeutic response, 
whereas in the case of a non-target a slow off-rate is not deriable as it can cause 
unwanted side effects [76]. 
2.2.4.2 Complex interactions 
It is always advisable to fit a dataset with the simplest possible model that describes 
the data adequately and which is physically meaningful to the dataset. However, 
there are many practical cases where the simple one-to-one kinetic model is not 
correct, and a more complex kinetic model needs to be applied. Aside from some 
practical instrument-related kinetic models (diffusion- and depletion-corrected 
kinetics), there are various kinetic models that are relevant in different cases [74,77]. 
The two most notable models are the so called “bivalent” and “one-to-two” kinetic 
models [74]. The bivalent kinetic model has been developed to describe the situation 
where there is a second binding step or conformational change after the first binding 
event. A common example of such interactions is antibodies, which have two active 
binding sites. If the target sites in the antibodies are close enough, then both of these 
sites will bind sequentially. This kind of behaviour cannot be described by the one-to-
one kinetic model, but needs a different expression:  
(3) ? ? ???
?????
???
?????
?????
???
????? , 
where AB’ is the product of the second binding step.  
The one-to-two binding kinetic model describes a situation where there is one 
analyte but two binding sites on the target molecule or surface. For example, human 
serum albumin has multiple binding sites, and the drug warfarin binds to two of 
them. Also a heterogeneous immobilization of the target molecule on the surface, 
caused for example by an insufficient stability of the target, can lead to such 
situations. In this case, we have two independent binding reactions, which both 
create a signal in the assay. 
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(4) ? ? ???
?????
???
?????;  ? ? ???
?????
???
????? 
Even though these models have been created for specific situations, they also work 
surprisingly well with more complex cases. Interactions of proteins with materials 
can mostly be modelled with the one-to-two model. In a physical sense there are 
much more than two different binding sites, but usually the two strongest are so 
dominant that it is not possible to detect other binding events [78].  
2.3 BIOMIMETIC INTERFACES AND MEMBRANES 
2.3.1 CELL MODEL MEMBRANES 
Supported lipid bilayers (SLBs) and supported vesicular layers (SVLs) are surface-
anchored and/or supported membrane structures composed of phospholipids, such 
as phosphadityl cholines, sphingomyelins and other naturally occurring or synthetic 
lipids. While there are many different support strategies for the SLBs (and SVLs), 
only the methodologies that can be used with in situ label-free sensing techniques are 
considered here. The lipids are supported by a solid surface, and the support 
properties often influence the properties and morphology of the membrane structure 
(i.e. SLB or SVL). The SLBs are often classified based on the type of support structure 
used (i.e. polymer-supported, protein-tethered etc. SLBs [12]). However, in principle 
the support structure is only a mean to form the SLB, so for an end user studying 
biochemical or biophysical interactions of SLBs with e.g. proteins will not find this 
classification useful. SLBs can be either simple, single-component constructions 
(such as palmitoyl-oleyl phosphaditylcholine [40]), mixtures of several compounds 
(such as egg-extract phosphaditylcholines, charged phosphatidyserine and 
cholesterol [21]), or even complex membrane extracts with membrane receptors, 
proteins and polysaccharides [79].  
 
Figure 2 An artistic impression of the structure of a liposome (left) and a lipid bilayer (right). 
2.3.2 ESTABLISHED TECHNOLOGIES UTILIZING BIOMIMETIC MEMBRANES 
The most widely used applications of SLBs and SVLs are in the field of permeation 
screening in the early in vitro screening of drugs. The most important SLB-based 
standardized medium- or high-throughput screening methods that are widely used 
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are the PAMPA and immobilized artificial membranes (IAM) [15,1,80]. The golden 
standard methods still used for the intestinal permeation screening are cell culture 
methods [15,81]. Another interesting related method is the patch clamp, which is a 
kind of a hybrid between the cell and the SLB methods [82]. Label-free SPR 
biosensors with immobilized liposomes have also been introduced for drug 
permeation screening [83,84]. The methods have been summarized in Table2. 
PAMPA utilizes a filter-supported SLB or SVL (i.e. a membrane deposited from an 
organic solvent, which forms a mixed barrier of the SLB and the solvent in the filter). 
The sampling in PAMPA is performed from acceptor and donor compartments in a 
well plate for determining the relative drug concentrations. The PAMPA membrane is 
in general not well defined and the organic solvents involved reduce the biological 
relevance of the method. Despite of this, PAMPA can usually predict passive 
permeation of drugs in a relatively good fashion, and definitely better than the 
traditional octanol-water partition assay, especially for charged lipids. A new 
approach similar to PAMPA in terms of filter supported SLB has also been proposed 
for predicting passive permeation of drugs [80]. This new approach does not use 
organic solvent and forms a tighter barrier than PAMPA. This solvent free PAMPA 
has been shown to give higher predictive ability of drug permeability compared to 
both human and Caco-2 cell line for passively permeating drugs [80].  
The IAM method is basically a relative chromatography method, and functions 
exactly as any other chromatography methods. The permeation is assessed from a 
relative partition coefficient obtained from the retention time that the drug spends in 
the column. This means that the information is always relative to standard 
compounds used in the assay for calibration. The IAM performs well when used to 
predict the relative permeation of drugs of a homology series, but is not as useful if 
the sample set is structurally diverce [15,80]. 
The cell permeation assays also use a filter support, onto which the cells are 
cultivated as a tight monolayer. The cell methods for permeability studies are 
laborious and need much more equipment than the SLB methods, but they are also 
able to monitor the permeation of actively transported compounds and other 
transport-related interactions [15,1]. In the patch clamp method, a cell’s outer 
membrane is fixed to a glass capillary, creating a patch of the cell membrane which is 
then perturbated with the compounds of interest. Patch clamp has been shown to 
have an extremely high level of predictability for active transport and protein 
interactions, but it is a difficult method to perform in practice [82]. 
The traditional established methods are effective in providing information of the 
permeation and partitioning of drugs. However, they offer little information of the 
uptake mechanism of the drug, the effect of the drug on the cell membrane and of 
other biophysical interactions the drug has with the membrane. This is mostly due to 
the nature of the methods. They provide static information that is measured after the 
interaction event itself, and are unable to provide real-time information on the 
interactions, whereas the real-time biosensors can provide useful measurement 
methods which can provide complementary kinetic information to the traditional 
static methods for better understanding drug-cell surface interactions and their role 
on drug permeation and partitioning. 
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2.3.3 BIOCHEMICAL INTERACTIONS WITH LABEL-FREE DETECTION 
TECHNOLOGIES 
The most common application for label-free biosensing especially for proteins and 
drug molecules is the molecule-molecule interaction screening. The yearly reviews of 
optical biosensors show that these methods have established themselves as standard 
methods in this area. Every year there are thousands of publications made by 
utilizing the label-free biosensors [38,39]. As the methods are quite established, there 
are a lot of standardized protocols and assay formats available both from instrument 
manufacturers and the scientific community. Unfortunately, the interactions are not 
always that simple, and sometimes a successful experiment will need either non-
standard assays or a new surface chemistry design [26].  
 
2.3.4 SUPPORTED LIPID BILAYERS FOR LABEL-FREE BIOSENSORS 
2.3.4.1 Immobilized liposomes 
SVLs are often convenient in applications which clearly do not dependent on 
membrane morphology or lipid diffusion inside the lipid bilayer. The passive drug 
permeation through the lipid layer and some membrane receptor interactions are 
examples of such applications. It is typically simpler to keep the liposomal 
morphology than form bilayers, because the liposomes are thermodynamically quite 
stable and there are assay protocols and commercial sensor coatings that support the 
liposomes without allowing them to fuse into a bilayer. The usual anchorings for 
liposomes are either hydrophobic linker molecules in thick hydrogels, such as the 
commercial “Biacore L1” sensor, which is based on a 100 nm thick 
carboxymethyldextran (CMD) hydrogel with hydrophobic linkers [84], or specific 
linking systems such as avidin-biotin [12]. These are in general utilized with SPR 
detection technology, and during their use the lipid layer morphology is commonly 
disregarded.  
The use of such tethered SVLs with SPR is quite an effective way to screen 
receptor interactions similar to other one-to-one interactions [14]. This is a relatively 
usual way of screening interactions in the cases where the proteins in question are 
not stable when removed from the membrane environment. There are some 
challenges with these assays, mostly conserning the protein concentration in the 
vesicles which is often too low. There are also some practical issues in creating 
effective reference chemistries for these assays. One of the interesting applications of 
SVLs is detecting a molecule passing through pores through a lipid membrane, as 
demonstrated by Brändén et al. who studied the transport of sucrose through melitin 
pores [85]. As mentioned earlier, SVLs in combination with SPR can also be used to 
screen selections of drugs for their partitioning into a lipid membrane similar to the 
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PAMPA assay. This was demonstrated by Baird et al. using a large set of 
commercially available drug compounds [84].  
While the creation of SVLs for label-free biosensing purposes is quite well 
established, it is not easy to investigate or replicate the surface coating of commercial 
sensors and study its effect on the SVL formation due to the commercial nature of the 
sensors. The differences in the support chemistries used between various label-free 
technologies also indicate that a lot is still unknown about the SVL formation. 
Therefore, there is a need for clarifying the role of surface chemistry on the formation 
of SVLs and develop suitable chemistries for promoting the SVL formation in a 
reproducible manner. 
2.3.4.2 Planar lipid bilayers 
Planar solid supported lipid bilayers (SLBs) are in general more difficult to 
produce than SVLs. There are two main methods for producing SLBs: Self-assembly 
from liposome solution (i.e. vesicle spreading) or Langmuir-Blodgett deposition. The 
self-assembly method is more convenient in general, as the Langmuir-Blodgett 
technique is a quite time-consuming thin film fabrication technology. The current 
knowledge indicates that planar lipid bilayers are only formed when there are such 
interactions between the lipids and the surface that promote rupturing of liposomes, 
e.g. phosphocholine interaction with silicon dioxide surface in the presence of 
calcium [40], or incorporated biotin – avidin interactions [12]. Also, the self-
assembly is quite demanding in terms of other conditions, such as pH, ionic strength, 
temperature and the liposome stability [41]. In general, even small amounts of 
stabilizing components in the liposome will prevent the self-assembly into lipid 
bilayers altogether, which can lead to a situation that only whole liposomes will be 
adsorbed on the surface. 
The support structure under the SLBs also affects its usability for different 
interaction experiments. Extremely strong surface interactions between the support 
and the lipids will hinder the diffusion of the membrane components, and affect the 
interaction of the lipids with both the membrane incorporated functionalities and 
analytes in the surrounding liquid [12]. Similarly, insufficient space between the 
support and the SLB, such as with SiO2-supported SLBs can lead to an incorrect 
folding or denaturation of membrane proteins [12]. 
Another challenge for a more general utilization of planar SLBs is the instability of 
the membranes when passing through an air-water interface. There are a few recent 
examples of stable lipid bilayer systems that can resist the transition through an air-
water interface [86,87], but it seems that these methods are still extremely selective 
in terms of lipid composition and experimental conditions. 
As a result, there is a clear demand for new surface supports in order to improve 
the properties of biomimetic membranes. The ultimate goal would be to find a 
general support and a method for the preparation of SLBs containing incorporated 
and non-denaturated membrane proteins or even extracted cell membranes, which 
would also have at least a decent air-stability.   
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2.3.4.3 Controlling supported lipid layer morphology 
A morphology control of supported lipid layers between curved SVLs and planar 
SLBs might first seem unnecessary. There have, however, been some clear indications 
that some biochemical reactions between the SLB and analytes do not take place in 
the same way if the morphology of the lipid layer is not right [21,88]. Nanoparticle 
interactions with lipid layers probably also have some dependency on the lipid layer 
morphology, as the size of nanoparticles is often within the same size range as the 
size of liposomes. Nanoparticles are also affected by fluid dynamics in a greater 
extent than small molecules due to the much smaller diffusion coefficient of e.g. small 
drug molecules compared with nanoparticles. 
As discussed previously, the control of the morphology of supported lipid layers 
between SVLs and planar SLBs is actually a quite challenging task. In general the self-
assembly of a planar SLB is a rather sensitive process in terms of lipid composition, 
sensor coating, temperature and flow. Many protocols for preparing SLBs actually 
seem to be limited to a specific coating–lipid combination, such as the most common 
protocols of the use of phosphocholines to form planar SLBs on SiO2 surfaces [41] 
and use of polyethylene glycol to trigger vesicle fusion for liposomes containing non-
charged phosphatidylethanolamine lipids [79]. As one can imagine, the specificity of 
these reactions greatly limits the amount of possible lipid compositions to be used to 
form planar bilayers.  
One important factor to consider when discussing lipid layer morphology is the 
possibility to detect the formation of the lipid bilayer, and the capability to 
distinguish between a planar SLB and a SVL. The QCM technique is extremely 
sensitive for monitoring the SLB formation, as there is a large change in surface 
bound mass when a vesicle ruptures, consequently releasing the water inside the 
vesicle. A general conception has been that optical methods are not at all able to 
detect the rupturing of vesicles in a similar manner as the QCM technique. There is 
even a report by Keller et al. that claim that detecting vesicle rupture with optical 
techniques is impossible altogether [40]. While this article opened up nearly a whole 
new research field with SLBs utilizing the QCM-liposome self-assembly, the SPR 
work used as reference in the report is questionable as the measurement conditions 
and the surface are not identical. The QCM work was done with SiO2-coated sensors, 
while the SPR work most probably was performed with gold-coated sensors. It seems 
more likely that the inability not to see the self-assembly of a bilayer with SPR in the 
report by Keller et al. is more due to the instrument used and not to the SPR method 
itself.  
While fluorescence recovery after photobleaching (FRAP) and AFM are often used 
[89] for verifying SLB formation, they are ex situ methods and require that the sensor 
surface is removed from e.g. the QCM and SPR instrument and flow channels. This 
means that the lipid layer passes through an air-water interface during the transfer of 
the sensor surface between different characterization instruments. This is often 
problematic for the stability of the SVL or SLB on the sensor surface. Similarly, when 
performing the lipid layer deposition ex situ, then the conditions of the liposome self-
assembly are not comparable to conditions inside the QCM and SPR instrument and 
flow channels, especially in terms of flow which is known to be an important factor 
influencing the self assembly [19,16]. But, if we actually make an optical model of a 
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liposomal layer, and compare it with a similar model of a planar SLB, we can see that 
there is actually a clear difference which should be detectable in the SPR  if the 
instrument output is more flexible  than only a time-signal sensorgram [16].  
Especially when utilizing multiple-wavelength SPR it should be possible to provide a 
clear differentiation between SLB and SVL formation [53]. Furthermore, the 
utilization of the anomalous behaviour of the SPR signal when trapping compounds 
that absorb light inside the liposomes should provide an alternative mean for 
differentiating between SLB and SVL formation.   
 
Figure 3 An artistic impression of supported lipid bilayers on (A) a hard supporting surface, (B)  a thin 
hydrogel support and (C) a supported vehicular layer on a hydrogel support.  
2.3.5 CELL MONOLAYERS FOR LABEL-FREE BIOSENSORS 
It is of interest to use cell monolayers in surface-specific interaction experiments 
because the whole biological machinery of the cells is present and intact, which is not 
the case with SLBs. This makes it possible to monitor such cell processes with these 
cell assays which are dependent on the cell machinery. This is of course also possible 
with traditional well plate assays. However, by combining cells with label-free 
technologies gives access to a different timescale (i.e. from seconds to hours) and 
enable an integration of dynamic conditions. Some interesting studies have recently 
been reported where label-free biosensing is combined with cells, for example for 
monitoring cell toxicity of compounds [90], receptor mediated signaling [91] and 
endocytic vesicle formation [92]. 
Extremely interesting areas where the label-free cell assays can be applied are 
nanoparticle-cell interactions. The size of the nanoparticle makes it much more 
sensitive to the dynamic environment than small molecules or proteins, since the 
shear and diffusion affects the mass transfer of nanoparticles to a larger extent than 
small molecules or proteins. Also, the ability to monitor cell processes in the 
timescale not achievable in sampling-based experimental setups is a clear advantage, 
because this can provide biophysical information of such interactions and cell 
phenomena that is not easily achieved with other methods.  
Label-free biosensing with cells is a new and promising field, which is suffering 
from the lack of understanding of both signal transduction and measurements 
methodologies. The methods, however, show great promise in providing new 
information of interactions and biophysics of cells in a timescale that has not been 
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previously accessible. There is a clear need to improve the understanding of both 
signal transduction and the cell culture protocols for label-free biosensing in order to 
make these label-free assays more appealing for a wider user base.  
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3  AIMS OF THE STUDY 
The general aim of the research described in this thesis was to improve current- 
and develop new biomimetic platforms that could be utilized in future studies of 
biochemical and biophysical interactions between drugs, biomacromolecules and 
cells. 
 
The specific aims were: 
 to develop label-free biochemical detection assay surfaces for challenging 
analytes 
 to improve the label-free detection sensitivity and specificity through a hybrid 
labelled technology 
 to establish an analysis methodology based on multiple-wavelength SPR signal 
analysis for determining optical properties of both nanoscale and thick layers  
 to develop a platform for preparing biomimetic interfaces for real-time 
measurements of cell surface interactions 
 to establish a correlation between the SPR signal and the living cell response 
upon stimulus with drugs 
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4 I KINETICS OF PKC
ε
 ACTIVATING AND 
INHIBITING LLAMA SINGLE CHAIN 
ANTIBODIES AND THEIR EFFECT ON PKC
ε
 
TRANSLOCATION IN HELA CELLS 
Abstract 
 
Dysregulation of PKCε is involved in several serious diseases such as cancer, type II 
diabetes and Alzheimer's disease. Therefore, specific activators and inhibitors of 
PKCε hold promise as future therapeutics, in addition to being useful in research into 
PKCε regulated pathways. We have previously described llama single chain 
antibodies (VHHs) that specifically activate (A10, C1 and D1) or inhibit (E6 and G8) 
human recombinant PKCε. Here we report a thorough kinetic analysis of these 
VHHs. The inhibiting VHHs act as non-competitive inhibitors of PKCε activity, 
whereas the activating VHHs have several different modes of action, either increasing 
Vmax and/or decreasing Km values. We also show that the binding of the VHHs to 
PKCε is conformation-dependent, rendering the determination of affinities difficult. 
Apparent affinities are in the micromolar range based on surface plasmon resonance 
studies. Furthermore, the VHHs have no effect on the activity of rat PKCε nor can 
they bind the rat form of the protein in immunoprecipitation studies despite the 98% 
identity between the human and rat PKCε proteins. Finally, we show for the first time 
that the VHHs can influence PKCε function also in cells, since an activating VHH 
increases the rate of PKCε translocation in response to PMA in HeLa cells, whereas 
an inhibiting VHH slows down the translocation. These results give insight into the 
mechanisms of PKCε activity modulation and highlight the importance of protein 
conformation on VHH binding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Adapted from (License CC BY 3.0): Summanen M, Granqvist N, Tuominen R, 
Yliperttula M, Verrips C, Boonstra J, Blanchetot C, Ekokoski E (2012) Kinetics of 
PKCε activating and inhibiting llama single chain antibodies and their effect on PKCε 
translocation in HeLa cells. PLoS ONE 7 (4). doi:10.1371/journal.pone.0035630 
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4.1 INTRODUCTION 
Protein kinase C (PKC) is a family of serine/threonine kinases that regulate several 
signaling pathways in cells. The ten PKC isozymes have distinct biological functions 
and are divided into three groups based on cofactor requirements [1]. All of the PKC 
isozymes are regulated by phosphatidylserine (PS). In addition, conventional PKCs 
(α, βI, βII and γ) are activated by Ca2+and diacylglycerol (DAG), novel PKCs (δ, ε, η 
and θ) require only DAG for activation, and atypical PKCs (ζ and ι/λ) are insensitive 
to both DAG and Ca2+ [2]. Conventional and novel PKC isozymes translocate to the 
plasma membrane when DAG or its surrogate, phorbol 12-myristate 13-acetate 
(PMA), which is often used as a PKC activator in cellular assays, become available [3]. 
In addition to cofactor binding, PKC activity is also regulated by priming 
phosphorylations of three conserved phosphorylation motifs [1] and protein-protein 
interactions such as binding to receptors for activated C kinase (RACKs) [4]. 
PKCε plays essential roles in a variety of signaling systems including those 
regulating proliferation, differentiation, gene expression, metabolism, transport, and 
muscle contraction[5]. Therefore, it is not surprising that its dysregulation is 
implicated as a player in several serious diseases including cancer [6], [7], diabetes 
mellitus [8], [9] and Alzheimer's disease[10]. 
In cancer, PKCε is considered a transforming oncogene that can contribute to 
malignancy either by enhancing cell proliferation or by inhibiting cell death [6]. PKCε 
has been found to be overexpressed in tumor-derived cell lines and in tumor 
specimens from various organ sites, and is considered to be the PKC isozyme with the 
greatest oncogenic potential [11]. Furthermore,in vitro studies have shown that 
overexpression of PKCε increases proliferation, motility and invasion of fibroblasts or 
immortalized epithelial cell lines [7]. One of the mechanisms by which PKCε controls 
cell division is through its role in cytokinesis. PKCε associates with 14-3-3 scaffold 
proteins to regulate abscission, a process which requires PKCε kinase activity [12]. 
In type II diabetes, PKCε has been identified as one of the proteins involved in 
insulin resistance [13]. Activated PKCε reduces the insulin receptor (IR) gene 
promoter activation, decreasing the number of IR's on the cell surface, thereby 
leading to a decrease in insulin sensitivity [8]. The decrease in IR numbers on the cell 
surface is mediated by the transcription factor HMGA1, which is inhibited from 
binding to the IR promoter by a phosphorylation catalyzed by PKCε [8], [14]. 
In Alzheimer's disease (AD), PKCε activators, cyclopropanated fatty acid 
derivatives DCP-LA and DHA-CP6, have been found to reduce amyloid β levels by 
enhancing the degradation of amyloid precursor protein (APP) [15], whereas 
overexpression of APP in turn decreases the levels of both membrane-bound active 
PKCε and cytosolic inactive PKCε in three different cell lines [16]. Moreover, 
overexpression of constitutively active PKCε leads to increased secretion of the 
neuroprotective peptide sAPP, which is cleaved from APP by α-secretase [17]. 
Preliminary animal studies support the role of PKCε in Alzheimer's disease, since 
PKCε activation in a transgenic mouse strain containing familial AD mutations was 
found to prevent amyloid plaques, synaptic loss and cognitive deficits [18]. 
PKCε is considered a desirable drug target for the treatment of cancer, AD and 
diabetes among other diseases. However, since different PKC isozymes can have 
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different or even opposing roles in the same process [19], any therapeutic agents 
would have to be PKCε isozyme specific in order to have the desired therapeutic 
effect. The group of Dr. Mochly-Rosen has described the identification and 
characterization of a PKCε translocation inhibitor (εV1-2) [20]and a PKCε agonist 
peptide (ψεRACK) derived from the PKCε RACK [21]. Furthermore, they have shown 
that other peptides derived from the C2 domain of PKCε have the potential to act as 
PKCε agonists or antagonists [22]. 
We have previously reported the selection and screening of another class of PKCε 
specific activators and inhibitors, namely VHHs [23]. VHHs are the antigen binding 
regions of llama single chain antibodies that contain three complementary 
determining regions (CDRs) involved in antigen binding [24]. VHHs are highly 
soluble and stable, antigen-specific, and easy to produce [25]. They tend to have 
nanomolar affinities to their target antigens, and VHHs with affinities even in the 
picomolar range have been described [24]. Due to their unique structure, VHHs can 
also recognize conformational epitopes such as enzyme active sites that cannot be 
recognized by conventional antibodies. Furthermore, especially the long CRD3 loops 
of VHHs could serve as perfect leads for the design of new peptide drugs against 
various enzymes [25]. These advantages of VHHs compared to conventional 
antibodies, together with the positive data from the first clinical trials carried out 
with VHHs, indicate that VHHs are promising therapeutics, which will undoubtedly 
contribute to medicine in the future [26]. 
Here we report further details of the PKCε specific VHH activators (A10, C1 and 
D1) and inhibitors (E6 and G8) described previously [23]. Based on surface plasmon 
resonance (SPR) studies, the three activators and two inhibitors have affinities in the 
micromolar range. Furthermore, we show that the VHHs display species specificity 
since they do not bind the rat PKCε despite the 98% identity between the human and 
rat proteins. These VHHs were also tested in kinase activity assays to determine the 
Michaelis-Menten kinetics of activation or inhibition. Finally, we show that the VHHs 
have an effect on PKCε activity in a cellular context, since the activator A10 increases 
both the rate and degree of PKCε translocation in response to PMA stimulation in 
HeLa cells, whereas the inhibitor G8 slows down PKCε translocation. The results 
presented here give insight into the mechanisms of PKCε activation or inhibition by 
VHHs and highlight the conformation specific nature of the binding between these 
VHHs and their target protein. Moreover, the results demonstrate that these VHHs 
expressed inside HeLa cells as intrabodies have the ability to influence PKCε 
translocation, a step that is required for PKCε activation. 
4.2 RESULTS 
4.2.1 AFFINITY MEASUREMENTS USING SURFACE PLASMON RESONANCE 
We have already shown by immunoprecipitation (IP) and kinase activity assays that 
the VHH activators and inhibitors of PKCε bind the human PKCε protein [23]. In the 
present study we further characterized the VHHs by determining their affinities to 
PKCε. Therefore, affinity measurements with surface plasmon resonance (SPR) 
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technology were performed. First, we tried to determine the affinities using Biacore 
SPR technology (GE Healthcare, UK), which is commonly used to study the 
interactions of VHHs and their antigens [27]–[29]. A CM5 chip was coated with 
human recombinant PKCε using standard amino-coupling, and binding of VHHs to 
PKCε was studied in a Biacore T100 instrument. None of the tested VHHs bound to 
PKCε in this setup (data not shown). Next, each VHH was amino-coupled to the 
surface of a CM5 chip and the binding of PKCε to the flow cell surface was studied. 
This setup also failed, since PKCε bound to the surface of the reference flow cell as 
well as the VHH-coated flow cells (data not shown). These results were in strong 
contrast to the enzyme-linked immunosorbent assay (ELISA) and IP results 
described previously [23]. 
The Bionavis SPR Navi 200-equipment was then used to study binding affinities. 
When PKCε was amino-coupled to the surface of the flow cell, none of the VHHs 
showed binding to PKCε, as was the case with Biacore. However, when the dextran 
hydrogel was amine-functionalized using ethylene diamine and PKCε was carboxyl-
coupled to the surface of the flow cell, VHH binding to PKCε was detected (figures 
1 and 2). The VHHs were injected in serial dilutions with five different concentrations 
for every VHH. The middle concentration was injected twice and served as an 
internal control. The resulting data was analyzed with TraceDrawer 1.3 from 
Bionavis. 
The binding of VHHs A10, C1, D1 and E6 to PKCε was best fitted with second 
order Langmuir binding models based on the forms of the binding curves. Therefore, 
two association constants (ka values), two dissociation constants (kd values) and two 
affinities (KD values) were calculated for each of these VHHs. The most likely 
explanation for the second order models is that PKCε was present in two or more 
different conformations on the surface of the flow cell, and binding of the VHHs to 
two of these conformations, with the strongest interaction affinities to VHHs, could 
be detected. An alternative explanation is that the VHH samples contained two 
different proteins that bound PKCε, but this is highly unlikely since the purity of the 
VHH samples was always checked on a Coomassie stained protein gel and found to be 
over 95% (data not shown). The G8 data was fitted with a first order Langmuir 
model, resulting in single ka, kd and KD values for this VHH. 
Out of the activators (A10, C1 and D1), C1 had the highest affinities for PKCε 
coupled to the surface of the flow cell (figure 1B and table 1), namely 3.38 μM and 7.3 
μM. D1 had affinities of 44.2 μM and 7.91 μM (figure 1C and table 1) and ranked 
second in affinity among the PKCε activating VHHs. A10 had the lowest affinities of 
the three activators (25.4 μM and 104 μM;figure 1A and table 1). In kinase activity 
assays, C1 caused the greatest increase in PKCε activity, followed by D1 and A10 [23]. 
Since C1 had both the highest affinity of the three activators and led to the greatest 
increase in PKCε activity, followed by D1 and A10, the affinities measured here for the 
three activators support the results from kinase activity assays. 
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Figure 1  SPR sensograms and fits for PKCε activating VHHs. 
SPR sensograms and fits for second-order Langmuir binding models are shown for VHHs A10 
(A), C1 (B) and D1 (C). The VHH injection time was 3 min, followed by a dissociation time of 5 
min. The surface was regenerated with an injection of 10 mM NaOH for 3 min, followed by a 
stabilization time of 5 min between each VHH injection. Five concentrations of each VHH were 
used, with the middle concentration injected twice as an internal control. The VHH 
concentrations (in µg/ml) are marked adjacent to each fit on the right hand side of the figure. 
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Figure 2 SPR sensograms and fits for PKCε inhibiting VHHs. 
SPR sensograms and fits for a second-order Langmuir binding model of VHH E6 (A) and a 
first-order Langmuir binding model of VHH G8 (B). The VHH injection time was 3 min, followed 
by a dissociation time of 5 min. The surface was regenerated with an injection of 10 mM 
NaOH for 3 min, followed by a stabilization time of 5 min between each VHH injection. Five 
concentrations of each VHH were used, with the middle concentration injected twice as an 
internal control. The VHH concentrations (in µg/ml) are marked adjacent to each fit on the right 
hand side of the figure. 
Of the two inhibitors (E6 and G8), E6 (figure 2A) was a better binder of PKCε 
immobilized to the flow cell surface than G8 (figure 2B). The affinities of E6 to PKCε 
in this setup were 587 nM and 9.71 μM, whereas the KD value for G8 was calculated to 
be 102 μM (table 1). As was the case with the activators, the obtained affinity 
constants support the results from kinase activity assays, where E6 is a more potent 
inhibitor of PKCε than G8 [23]. 
Table 1. Association and dissociation constants for the interaction of VHHs with PKCε obtained 
from SPR measurements. 
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4.2.2 SPECIES SPECIFICITY OF PKC
ε
 ACTIVATING AND INHIBITING VHHS 
We have previously shown that VHHs A10, C1 and D1 increase human recombinant 
PKCε kinase activity, whereas VHHs E6 and G8 decrease kinase activity [23]. Rat 
brain extract is often used as an alternative source of PKC for experiments such as 
kinase activity assays, since it is known to contain many of the PKC isozymes, 
including PKCε [30], [31]. However, when kinase activity assays with the VHH 
activators and inhibitors of PKCε were performed using rat brain extract, no effect on 
kinase activity was seen (data not shown), even though based on Western blotting 
PKCε was present in the rat brain extract (figure 3A). The most likely explanation for 
this is that the VHHs do not bind the rat PKCε protein. 
 
Figure 3 PKCε in rat brain extract. 
(A) 15 µg of rat brain extract was separated on a SDS-PAGE gel. PKCε was detected with 
anti-PKCε and HRP-conjugated goat anti-mouse antibodies. (B) Immunoprecipitations were 
performed with rat brain extract using a commercial anti-PKCε antibody (IgG Ab) and VHHs. 
PKCε (marked with an arrowhead) is visible at 90 kDa on lane 1. The bands at 55 kDa and 25 
kDa on lane 1 represent the heavy and light chains of the anti-PKCε antibody. The bands at 
16 kDa for A10, C1, D1, E6 and G8 represent the VHHs. A sample of uncoated protein A 
sepharose beads was included as a negative control (lane 2 = ctrl) 
All of the VHHs that have been shown to have an effect on human PKCε kinase 
activity are able to immunoprecipitate human recombinant PKCε from Sf9 cell 
lysate [23]. To test whether the VHHs can also bind the rat PKCε protein despite the 
fact that they cannot influence its kinase activity, IPs were performed with rat brain 
extract. In addition, an IP with a commercial anti-PKCε antibody known to bind the 
rat form of the protein was included as a control. The five VHHs and the commercial 
anti-PKCε antibody were successfully captured by protein A beads (figure 3B). 
However, rat PKCε was only immunoprecipitated by the commercial anti-PKCε 
antibody and not by any of the VHHs. Therefore, the VHH activators and inhibitors 
of PKCε do not bind the rat PKCε protein, and hence cannot have an effect on its 
kinase activity. These results suggest that the VHHs are species-specific towards 
human PKCε, and confirm the very high specificity of the VHHs to human PKCε 
versus other PKC isozymes, an issue which could be a concern with peptide and other 
small molecule activators or inhibitors. 
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4.2.3 KINETIC MEASUREMENTS OF PKC
ε
 ACTIVATION AND INHIBITION 
To characterize the kinetics of PKCε activation or inhibition by VHHs, kinase activity 
assays were performed with varying concentrations of the substrate peptide. The 
VHH concentration was kept constant (1 μg/well) for each experiment. When 
substrate concentrations are varied, the resulting data can be used to calculate the 
Michaelis-Menten kinetics of the activation or inhibition. 
Results from the PKCε kinase activity assay with PKCε activators PS and 1,2-
dioctanoyl-sn-glycerol (DOG; a DAG analogue) show that the three VHHs that act as 
PKCε activators have different mechanisms of activation (figure 4A and table 2). 
VHH A10 leads to increased PKCε activation by almost doubling the Vmax value, or 
the maximum rate achieved by the system (141 nmol/min/mg for control and 253 
nmol/min/mg for A10), whereas it has almost no effect on the Km value of the 
reaction (figure 4A). In contrast, VHHs C1 and D1 have a much smaller effect on the 
Vmax, but they decrease the Km value of the system from 424 μM for the control, to 81 
μM for C1 and 126 μM for D1. A lower Km value indicates that the reaction is faster 
relative to the Vmax, so C1 and D1 seem to increase the speed of the reaction instead of 
the maximum rate of the reaction. Since the Km value is influenced both by the 
affinity of the enzyme to the substrate and the rate at which the substrate bound to 
the enzyme is converted to the product, the lower Km value measured with VHHs C1 
and D1 could indicate either an increase in the affinity or the rate at which the 
substrate is converted to the product. 
 
Figure 4 Kinetics of PKCε activation by VHHs A10, C1 and D1. 
The kinase activity of full-length PKCε in the presence (A) and absence (B) of PKC activators 
DOG and PS was measured with varying MARCKS substrate concentrations. The VHH 
concentration was constant (1 µg/well) for each experiment. The data is presented as 
percentage maximal control activity (control activity with 1000 µM substrate) ± SEM and 
represents at least 3 independent experiments, each with duplicates. Note that the 
Vmax values for the VHHs have not been reached yet, see table 2 for analysis. 
The results for the activators were similar for the kinase activity assay that was 
performed with full-length PKCε without activators PS and DOG (figure 4B). Since 
VHHs A10, C1 and D1 have no effect or a very small effect on the activity of the 
catalytic domain alone [23], the Michaelis-Menten kinetics of the activators on the 
catalytic domain were not determined. 
Based on the Michaelis-Menten constants obtained for the two PKCε inhibiting 
VHHs E6 and G8, VHH E6 is a more efficient inhibitor of PKCε than G8 is. In the 
assay using the full-length PKCε protein with the activators DOG and PS present 
I Kinetics of PKCε Activating and Inhibiting Llama Single Chain Antibodies and Their Effect on PKCε 
Translocation in HeLa Cells 
50 
(figure 5A and table 2), E6 decreases the Vmax from 141 nmol/min/mg (control) to 29 
nmol/min/mg, whereas G8 leads to a more moderate decrease (Vmax of 113 
nmol/min/mg). 
When the PKCε activators DOG and PS are not included in the assay (figure 5B), 
the difference between E6 and G8 is less and even G8 decreases the Vmax by almost 
half. When the catalytic domain of PKCε is used instead of the full-length protein 
(figure 5C), the inhibition of kinase activity by E6 is so great that the Km value cannot 
be reliably measured. In this case, E6 decreases the Vmax from 120 nmol/min/mg to 
6.7 nmol/min/mg. G8 is also a more potent inhibitor of the catalytic domain than the 
full-length protein, since it decreases the Vmax of the reaction almost 3-fold. 
 
Figure 5 Kinetics of PKCε inhibition by VHHs E6 and G8. 
(A–B) The kinase activity of full-length PKCε in the presence (A) and absence (B) of PKC 
activators DOG and PS was measured with varying MARCKS substrate concentrations. (C) 
The kinase activity of the catalytic domain of PKCε was measured with varying MARCKS 
substrate concentrations. The VHH concentration was constant (1 µg/well) for each 
experiment. The data is presented as percentage maximal control activity (control activity with 
1000 µM substrate) ± SEM and represents at least 3 independent experiments, each with 
duplicates. The catalytic domain activity (C) with G8 is an exception with only 2 independent 
experiments with duplicates. 
Figure 6 Km and Vmax values for PKCε activating and inhibiting VHHs. 
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4.2.4 ANALYSIS OF PKC
ε
 INHIBITION BY VHHS E6 AND G8 
The mechanism of PKCε inhibition by VHHs E6 and G8 was studied with kinase 
activity assays with varying substrate and VHH concentrations. We have previously 
shown that the binding site of both E6 and G8 is in the catalytic domain of PKCε [23]. 
Therefore, Sf9 lysate expressing the catalytic domain of PKCε was used for these 
assays. 
The data from these assays was analyzed using non-linear regression models but 
is represented as a Lineweaver-Burk plot to allow for easy visualization of the Km and 
Vmaxvalues. As can be seen from figure 6, with both VHHs the Km of the reaction 
remains about the same when the VHH concentration increases. However, the 
Vmax decreases as the VHH E6 or G8 concentration increases. In the controls without 
VHH, the Vmax is 46.7 nmol/min/mg, whereas at the highest VHH concentrations 
used in this experiment, the Vmax is only 17.0 nmol/min/mg for E6 (figure 6A) and 
15.9 nmol/min/mg for G8 (figure 6B). 
According to the Michaelis-Menten kinetics, when the apparent Km remains about 
the same but the Vmax decreases with increasing inhibitor concentrations, the 
inhibition is non-competitive [32]. Therefore, E6 and G8 appear to be non-
competitive inhibitors of PKCε that do not compete with the substrate peptide 
MARCKS for binding to PKCε. 
 
Figure 7 E6 and G8 are non-competitive inhibitors of PKCε. 
The activity of the catalytic domain of PKCε was measured with varying MARCKS substrate 
concentrations and varying concentrations of VHHs E6 (A) and G8 (B). The data was 
analyzed using non-linear regression and the Michaelis-Menten kinetics model and represents 
3 independent experiments, each with duplicates. The data is presented as a Lineweaver-
Burk plot to allow for the easy visualization of Km and Vmax values. 
 
4.2.5 EFFECT OF ACTIVATOR A10 AND INHIBITOR G8 ON PKC
ε
 
TRANSLOCATION 
PKCε is known to translocate to the cell membrane in response to PMA 
stimulation [3], [33]. In order to study whether the VHHs have an effect on the 
translocation of PKCε, one of the activating VHHs (A10) and one of the inhibiting 
VHHs (G8) were cloned to a mammalian expression vector and a C-terminal 
mCherry-tag was introduced to the sequence. HeLa cells were then double-
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transfected with PKCε-EGFP and the A10-mCherry or G8-mCherry plasmids, or an 
mCherry control plasmid. Translocation studies were performed with a confocal 
microscope 24 hours after transfections by stimulating cells with 100 nM PMA and 
monitoring the cellular localization of PKCε-EGFP and mCherry constructs for 30 
minutes. 
In cells transfected with the mCherry control plasmid, about 70% of PKCε-EGFP 
remained in the cytoplasm 10 minutes after PMA stimulation (figure 7A and D). 
Strikingly, in cells transfected with the PKCε activator A10-mCherry, only 50% of 
PKCε-EGFP was still present in the cytoplasm at this time point (figure 7B and D). In 
contrast, in cells transfected with the PKCε inhibitor G8-mCherry, 90% of PKCε-
EGFP was still present in the cytoplasm of the cells 10 minutes after PMA stimulation 
(figure 7C–D). 
After 20 minutes, about 55% of PKCε-EGFP was present in the cytoplasm in 
mCherry transfected control cells. The amount of green fluorescence remained 
constant in the cytoplasm after this time point (figure 7A and D). In cells transfected 
with A10-mCherry, only about 40% of PKCε-EGFP was present in the cytoplasm 20 
minutes after PMA stimulation. As was the case with the mCherry control transfected 
cells, the amount of fluorescence in the cytoplasm remained at the same level from 20 
to 30 minutes in A10-mCherry transfected cells (figure 7B and D). In cells transfected 
with G8-mCherry, 70% of PKCε-EGFP remained in the cytoplasm of the cells at 20 
minutes after PMA stimulation. In these cells, more PKCε-EGFP translocated to the 
membranes during the last 10 minutes of the experiments, since at the end of 30 
minutes around 55% of PKCε-EGFP remained in the cytoplasm of G8-mCherry 
transfected cells (figure 7C–D). Even though a clear difference in translocation speed 
could be seen between mCherry transfected control cells and cells transfected with 
the PKCε inhibitor G8-mCherry, this difference did not reach statistical significance 
at any of the time points. The difference in PKCε-EGFP translocation between control 
cells transfected with mCherry and A10-mCherry transfected cells reached statistical 
significance at 20 and 30 minutes after PMA stimulation. Therefore, the PKCε 
activator A10 increases both the rate and the extent of PMA-induced PKCε 
translocation in HeLa cells, whereas the inhibitor G8 slows down the rate of PKCε 
translocation from the cytoplasm to the membranes. 
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Figure 8 Activator A10 increases and inhibitor G8 decreases the rate of PMA-induced PKCε-
EGFP translocation in HeLa cells. 
(A–C) Representative images of HeLa cells transfected with PKCε-EGFP and mCherry (A), 
A10-mCherry (B) or G8-mCherry (C) taken with a confocal microscope at 1, 10, 20 and 30 
minutes after adding 100 nM PMA. (D) Quantification of PKCε-EGFP translocation from the 
cytoplasm over time. Data is presented as percentage relative fluorescence in the cytoplasm 
of cells ± SEM from at least 2 independent experiments with 4–6 cells per experiment 
(mCherry n = 4, A10-mCherry n = 3, G8-mCherry n = 2). The difference between cells 
transfected with the mCherry control plasmid and cells transfected with A10-mCherry was 
statistically significant (p<0.05) at 20 and 30 minutes (denoted with *). 
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4.3 DISCUSSION 
VHH antibodies generally have affinities comparable to those of conventional 
antibody fragments, with KD values in the nanomolar range [25], and VHHs with 
affinity constants as low as 100 pM have been described [24]. The high affinities 
displayed by most VHHs are one of the main advantages of VHH antibodies in 
research and drug development. However, here we report affinity constants for PKCε 
activating and inhibiting VHHs ranging from 587 nM to 104 μM. 
One reason for the relatively low affinities described here could be the fact that 
only one round of VHH selections was carried out to obtain PKCε binders [23]. 
However, selections were done from an immune VHH library and usually antigen 
affinities of VHHs from immunized libraries are 10–100 times better than the 
affinities of VHHs isolated from naïve or synthetic libraries [25]. 
Another factor that probably contributes to the relatively low KD values is the fact 
that these VHHs can only bind the native form of PKCε. The VHHs can bind human 
PKCε in immunoprecipitations and kinase activity assays, but not in Western blots 
where the PKCε protein has been denatured [23]. Furthermore, the VHHs tested here 
show relatively weak binding in VHH ELISAs (Summanen et al., unpublished 
results), where PKCε has been coated on the wells of 96-well plates. 
Assays such as ELISA and SPR, where the antigen has to be immobilized on a 
surface in order to measure an interaction, can be problematic when conformation 
dependent interactions are studied [34]. When the protein is immobilized using 
functional groups such as −NH2 or −COOH groups, the protein molecules are 
randomly oriented on the surface [35]. Therefore, only some of the protein molecules 
will be present in an orientation that can be recognized by the interaction partner, in 
this case the VHHs. Furthermore, when the interaction between randomly 
immobilized protein and the surface is too strong, there is a possibility of protein 
denaturation [35]. 
Since the affinities of the five VHHs studied here could not be measured at all with 
Biacore or Bionavis SPR when PKCε was amino-coupled to the chip, it is clear that 
the orientation of PKCε in the chip is crucial for measuring binding. Binding was 
observed when PKCε was carboxyl-coupled instead, but also in this case only some of 
the coated PKCε molecules would have been in the correct orientation and 
conformation. The critical role of protein orientation in SPR measurements is 
emphasized by the finding that oriented immobilization of an antibody increased its 
immunobinding efficacy approximately two-fold compared to standard amino-
coupling [36]. Therefore, the best option would have been to immobilize PKCε to the 
flow cell in a controlled orientation via for example a His-tag [35], [37], but due to 
technical restrictions we were not able to perform such measurements. 
As the interaction between the VHHs and PKCε seems to be conformation 
dependent, the affinity constants measured here are not likely to be the absolute 
affinities of these VHHs to PKCε in the solution phase. The reported KD values should 
therefore not be compared to the affinities reported for VHH antibodies elsewhere. 
However, the obtained affinity constants can be used for internal comparison to 
determine which PKCε binders display the strongest interaction to PKCε. The 
scientific value of the KD's reported here is evident from the fact that the affinities do 
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support the data obtained from other experimental setups. Particularly, VHH C1, the 
strongest activator of PKCε, also has the strongest affinity for PKCε among the three 
activating VHHs. Furthermore, E6, which is a more potent inhibitor of PKCε kinase 
activity than G8, also has a higher affinity for PKCε than G8. 
We also showed that in addition to the VHHs being conformation dependent, they 
seem to be species-specific as well. While all five VHHs bind human PKCε and either 
increase or decrease its kinase activity, they have no effect on the kinase activity of rat 
PKCε, nor did they bind it in an IP. Both human and rat (Rattus norwegicus) PKCε 
proteins are 737 amino acids in length, and identical for 726 of these amino acids 
(98%). Within the catalytic domain, where all of the VHHs described here bind to, the 
human and rat proteins differ in only eight amino acids. One would expect PKCε 
specific antibodies to bind to both proteins since the differences between them are so 
small. However, as reported here, the VHHs do not bind rat PKCε, which again 
demonstrates how subtle differences in amino acid composition or protein 
conformation play a critical role in the binding of these PKCε activating and 
inhibiting VHHs. Further mapping of the VHH binding site will show if the observed 
species specificity is due to a specific amino acid substitution or a small 
conformational difference between the human and rat proteins. 
The kinetics of the PKCε activation and inhibition were also studied in more 
detail. We show here that the three activators A10, C1 and D1 increase PKCε activity 
in different ways. A10 nearly doubles the maximum rate of the reaction, whereas C1 
and D1 have almost no effect on the Vmax but increase the speed of the reaction 
relative to the Vmax, as is evident from the smaller Km values reported for these VHHs. 
These results were similar with and without the PKC activators DOG and PS present 
in the assay. We know from previous studies [23] that all of the activating VHHs bind 
the catalytic domain of PKCε. Since the VHHs can increase PKCε kinase activity in 
an in vitro assay without any additional proteins present, it seems likely that the 
VHH binding somehow stabilizes the active conformation of PKCε. In order to 
determine the method of PKCε activation for each VHH, the exact binding sites for 
each VHH must be studied. 
There are also differences between the two PKCε inhibiting VHHs E6 and G8. 
Based on the kinase activity assay results reported here, E6 is a more potent inhibitor 
of PKCε, since it leads to a larger decrease in the maximum rate of the reaction. With 
full-length PKCε, the Vmaxis only around 20% of the control with E6, whereas G8 has 
a much smaller effect on full-length PKCε activity. When the catalytic domain is used 
instead of the full-length protein, G8 also displays a larger degree of inhibition. This 
supports previous results [23], where G8 was found to be a better inhibitor of the 
catalytic domain alone than the full-length protein, possibly because in the full-length 
protein, the G8 binding site could be partially concealed. 
According to Michaelis-Menten kinetics, both E6 and G8 are non-competitive 
inhibitors of PKCε, since increasing VHH concentrations had no effect on the 
apparent Km of the system but demonstrated clear decreases in Vmax. Therefore, we 
can rule out the substrate-binding site from the possible binding sites of E6 and G8 
within the catalytic domain of PKCε. However, as is the case with the activating 
VHHs, there are several possible mechanisms by which E6 and G8 can have an effect 
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on PKCε kinase activity. A more detailed explanation of PKCε inhibition warrants a 
study into the exact binding sites of E6 and G8 in the catalytic domain of PKCε. 
Remarkably, we also demonstrated for the first time that the PKCε activating and 
inhibiting VHHs can influence PKCε activity when expressed inside HeLa cells. Upon 
PMA stimulation, PKCε translocates from the cytoplasm to the plasma membrane, as 
was shown with EGFP-tagged PKCε in HeLa cells. The activating VHH A10 expressed 
inside HeLa cells with a C-terminal mCherry-tag increased both the rate and the 
degree of PKCε translocation compared to the control. On the other hand, the 
inhibiting VHH G8 decreased the rate of PKCε translocation in response to PMA. 
Since PKCε translocation is required for activation, we can conclude that the VHHs 
can influence PKCε activity also in a cellular context. These results highlight the 
potential of activity modulating VHHs in PKCε research and drug development. 
Furthermore, the observed cellular effects suggest that the affinities of the VHHs to 
PKCε are in fact better than the micromolar affinities obtained from SPR 
experiments. Inside cells, both PKCε and the VHHs will be properly folded, allowing 
the VHHs to bind to their conformational epitopes on PKCε surface. 
The results described here provide important additional information about the 
VHH activators and inhibitors of PKCε. In addition to the peptide-based PKCε 
agonists and translocation antagonists [20], [21], these VHHs are the only strictly 
PKCε isozyme specific activators and inhibitors described so far. Since the different 
PKC isozymes can have overlapping and sometimes even opposing roles in many 
biological processes, such isozyme specific compounds that influence kinase activity 
are crucial in studying the role of PKCε in various contexts. Furthermore, PKCε 
specific VHHs could in the future be developed into therapeutics against diseases 
such as cancer or type II diabetes, or the CDR regions of VHHs could be used to 
design novel peptide-based therapies against these life-threatening diseases. 
4.4 MATERIALS AND METHODS 
4.4.1 MATERIALS 
Mercaptoundecanol, epichlorohydrin, dextran (500 kDa from Leuconostoc spp.), 
bromoacetic adid, N-ethyl-N′-(dimethylaminopropyl) carbodiimide (EDC), N-
hydroxysuccinimide (NHS), phosphate buffered saline (PBS) tablets, and 
ethanoldiamine were all obtained from Sigma Aldrich (St. Louis, MO). Gold-coated 
SPR sensor slides were obtained from BioNavis Ltd (Tampere, Finland). 
4.4.2 PRODUCTION AND PURIFICATION OF VHHS 
Monoclonal VHH antibodies were produced and purified as previously 
described [23]. Briefly, VHH production in E. coli JM109-strain was induced by the 
addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) overnight at 30°C. 
Periplasmic fractions were prepared by freezing the bacterial cell pellets for 1 h at 
−80°C to break the outer membrane of E. coli and resuspending cells in 10 ml of 
phosphate buffered saline (PBS), followed by mixing for 2 h at 4°C. VHHs were 
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purified from the periplasmic fraction using the his-tag and Talon Metal Affinity 
Resin (Clontech, CA) and eluted with 300 mM imidazole. Eluted VHHs were dialysed 
against PBS overnight at 4°C and stored at −20°C until used. 
4.4.3 EXPRESSION OF PKC
ε
 IN SF9 CELLS 
Human full-length PKCε and its catalytic domain (amino acids 298–737) were 
produced in Sf9 cells using the baculovirus expression system (Bac-to-Bac, 
Invitrogen, Carlsbad, CA). The cloning of PKCε constructs and baculovirus stock 
production has been described before [23]. For expression of recombinant PKCε, Sf9 
cells were infected with an optimized amount of baculovirus stock and grown for 48 h 
at 27°C in suspension. The collected cells were washed with PBS and frozen until 
used. Crude cell lysates were prepared by resuspending cells in lysis buffer containing 
25 mM Tris-HCl, pH 7.5, 0.5 mM EGTA and 0.1% Triton X-100, supplemented with a 
protease inhibitor cocktail (Complete, Roche, Basel, Switzerland) and centrifuging for 
15 min at 4°C at 16.200 g. Protein concentrations of the supernatants were 
determined by Bradford assay (Sigma-Aldrich, St. Louis, MO) and used for kinase 
activity assays as described below. 
4.4.4 SURFACE PLASMON RESONANCE 
The affinity measurements were performed with BioNavis SPR Navi 200 
(BioNavis Ltd, Tampere, Finland). Carboxymethylated dextran hydrogel for ligand 
immobilization was self-synthesized according to the BioNavis protocol. First a self-
assembled monolayer of mercaptoundecanol was formed on clean gold-coated SPR 
sensor slides in an overnight reaction in ethanol and rinsed thoroughly. The sensor 
was then left to react for 3 h with epichlorohydrin (2% v/v) in 0.1 M NaOH, 
whereafter it was rinsed with Milli-Q H2O, transferred to 30 g/l solution of dextran in 
0.1 M NaOH and left to react for 24 h. After washing thoroughly with Milli-Q H2O the 
sensor was immersed in 0.5 M bromoacetic acid in 2 M NaOH for 24 h. After this 
reaction the sensor was thoroughly washed with Milli-Q H2O and stored at +8°C until 
used in protein immobilization reaction. 
Protein immobilization to the hydrogel was performed with reverse activated ester 
synthesis according to the BioNavis protocol. In brief, the immobilization was 
performed in situ in the instrument using Sigma's PBS (0.01 M phosphate buffer, 2.7 
mM KCl and 137 mM NaCl, pH 7.4) as background and injection buffer. A flow rate of 
20 μl/min and an injection time of 8 min was used for all injections. Reference 
surface was created in flow channel 2 in parallel with the protein immobilization. The 
channel was treated in exactly the same manner as the sample channel, except that 
instead of PKCε protein blank PBS was injected. 
The flow cell surface was cleaned with an injection of a solution containing 2 M 
NaCl and 10 mM NaOH. Activation of the surface was performed by an injection of a 
solution consisting of 200 mM EDC and 50 mM NHS. Ethylene diamine (10 mg/ml) 
was injected in order to amine-functionalize the dextran hydrogel. PKCε was diluted 
to 10,5 μg/ml with the EDC/NHS activation solution, mixed well and immediately 
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injected to the instrument. Protein immobilization of approximately 80 pg/mm2 was 
observed. 
The experiments were performed in HBS (Hepes buffered saline; 20 mM Hepes, 
pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.001% Tween-20) measurement buffer, with a 
temperature of 21°C and a flow rate of 20 μl/min with 8 min injection times. Serial 
dilutions of the VHHs (A10 and C1: 5 μg/ml to 80 μg/ml; D1 and E6: 6.25 μg/ml to 
100 μg/ml; G8: 12.5 μg/ml to 200 μg/ml) were injected, as is required for kinetic 
analysis of molecular interactions [38]. NaOH (10 mM) was found to be an effective 
regeneration agent for the system, and was used as regeneration solution between 
each consecutive injection. 
4.4.5 RAT BRAIN EXTRACT PREPARATION 
Two rats were asphyxiated with CO2 gas and then decapitated. The skulls were cut 
open and the brain tissue was scraped into ice cold PBS. The brain tissue was then 
homogenized with Dounce tissue homogenizer in buffer containing 10 mM HEPES 
pH 7.5 and 2 mM EDTA. The homogenized tissue was centrifuged at 1000 g for 10 
min at 4°C. The resulting supernatant was centrifuged further for 1 h at 40 000 g at 
4°C. The extract was then poured into an ion exchange column containing 
diethylaminoethyl cellulose (DEAE) in column equalization buffer (10 mM HEPES 
pH 7.5, 2 mM EGTA and 2 mM EDTA). The column containing the extract was 
extensively washed with column equalization buffer and the remaining bound 
proteins were subsequently eluted with buffer containing 10 mM HEPES pH 7.5, 2 
mM EGTA, 2 mM EDTA, 200 mM NaCl, and 10 mM β-mercaptoethanol. The eluted 
protein fractions were combined and the protein content was determined. The brain 
extract was stored at −20°C after addition of 50% glycerol (final concentration). 
4.4.6 WESTERN BLOTS 
To confirm the presence of PKCε in rat brain extract, 15 μg of protein from rat 
brain extract was separated by SDS-PAGE gels and blotted onto a PVDF-membrane. 
The blot was probed with 1:1000 dilution of mouse anti-PKCε antibody (BD 
Biosciences, NJ), followed by a 1:4000 dilution of HRP-conjugated goat anti-mouse 
antibody (Santa Cruz Biotechnology, CA). 
4.4.7 IMMUNOPRECIPITATIONS OF PKC
ε
 FROM RAT BRAIN EXTRACT 
Immunoprecipitations (IPs) were done to check whether the VHHs can bind the 
rat PKCε protein. IPs were started by incubating 30 μl of Protein A sepharose CL-4B 
beads (GE Healthcare, United Kingdom) washed once with immunoprecipitation 
buffer (IPB; 25 mM Tris-HCl pH 7.5, 0.1% Triton X-100) with 3 μg of VHH in 1 ml of 
IPB for 1 h at 4°C with continuous shaking. Simultaneously, a sample of protein A 
sepharose was also coated with 1 μg of commercial PKCε antibody (BD Biosciences, 
NJ) in 1 ml IPB and was used as a positive control. The antibody-coated protein A 
beads were blocked with 1% BSA in IPB for 15 min at 4°C and washed once with IPB. 
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Rat brain extract (200 μg/sample) was added to the beads and incubated overnight 
with continuous shaking at 4°C. The beads were washed 4 times with IPB and 
resuspended in 15 μl of 2× Laemmli sample buffer. Samples were loaded onto 15% 
SDS-PAGE gels for separation of proteins, electrotransferred to PDVF membranes 
and the membranes were then incubated with anti-PKCε (BD Biosciences, NJ) or 
anti-tetra His (Qiagen, Venlo, the Netherlands) antibodies followed by HRP-
conjugated anti-mouse antibodies (Santa Cruz Biotechnology, CA). 
4.4.8 KINASE ACTIVITY ASSAYS 
Kinase activity assays were carried out as described before [23]. Briefly, kinase 
activity was determined by measuring the incorporation of [γ-32P] into a PKC 
substrate peptide MARCKS (FKKSFKL). For determining Km and Vmax values, 5 μg of 
protein from Sf9 cell lysate expressing full-length PKCε or PKCε catalytic domain was 
pre-incubated with 1 μg of VHH and the substrate (0 μM–1000 μM) in a total volume 
of 25 μl for 10 min at 30°C in a 96-well plate. Reaction mix (75 μl/well) was added, 
yielding final concentrations of 10 mM HEPES pH 7.5, 7 mM MgCl2, 0.25 mM EGTA, 
100 μM cold ATP and 0.3 μM [γ-32P]ATP. Activity of the full-length PKCε was 
measured with and without PKC activators phosphatidylserine (40 μg/ml) and 1,2-
dioctanoyl-sn-glycerol (DOG; 8 μg/ml). Kinase reactions were performed for 5 min at 
30°C, after which 25 μl/well was pipetted to a P81 cation exchange paper (Whatman, 
Kent, United Kingdom). The papers were washed with 75 mM phosphoric acid, dried 
and placed in scintillation tubes with scintillation fluid. Radioactivity was measured 
by liquid scintillation counting (1414 Winspectral, Wallac, Finland). For the analysis 
of PKCε inhibition by E6 and G8, the assay was performed in the same way, except 
that only the catalytic domain of PKCε was used and VHH concentrations/well 
ranged from 20–161 nM (E6) and 21–668 nM (G8). Rat brain extract (1 μg/well) was 
used as an alternative source of PKCε. 
4.4.9 CLONING OF VHH-MCHERRY CONSTRUCTS AND PURIFICATION OF 
PLASMID DNA 
The activator A10 and the inhibitor G8 were cloned into the pcDNA3.1+ 
mammalian expression vector (Invitrogen, Carlsbad, CA) with a C-terminal mCherry 
tag. The mCherry plasmid was a generous gift from Prof. Roger Tsien (University of 
California, San Diego, CA). First, the mCherry-sequence was cloned into the 
pcDNA3.1+ vector using the BamHI and EcoRI restriction sites. The resulting 
mCherry-pcDNA3.1+ plasmid was verified by sequencing. 
The cDNA for the VHHs was PCR amplified from Pax50 bacterial expression 
vectors using the forward primer 5′-GGCGCTAGCATGGCAGAGGTGCAG-3′ and the 
reverse primer 5′-GGCAGATCTCCCGTGATGGTGATG-3′ to introduce the NheI 
and BglII restriction sites. The His6-tag that was on the C-terminus of the VHHs on 
the Pax50 expression vector was included in the cloning, so that the His6-tag is 
situated between the VHH and mCherry on the pcDNA3.1+ expression vector. The 
PCR amplified VHH fragments were digested with NheI andBglII and cloned into the 
mCherry-pcDNA3.1+ expression vector using the NheI and BamHI sites (BglII 
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and BamHI have complementary sticky ends). The resulting VHH-His6-mCherry 
constructs were verified by sequencing and the plasmids were produced in the E. 
coli strain JM109. 
Plasmid DNA for mammalian cell transfections was purified from E. coli cells 
using the PureYield™ Plasmid Midiprep System (Promega, Fitchburg, WI). To 
improve the purity of the eluted DNA, a subsequent ethanol precipitation step was 
performed and the dried DNA was diluted in TE buffer. The plasmid DNA was diluted 
to a concentration of 1 μg/μl and stored at −20°C. The PKCε-EGFP plasmid, which 
was a kind gift from Prof. Peter Parker (Cancer Research UK, London Research 
Institute), was produced and purified as described above. 
4.4.10 CELL CULTURE 
Human cervical cancer HeLa cells (CCL-2) were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA) and cultured in DMEM supplemented with 
10% fetal bovine serum (FBS). For transfections and treatments, DMEM without FBS 
was used. Cultures were incubated at 37°C in a humidified atmosphere of 5% carbon 
dioxide (CO2). 
4.4.11 HELA CELL TRANSFECTIONS AND TRANSLOCATION STUDIES 
For transfections, HeLa cells were seeded to 6-well plates (350 000 cells/well in 2 
ml of FBS-supplemented DMEM) and incubated overnight to allow attachment. 
Double transfections of PKCε-EGFP and mCherry, A10-mCherry or G8-mCherry 
were carried out in serum-free medium with the FuGENE HD transfection reagent 
(Roche, Penzberg, Germany) according to the manufacturer's instructions. 
Translocation studies were performed at 37°C with a Leica SP2 AOBS confocal laser 
scanning microscope 24 hours after transfections. Double transfected cells expressing 
both fluorescent proteins were chosen for the experiments, and the 488 nm argon ion 
laser and the 561 nm He-Ne laser were used for the detection of EGFP-tagged PKCε 
and VHH-mCherry constructs, respectively. Typically the translocation of PKCε-
EGFP was monitored in approximately 4–6 cells per experiment. Once double-
transfected cells were located under the microscope, 100 nM PMA was carefully 
added to the cells. Images from the same cells were taken for 30 min every 30 sec. 
Translocation of PKCε-EGFP after PMA addition was quantified by measuring the 
relative fluorescence intensity in a region of interest with a diameter of 5 μm placed in 
the cytoplasm of each cell. 
4.4.12 STATISTICAL ANALYSIS 
SPR kinetic analysis of the results was performed with TraceDrawer 1.3 for 
BioNavis Ltd (Tampere, Finland). The measurements were double referenced, 
meaning that each sample was referenced using a blank reference channel on line and 
also 0-samples were measured and referenced from all sensograms during data 
analysis. Double referencing is a common procedure in SPR biosensor 
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experiments [38]. The sensograms were fitted with either first order or, when 
appropriate, second order Langmuir binding models in the TraceDrawer software. 
The data from kinase activity assays was analyzed and Michaelis-Menten kinetics 
were calculated with GraphPad Prism 4 (GraphPad Software Inc., La Jolla, CA) 
software using non-linear regression. The translocation of PKCε-EGFP in HeLa cells 
was quantified using Leica confocal LAS AF Lite software (Leica Microsystems, 
Wetzlar, Germany). The statistical significances in translocation speed in cells 
transfected with the mCherry and VHH-mCherry constructs were calculated with 
SPSS 15.0 software (SPSS Inc., Chicago, IL, USA) using a one-way Anova with 
Dunnett's post-test. Statistical significance was denoted with * when p<0.05. 
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5 II LABEL-ENHANCED SURFACE PLASMON 
RESONANCE: A NEW CONCEPT FOR 
IMPROVED PERFORMANCE IN OPTICAL 
BIOSENSOR ANALYSIS 
Abstract 
 
Surface plasmon resonance (SPR) is a well-established optical biosensor technology 
with many proven applications in the study of molecular interactions as well as in 
surface and material science. SPR is usually applied in the label-free mode which may 
be advantageous in cases where the presence of a label may potentially interfere with 
the studied interactions per se. However, the fundamental challenges of label-free 
SPR in terms of limited sensitivity and specificity are well known. Here we present a 
new concept called label-enhanced SPR, which is based on utilizing strongly 
absorbing dye molecules in combination with the evaluation of the full shape of the 
SPR curve, whereby the sensitivity as well as the specificity of SPR is significantly 
improved. The performance of the new label-enhanced SPR method was 
demonstrated by two simple model assays: a small molecule assay and a DNA 
hybridization assay. The small molecule assay was used to demonstrate the sensitivity 
enhancement of the method, and how competitive assays can be used for relative 
affinity determination. The DNA assay was used to demonstrate the selectivity of the 
assay, and the capabilities in eliminating noise from bulk liquid composition 
variations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Adapted from (License CC BY 3.0): Granqvist N, Hanning A, Eng L, Tuppurainen J, 
Viitala T (2013) Label-Enhanced Surface Plasmon Resonance: A New Concept for 
Improved Performance in Optical Biosensor Analysis. Sensors 13 (11):15348-15363. 
doi:10.3390/s131115348 
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5.1 INTRODUCTION 
Label-free biosensors based on a variety of physical transduction principles, e.g., 
optical, electrochemical and gravimetric transduction, are well-established research 
tools. Among optical biosensors, the sensors based on surface plasmon resonance 
(SPR) have gained the most widespread acceptance within application areas such as 
protein-protein interaction studies and drug screening, including fragment screening 
[1–3]. Ever since the pioneering SPR biosensor work of Liedberg et al. [4] and of 
Flanagan and Pantell [5], considerable scientific effort has been invested into 
improving the analytical performance–in particular the analytical sensitivity–of SPR 
instruments. Today, SPR is a highly mature technology, and there are thousands of 
research papers published on applications of SPR-based biomolecular interaction 
analysis [6,7]. 
The most distinct advantage of label-free sensor methods is the actual absence of a 
label that may potentially alter the chemical properties of the analyte and interfere 
with the biochemical binding event. However, it is well known that this absence of a 
label inherently causes SPR, like other label-free methods in general, to display 
certain performance limitations, most notably concerning sensitivity and specificity. 
Even though the sensitivity of SPR instruments has been steadily refined over the last 
20 years, it still does not compare favourably with label-based methods like e.g., 
fluorescence and radiochemical methods. The sensitivity of SPR instruments may 
often be inadequate when dealing with small molecules, low concentrations, weak or 
slow binding events, or in cases where there are limited amounts of biochemically 
active binding partners immobilized on the sensor surface [8–10]. It has been 
discussed [11] if the sensitivity of SPR instruments can be further improved or 
whether the theoretically achievable sensitivity limit has already been reached. 
Additionally, in many practical situations, noise sources such as temperature and 
pressure variations and variations in the composition of the bulk liquid, may 
dominate over pure instrument noise and thus limit the practically achievable 
detection limit [12]. When it comes to specificity, SPR, like most other  
label-free methods, is a universal detection method that detects any substance that 
binds to the surface, irrespective of the identity of the substance. Non-specific 
binding of unidentified substances, notably proteins, from the sample solution that 
interferes with the detection of the actual analyte is a very common problem [13].  
Label-based methods, e.g., fluorescence, generally show superior sensitivity and 
specificity as compared to label-free methods. However, fluorescence may show other 
disadvantages apart from the potentially interfering presence of the label per se. 
Fluorescence-based sensor methods generally show inferior quantitative robustness, 
and are hampered by phenomena like quenching, photobleaching, and 
environmentally induced variations of the quantum yield [14]. In particular, in the 
case of SPR-excited fluorescence, the presence of the gold surface of the SPR sensor 
slide, which is a prerequisite for the strong, exciting evanescent field of the sensor, 
may cause severe quenching of the fluorophore [3,15]. Also, the highly specific nature 
of fluorescence detection may in many cases prove to be a limitation, since the 
binding of non-fluorescent substances, e.g., in the preceding immobilization step, 
cannot be monitored or quantified. 
II Label-Enhanced Surface Plasmon Resonance: A New Concept for Improved Performance in Optical 
Biosensor Analysis 
66 
With a view on the limitations of label-free as well as label-based methods 
presented above, we have developed the concept of label-enhanced SPR sensing. The 
concept is based on utilizing strongly absorbing dye molecules in combination with 
the evaluation of the full shape of the SPR curve. The sensitivity, on a mass basis, is 
significantly enhanced as compared to conventional label-free SPR. The influence of 
noise factors like temperature, pressure, and bulk liquid composition variations is 
also significantly reduced by using label-enhanced SPR sensing. The specificity, with 
respect to the label, is very high, which reduces the problem of non-specific binding. 
Additionally, label-enhanced SPR can be run simultaneously and in parallel with 
label-free SPR on standard SPR hardware. This means that all capabilities of 
conventional SPR, like universal monitoring of all binding steps, including 
immobilization, and the full real-time and kinetics capabilities, are completely 
retained. Consequently, all the advantages of label-free and label-based sensing are 
combined on one single instrument platform. In this paper, we outline the theory and 
the principles of label-enhanced SPR, and demonstrate the improved sensitivity and 
specificity using two simple biochemical model systems: a small molecule assay and a 
DNA hybridization assay (Figure 1).  
 
Figure 1 Artistic illustrations of the assays used in the study. (a) Small molecule assay: Sensor 
consisting of BSA (blue) and avidin (black), used in the competitive assay of biotin (green) and 
labelled (red) biotin; (b) DNA hybridization assay: The sensor had the same basic structure as 
in the small molecule assay, but single-stranded DNA was bound through biotin to the 
surface-bound avidin, and either non-labelled or labelled complementary DNA was introduced 
as the sample. 
5.2 EXPERIMENTAL SECTION  
5.2.1 THEORY 
The full quantitative theory of SPR, which takes its origins in Maxwell’s equations, 
has been dealt with in considerable detail elsewhere [16–19], therefore, only a 
simplified approach will be used here to outline the foundation of label-enhanced 
SPR. The approach is based on the Kretschmann optical configuration (prism 
coupling), which is the predominant optical configuration of SPR instruments today. 
The optical system consists of a glass sensor slide or prism, which is covered by a thin 
layer of gold in immediate contact with a dielectric medium, i.e., the sample, into 
which the evanescent field of the surface plasmon wave extends. Light from a 
monochromatic light source is guided through the prism on the back of the gold layer 
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and the intensity of the reflected light from the gold layer is monitored in the angular 
domain. This results in a graph of intensity as a function of angle, which shows a 
pronounced minimum due to light absorption and excitation of surface plasmons at a 
specific combination of light wavelength and reflection angle. This function is called 
the SPR curve or the SPR dip. In this case, the following equation is valid: 
 
np sin θ = Re [(εm εs/(εm + εs))½]    (1) 
 
where n denotes refractive index, θ denotes the angle of minimum intensity (due 
to surface plasmon excitation), ε denotes the complex permittivity, and subscripts p, 
m, and s denote the prism, metal, and sample, respectively. Equation (1) is the 
quantitative equation used in conventional, label-free SPR. np and εm are constant at 
a constant wavelength. The imaginary part of εs can be neglected for  
non-absorbing samples, which reduces εs to ns2. Consequently, the angle θ becomes a 
simple function of ns, i.e., the weighted average of the refractive index in the 
evanescent field zone, which is a measure of the amount of substance bound to the 
sensor surface. For absorbing samples, θ depends also on the imaginary part of εs, 
i.e., on the absorption coefficient as of the sample. However, it is found both from 
theory and from experiments that this dependency is rather small [20–22]. Thus: 
 
 θ = f(ns, as) ≈ θ0 + k1 (ns – ns,0) + k2 (as – as,0)   (2) 
 
where the second expression is a linear approximation in the shape of a two-
dimensional Taylor expansion around an initial value θ0 and k1 and k2 are simple 
constants. The linear approximation is usually assumed to be valid within the normal 
working range of SPR [23]. However, even though the influence of the absorbance 
term in Equation (2) is rather small, an absorbing sample will influence not only the 
angle θ, but the entire shape of the SPR curve. The main effect of light absorption in 
the sample is a broadening of the curve due to attenuation of the surface plasmons; 
the higher the absorption, the higher the attenuation and the curve broadening. The 
full derivation of the shape of the curve is quite lengthy [19], and it is sufficient to 
state here that the dip width depends primarily on the absorbance as and to a smaller 
extent on the refractive index ns according to the approximate equation: 
 
W = 4γ/(np cos θ)     (3) 
 
where W is the angular half-width of the SPR curve (the full angular width of the 
SPR curve at 50% reflectivity) and γ is a factor that depends primarily on the 
absorbance of the sample. In analogy with Equation (2), this can be written as: 
 
W = g(ns, as) ≈ W0 + k3 (ns – ns,0) + k4 (as – as,0)  (4) 
 
Note that the ns term dominates in Equation (2), while the as term dominates in 
Equation (4). Equations (2) and (4) may now be differentiated: 
 
 
II Label-Enhanced Surface Plasmon Resonance: A New Concept for Improved Performance in Optical 
Biosensor Analysis 
68 
∆θ = k1 ∆ns + k2 ∆as 
∆W = k3 ∆ns + k4 ∆as     (5) 
 
Equation (5) is a simple linear equation system with two unknowns: ns and as. 
Hence, both unknowns can be solved by measuring ∆θ and ∆W. The constants k1–k4 
are empirical constants that appear through the Taylor expansions. They depend on 
the measurement wavelength, the optical properties of the prism, and the initial value 
of the sample refractive index, but are true constants at a defined experimental setup. 
The ns term is the ordinary refractive index signal measured in conventional SPR. 
However, a significant improvement of the sensitivity can be obtained by using label-
enhanced SPR and by selecting the label to be a dye molecule with an anomalously 
high refractive index at the measurement wavelength [24–26]. According to the 
Kramers-Kronig relations of fundamental optics [25], the maximum value of the 
refractive index of an absorbing compound appears at a slightly longer wavelength 
than the absorption maximum.  
The as term is a measure of the absorbance, i.e., a highly specific measure of the 
amount of dye-label adsorbed onto the sensor surface. This is the basis of the high 
specificity of label-enhanced SPR. Except in the very unlikely case of non-specific 
binding of coloured substances from the sample solution, the as term is unaffected by 
non-specific binding. Also, since most sources of noise, e.g., temperature, pressure, 
and bulk composition variations, do not contribute to the as term, this term will show 
very low system noise, which also contributes to the improved analytical sensitivity. 
Thus, in order to maximize the sensitivity of label-enhanced SPR, it is 
advantageous to select the dye label to have as high a refractive index and as high an 
absorption coefficient as possible at the measurement wavelength. In order to fulfil 
both these criteria, the dye should be selected to have an absorption maximum at a 
slightly shorter wavelength than the SPR measurement wavelength at hand. 
However, from a more practical point of view, other properties of the label also come 
into play, like e.g., solubility, molecular weight, molecular charge, chemical reactivity, 
hydrophobicity/hydrophilicity, chemical stability, photostability, purity, and cost of 
synthesis. 
5.2.2 MATERIALS 
Sodium hydroxide, 20× saline sodium citrate buffer (SSC), sodium dodecyl sulphate 
(SDS), dimethylsulfoxide (DMSO), sucrose, biotin (native biotin), avidin, and biotin-
labelled bovine serum albumin (biotin-BSA) were obtained from Sigma-Aldrich 
(Helsinki, Finland). Biotin-labelled 25-mer DNA oligonucleotide probe (probe DNA) 
and complementary 25-mer DNA oligonucleotide (native DNA) were obtained from 
IDT (Helsinki, Finland). Biotin labelled with dye B12 (labelled biotin) and 
complementary 25-mer DNA oligonucleotide labelled with dye B10 (labelled DNA) 
were obtained from Episentec (Solna, Sweden). 2×SSC used in the experiments was 
diluted from 20× to a 2× working solution (SSC, 20 mM sodium citrate, 300 mM 
NaCl, pH 7.4) using Milli-Q grade water with a resistivity of 18.2 MΩ·cm.  
SPR gold sensor slides were obtained from BioNavis (Tampere, Finland). The SPR 
sensors were used immediately after cleaning with a hydrogen peroxide-ammonia-
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water solution according to the protocol suggested by the manufacturer. Shortly, the 
sensors were cleaned in a boiling 1:1:5 solution of hydrogen peroxide-ammonia-water 
for 10 min, washed carefully with plenty of water, and wiped with a cotton-tipped 
applicator wetted with a 4% SDS solution followed by drying with nitrogen. The SPR 
instrument used in the measurements was a BioNavis SPR Navi 200-L, equipped 
with 785 nm and 670 nm light sources. The liquid handling in the experiments was 
performed using the built-in peristaltic pump and 12-port chromatography injector, 
and the flow cell used had 1 μL inner volume. All measurements were performed at 25 
°C. 
The SPR data was analysed using the SPR Navi Data Viewer and the 
EpiGrammer™ (Episentec) programs. Conventional or “standard” SPR sensorgrams, 
monitoring purely the refractive index ns, are reported as ∆θ values in units of 
degrees. Enhanced sensorgrams, displaying the absorption coefficient after solving 
the linear equation system of Equation (5), are reported as as values. The as values 
may mathematically also be reported in units of degrees. However, after solving 
Equation (5), in which the constants may vary somewhat due to varying experimental 
conditions, it is not physically meaningful to compare these as units to “standard” 
degrees. Therefore, as values are reported in arbitrary units (a.u.) instead. 
5.2.3 SMALL MOLECULE ASSAY  
The sensor slides for the small molecule assay were prepared in situ in the instrument 
by using a freshly cleaned sensor slide. 2×SSC with 5% DMSO added for solubility 
enhancement was used as the running and sample buffer for all measurements. The 
buffer flow was 50 μL/min, and the duration of all sample injections were 2 min. The 
sensor surfaces were first functionalized with biotin-BSA by injecting 100 μg/mL of 
biotin-BSA and allowing the protein to spontaneously self-assemble on the gold. This 
was followed by two subsequent injections of 100 μg/mL of avidin. After the baseline 
had stabilized, either pure samples of native biotin or labelled biotin, or samples of 
mixed native biotin and labelled biotin (total biotin concentration 50 μM; mixing 
ratios 0.0, 0.11, 0.25, 0.4, 0.6 and 1.0 native/labelled), were injected. The 
concentrations used were high compared to the biotin affinity, and were meant to 
fully saturate the binding during the relatively short injection time. Since the sensor 
slides were not regenerable after the biotin injections, a new sensor slide was used for 
each mixing ratio, and since the amount of avidin varied between sensor slides, the 
signals of the analyte injections were normalized relative to the avidin binding signal 
for each sensor slide (Table 1). The use of non-regenerable sensor slides is of course 
not very practical in a high-throughput assay, but served well to demonstrate the 
performance in the present experiments. The biotin binding signal was averaged over 
a two minute interval after the passing of the sample injection pulse through the 
system.  
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b/a Immobilized Avidin 
(mdeg) 
Enhanced 
Signal (a.u.) 
Normalized 
Signal (a.u.) 
1/Normalized 
Signal (a.u. 103) 
0.0 163 39.0 0.2393 4.18 
0.1 94 15.7 0.1670 5.99 
0.2 138 14.4 0.1043 9.58 
0.4 191 13.0 0.0681 14.69 
0.6 239 13.4 0.0561 17.84 
1.0 117 4.4 0.0376 26.59 
 
Table 2. Results of labelled and native biotin competitive interaction assay. The amount of 
immobilized avidin was used to normalize the label-enhanced SPR signal. The ratio (b/a) 
is the ratio of native biotin concentration (b) to labelled biotin concentration (a). The 
results are plotted in Figure 2. 
5.2.4 DNA HYBRIDIZATION ASSAY 
The sensor surface for the DNA detection assay was prepared in situ in the 
instrument by using a freshly cleaned sensor slide. 2×SSC was used as the running 
and sample buffer for all measurements. The buffer flow used was 100 μL/min, and 
the duration of all sample injections was 2 min. The sensor surface was first 
functionalized with biotin-BSA by injecting 100 μg/mL of biotin-BSA and allowing 
the protein to spontaneously self-assemble on the gold. This was followed by two 
subsequent injections of 100 μg/mL of avidin and 25 μg/mL of biotinylated probe 
DNA. After the baseline had stabilized, several subsequent injections of native DNA 
and labelled DNA at a concentration of 25 μM were performed, with 10 mM sodium 
hydroxide regeneration injections between the sample injections. 
In the noise reduction experiments (Section 4.4), hybridization of labelled DNA 
oligonucleotides was performed as above, but with sucrose in the concentration range 
0%–0.3% added to the DNA sample solutions. 
5.3 RESULTS AND DISCUSSION 
5.3.1 SMALL MOLECULE ASSAY: SENSITIVITY 
A first set of experiments was designed to demonstrate the enhanced sensitivity of 
label-enhanced SPR. Firstly, a 400 μM sample of native biotin was injected onto an 
avidin sensor slide, and the sensorgram was registered in conventional SPR mode. 
The result is shown in the upper panel of Figure 1. After the initial baseline, there is a 
large, negative injection peak, but after the sample plug has passed, there is no 
detectable signal from biotin binding. Secondly, a 5 μM sample of labelled biotin was 
injected onto another avidin sensor slide, and the sensorgram was registered in the 
enhanced, absorbance-measuring mode. The result is shown in the lower panel of 
Figure 2. There is a small overshoot from the injection, but after the sample plug has 
passed, there is a strong, stable signal from the binding of labelled biotin. The signal-
to-noise ratio of the binding signal, as compared to the noise (standard deviation) of 
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the initial baseline, is about 100. Thus, in effect, the analytical sensitivity with respect 
to biotin binding is enhanced 100×. 
It is to be noted that the avidin sensor slide provides a low-capacity surface, 
consisting essentially of a monolayer of avidin molecules, and consequently a low 
signal is to be expected upon biotin binding. Molecules of the size of biotin (244 Da) 
can, under optimized conditions, be detected using conventional SPR when binding 
to a high-capacity surface based on a three-dimensional, hydrophilic network (e.g., a 
dextran matrix) [27]. However, the present experiments were not designed to show 
the absolute signal level achievable for biotin binding, but rather the sensitivity 
enhancement achievable using dye labelling.  
 
Figure 2 Comparison between signal generation of native biotin (upper panel) and labelled biotin (lower 
panel), demonstrating the sensitivity enhancement of the label-enhanced SPR method. The 
standard sensorgram of native biotin (400 µM in PBS) does not produce any detectable signal 
after the injection (the negative peak is due to the bulk effect), while the enhanced sensorgram 
of labelled biotin (25 µM in running buffer) produces a strong signal with a signal-to-noise ratio 
of about 100. 
Even though the binding of even small molecules in many cases can be detected 
using standard SPR, such monitoring often requires specialized and unfavourable 
conditions. The detection often requires immobilization of a large amount of binding 
partner, e.g., protein, on the sensor slide surface and a high density of surface binding 
sites, which may cause problems with steric effects and crowding (and even avidity 
effects for multivalent binders) [28]. In the important application field of drug 
screening on cell membrane receptors, for example, the densely packed environment 
in a dextran matrix is far from the biologically relevant environment of physically 
isolated receptor proteins in an essentially flat membrane surface. Also, as is well 
known, a high density of surface sites regularly causes problems with mass transport 
limitation effects in kinetic analysis [3], and in particular so since the diffusion is 
further restricted in a dense matrix as compared to free solution. Standard SPR 
detection in drug or fragment screening generally requires high concentrations of the 
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screened compounds in solution to enhance the detectability [29,30], which leads to 
solubility problems and high non-specific binding. Consequently, it would be 
desirable to enhance the sensitivity of SPR detection of small molecules for a number 
of reasons. 
The high concentration of native biotin as compared to labelled biotin in the 
present experiments was used to ensure saturation of native biotin binding, and to 
eliminate the risk that labelled biotin would yield a stronger signal simply due to a 
higher binding constant to the surface. However, this risk was later ruled out during 
the experiments presented in Section 4.2. 
5.3.2 SMALL MOLECULE ASSAY: LINEARITY AND COMPETITION 
A second set of experiments was designed to show the linearity of the label-enhanced 
SPR method and its applicability to competitive analysis. Mixtures of varying ratios of 
native and labelled biotin, but at a constant total biotin concentration of 50 μM, were 
injected onto avidin sensor slides. The sensorgrams were registered in the enhanced 
mode, which only measures the binding of the dye-labelled biotin. The results are 
presented in Table 1 and in Figure 3, in which the inverted signal is plotted vs. the 
native/labelled biotin ratio. The standard deviation (of the inverted signal) between 
replicates was 0.38 units in these experiments. The residual experimental variability 
around the linear regression model in Figure 2 was 0.8%. Since the data in Figure 3, 
in accordance with the theory of competitive analysis (cf. Equation (6)), yields a 
straight line, the experiments serve to show that the label-enhanced SPR concept is 
applicable to competitive analysis. Thus, even though the biotin binding cannot be 
directly detected in the present system according to Section 4.1, the concentration of 
biotin in solution can be indirectly determined using competitive analysis. The 
competitive format has the potential to improve the detection limit of small 
molecules using SPR by about 100×. 
Based on the very plausible assumption that the binding of the small biotin 
molecules to well-defined, discrete binding sites on the avidin molecules follows a 
competitive Langmuir adsorption isotherm, the data may be fitted to the following 
equation [31]:  
 
1/Signal = 1/(KC) + (b/a) kb/(ka K C)   (6) 
 
where C is the total surface binding capacity of biotin, K is an arbitrary sensitivity 
constant of labelled biotin, ka and kb are the equilibrium adsorption constants of 
labelled and native biotin, respectively, and a and b are the solution concentrations of 
labelled and native biotin, respectively. The ratio of the binding constants, kb/ka, 
calculated from Equation (6), was 5.5, indicating that the affinity of native biotin is 
5.5 times higher than that of the labelled biotin. This difference is not unexpected, 
since the biotin binding sites of avidin are expected to show the highest binding 
affinity for native biotin, but, most importantly, this affinity difference does not 
reduce the practical usefulness of the competitive assay format.  
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Figure 3 Equilibrium interaction analysis of the competitive binding of native biotin and labelled biotin. 
The data points are described well by a linear regression line (R2 = 0.992) as predicted by 
Equation (6). The intersection and slope of the linear regression line were used to calculate 
the relative equilibrium binding constant of labelled biotin. 
The applicability to different assay formats is of critical importance for the 
usability of label-enhanced SPR. In many cases, when analysing complex samples of 
biochemical origin, it may simply not be possible to selectively label only the analyte, 
and in other cases, when there is a risk that the label will interfere with the binding 
event, it may not be desirable to label the analyte. In such cases, labelling of an 
analyte analogue combined with indirect monitoring of the binding event in a 
competitive assay may be used. As is well established, competitive assays can be used 
to determine both concentration affinity constants, and kinetic reaction constants 
[32–34]. To measure concentration, also inhibitive assays (a.k.a. competition in 
solution) and sandwich assays may be used. Both of these assay formats use a binder 
of the analyte which is labelled [6]. 
The good linear fit of the data in Figure 3 to Equation (6) also serves to justify the 
linear approximations made in Equations (2) and (4) in Section 2. The higher affinity 
for the native biotin as compared to the labelled biotin obtained from the competition 
assay verifies that the risk discussed in Section 4.1, i.e., that the high signal obtained 
for labelled biotin would be due to a higher affinity for labelled biotin compared to 
the native biotin, can be safely ruled out. 
5.3.3 DNA HYBRIDIZATION ASSAY: SPECIFICITY 
A third set of experiments was designed to validate the enhanced specificity of label-
enhanced SPR. Native and labelled 25-mer DNA oligonucleotides were alternately 
hybridized to a complementary strand immobilized on the sensor slide surface. The 
hybridization sensorgrams are shown in Figure 4, where the upper panel shows the 
standard SPR sensorgram and the lower panel shows the enhanced sensorgram. Note 
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that both sensorgrams represent the same run. The different injections are detailed in 
the figure caption. 
The most obvious feature of Figure 4 is the high specificity of labelled DNA as 
compared to native DNA in the enhanced sensorgram. There is a strong, stable signal 
from the labelled DNA (injections 2 and 3 at times 60 and 79 min), but no discernible 
signal from the native DNA (injections 1 and 4 at times 45 and 93 min). There are 
remaining features from the sodium hydroxide regeneration injections even in the 
enhanced sensorgram. This is due to the fact that these injections cause very large 
disturbances of the refractive index, which obviously fall outside the linear range of 
the method. 
 
Figure 4 Standard (upper panel) and enhanced (lower panel) sensorgrams of the hybridization of native 
and labelled DNA oligonucleotides. The enhanced sensorgram has been calculated from the 
standard SPR sensorgram according to Equation (5). Native DNA is injected at 44 and 93 min. 
Labelled DNA is injected at 60 and 79 min. Sodium hydroxide regeneration solution was 
injected at 47, 52, 70, and 85 min. 
The second feature is the absence of baseline drift in the enhanced sensorgram. 
This drift, which most probably is due to desorption of loosely bound protein from 
the surface during sodium hydroxide injections, is clearly seen in the standard 
sensorgram. The improved stability of the baseline in the enhanced sensorgram is 
another corollary of the high specificity, since the desorbed protein in itself does not 
absorb light at the SPR wavelength used. 
The signal enhancement effect is less apparent in this case than in the case of 
biotin in Sections 4.1–4.2. The reason for this is that the oligonucleotides as such are 
much heavier (about 10 kDa) than the biotin (244 Da), thereby causing a relatively 
stronger signal in the standard sensorgram. Still, the signal-to-noise ratio of the 
labelled DNA in the enhanced sensorgram is 2.5 times higher than that of the native 
DNA in the standard sensorgram. There are many applications where the sensitivity 
of standard SPR may be adequate, but where the improved specificity offered by dye-
labelled SPR may be a pronounced advantage, e.g., when analysing large proteins, 
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like antibodies at low concentration, in samples showing a high non-specific binding 
of proteins.  
5.3.4 DNA HYBRIDIZATION ASSAY: NOISE REDUCTION 
A fourth set of experiments was designed to demonstrate the immunity of label-
enhanced SPR to noise emanating from variations of the bulk solution environment, 
or more specifically from variations in the bulk liquid composition. Repeated 
hybridizations of dye-labelled DNA to a complementary DNA strand immobilized on 
the sensor slide surface were performed with different concentrations of sucrose 
added to the buffer. The sucrose additions were selected to represent large variations 
in the composition, and consequently the refractive index, of the buffer. Figure 5 
shows standard sensorgrams of DNA only, sucrose only, and DNA with added 
sucrose, as well as enhanced sensorgrams of a number of DNA hybridizations in the 
presence of varying amounts of sucrose. 
 
Figure 5 (Left): SPR minimum angle sensorgrams of labelled DNA, 0.3% sucrose, and labelled DNA 
mixed with 0.3% sucrose; (Right): Enhanced sensorgrams of labelled DNA mixed with 
different concentrations of sucrose. All the enhanced sensorgrams overlap, but an offset has 
been added to the ordinate for clarity. 
Figure 5 clearly shows that the strong disturbances from the sucrose additions in 
the standard sensorgrams are absent in the enhanced sensorgrams. The large bulk 
refractive index variations induced by sucrose are efficiently eliminated, which is yet 
another embodiment of the high specificity of label-enhanced SPR. It is rather 
apparent that the hybridization kinetics, obscured in the standard sensorgrams, can 
easily and robustly be quantified in the enhanced sensorgrams. The DNA hybrids are 
so stable that the hybridization level can still be measured after the passing of the 
injection pulse, but for fast associating or dissociating species, it is essential to be able 
to discern the surface interaction process from the refractive index disturbance 
caused by the sample injection pulse. 
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Most often, it is impossible to exactly match the bulk refractive index of the 
injected sample with that of the running buffer. This problem is especially pertinent 
in connection with small molecule drug screening or fragment screening using SPR 
[29,35], where fast and weak interactions combined with the inherent low signal 
levels of small molecules may cause detection problems. The compounds to be 
screened are most often stored in DMSO, and it is practically impossible to exactly 
match the DMSO concentration of all samples with that of the running buffer. 
Therefore, bulk disturbances are commonly encountered in standard SPR. There are 
existing procedures for minimizing the influence of bulk disturbances in standard 
SPR, but these require double or triple referencing with a reference flow channel, 
blank samples and the creation of calibration curves composed of several injections of 
DMSO at different concentrations [36,37]. It is quite clear that there is a great 
interest in simplifying these procedures in order to decrease the complexity, 
experimental time, and uncertainty of drug screening.  
The present experiments demonstrate how refractive index variations due to 
composition variations of the bulk solution can be efficiently eliminated using label-
enhanced SPR. Other dominating noise factors in SPR originate from temperature 
and pressure variations of the bulk solution. Since such variations cause the same 
kind of bulk refractive index variations as do composition variations, it seems safe to 
assume that also temperature and pressure noise can be efficiently reduced, even 
though this is not explicitly demonstrated by the experiments. 
5.3.5 A COMPARISON OF SIGNAL ENHANCEMENT TECHNIQUES FOR SPR 
There are a number of suggestions in the literature on the use of heavy labels, e.g., 
metal and plastic nanoparticles or high molecular weight compounds, to enhance 
assay sensitivity by a mere mass increase [38–40] . However, these suggestions show 
a number of limitations as compared to dye-label enhancement. Firstly, and most 
importantly, non-absorbing labels do not offer the improved specificity that 
absorbing labels do. Secondly, slow diffusive mass transport and steric hindrance 
exclude the use of heavy labels in kinetic analysis. Thirdly, the steric and entropic 
interference with biochemical binding events is much more pronounced for large 
labels, like e.g., latex particles, than for dye labels that are small molecules, excluding 
the use of heavy labels in equilibrium analysis. And fourthly, simple and reliable 
methods to achieve a controlled 1:1 coupling of biomolecules to larger particles are 
scarce, while there exists a rich and well-established range of methods for the 
controlled labelling and purification of molecular species [41]. Consequently, the use 
of heavy labels to increase the analytical sensitivity in SPR is generally limited to 
specialized cases of mere concentration analysis. 
Another way to improve the sensitivity of SPR is to utilize surface plasmon 
fluorescence. However, fluorescence methods are plagued by the quenching problems 
discussed in Section 1 [3,15], while quantitative label-enhanced SPR, based on 
absorbance of light rather than on fluorescence, offers a much more robust method 
that is immune to quenching problems. Also, the highly specific nature of 
fluorescence detection does not allow the monitoring and quantification of non-
labelled binding steps, like e.g., the important receptor immobilization step. It would, 
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in principle, be possible to combine standard SPR and surface plasmon fluorescence 
in one single instrument [42], but such an instrument would be optically complex 
and expensive. To the best of the authors’ knowledge, no such combined commercial 
instrument exists today. 
The sensitivity enhancement effect demonstrated using label-enhanced SPR is, 
quite naturally, largest for small analyte molecules. In the present work, we 
demonstrate a 100 increase of the achievable signal-to-noise ratio for the 244 Da 
biotin model molecule. For larger analyte molecules, with a molecular weight of a few 
kDa, e.g., peptides or oligonucleotides, the sensitivity increase is on the order of 10, 
which is still a sizeable improvement for critical applications. For full size proteins, 
larger than about 25 kDa, no signal enhancement effect is obtained using a single dye 
label, but in this case multiple labelling may be used to further enhance the signal. 
However, such large molecules usually generate enough signal to be conveniently 
analysed by conventional SPR. Nevertheless, the improved specificity is a benefit of 
label-enhanced SPR irrespective of the size of the analyte molecule. This improved 
specificity may be advantageous also in the analysis of antibodies and other heavy 
proteins in crude samples, e.g., serum samples or culture media samples, with a high 
level of non-specific binding. 
5.4 CONCLUSIONS 
The label-enhanced SPR method can improve the analytical sensitivity of small-
molecule detection in SPR about 100-fold. By working in the competitive mode, the 
detection limit in small molecule analysis can be improved analogously even without 
direct labelling of the analyte. The method exhibits a high specificity with respect to 
the labelled compound, which may be of importance also in assays where the 
sensitivity of standard SPR is adequate, but where there is a high level of non-specific 
binding. A consequence of the high specificity is also that noise emanating from 
refractive index variations of the bulk liquid is eliminated. Since label-enhanced SPR 
can be run simultaneously and in parallel with conventional SPR, all the capabilities 
of label-free SPR and label-enhanced SPR can be combined on one standard SPR 
instrument platform. Consequently, the combination of label-free and label-enhanced 
SPR is foreseen to significantly widen the application field of optical biosensors 
within biotechnology, biochemistry, and drug discovery. 
5.5 ACKNOWLEDGMENTS 
Part of this research was funded by Academy of Finland (Grant No: 137053 and 
140980). Niko Granqvist wants to thank the Foundation of Anja and Mirja Tissari 
from the Finnish Cultural Foundation (Suomen Kulttuurirahasto). Special thanks to 
Janusz W. Sadowski of BioNavis Oy and Marjo Yliperttula from University of 
Helsinki for valuable discussions. 
II Label-Enhanced Surface Plasmon Resonance: A New Concept for Improved Performance in Optical 
Biosensor Analysis 
78 
5.6 REFERENCES 
1. Cooper, M.A. Label-Free Biosensors: Techniques and Applications; Cambridge 
University Press: Cambridge, UK, 2009. 
2. Cooper, M.A.; Mayr, L.M. Label-Free Technologies for Drug Discovery; Wiley: 
Chichester, UK, 2011. 
3. Schasfoort, R.B.M.; Tudos, A.J. Handbook of Surface Plasmon Resonance; RSC: 
Cambridge, UK, 2008. 
4. Liedberg, B.; Nylander, C.; Lundström, I. Surface plasmon resonance for gas 
detection and biosensing. Sens. Actuat. 1983, 4, 299–304. 
5. Flanagan, M.; Pantell, R. Surface plasmon resonance and immunosensors. Elect. 
Lett. 1984, 20, 968–970. 
6. Homola, J. Surface plasmon resonance sensors for detection of chemical and 
biological species. Chem. Rev. 2008, 108, 462–493. 
7. Rich, R.L.; Myszka, D.G. Grading the commercial optical biosensor literature-class 
of 2008: ‘The mighty binders’. J. Mol. Recogn. 2010, 23, 1–64. 
8. Holdgate, G.A.; Anderson, M.; Edfeldt, F.; Geschwindner, S. Affinity-based, 
biophysical methods to detect and analyze ligand binding to recombinant 
proteins: Matching high information content with high throughput. J. Struct. Biol. 
2010, 172, 142–157. 
9. Rich, R.L.; Myszka, D.G. Why you should be using more SPR biosensor 
technology. Drug Disc. Tod: Technol. 2004, 1, 301–308. 
10. Rich, R.; Myszka, D. Higher-throughput, label-free, real-time molecular 
interaction analysis. Anal. Biochem. 2007, 361, 1–6. 
11. Piliarik, M.; Homola, J. Surface plasmon resonance (SPR) sensors: Approaching 
their limits? Opt. Express 2009, 17, 16505–16517. 
12. Fan, X.; White, I.; Shopova, S.; Zhu, H.; Suter, J.; Sun, Y. Sensitive optical 
biosensors for unlabeled targets: A review. Anal. Chim. Acta 2008, 620, 8–26. 
13. Ramachandran, N.; Larson, D.; Stark, P.; Hainsworth, E.; LaBaer, J. Emerging 
tools for real-time label-free detection of interactions on functional protein 
microarrays. FEBS J. 2005, 272, 5412–5425. 
14. Sauer, M.; Hofkens, J.; Enderlein, J. Handbook of Fluorescence Spectroscopy and 
Imaging: From Ensemble to Single Molecules; Wiley: Weinheim, Germany, 2011. 
15. Ekgasit, S.; Thammacharoen, C.; Yu, F.; Knoll, W. Evanescent field in surface 
plasmon resonance and surface plasmon field-enhanced fluorescence 
spectroscopies. Anal. Chem. 2004, 76, 2210–2219. 
16. Albers, W.; Vikholm-Lundin, I. Surface Plasmon Resonance on Nanoscale Organic 
Films. In Nano-Bio-Sensing; Carrara, S., Ed.; Springer: New York, USA, 2010. 
17. Sadowski, J.W.; Korhonen, I.K.; Peltonen, J.P. Characterization of thin films and 
their structures in surface plasmon resonance measurements. Opt. Eng. 1995, 34, 
2581–2586. 
18. Homola, J. Present and future of surface plasmon resonance biosensors. Anal. 
Bioanal. Chem. 2003, 377, 528–539. 
19. Homola, J., Electormagnetic Theory of Surface Plasmons. In Surface Plasmon 
Resonance Based Sensors; Homola, J., Ed.; Springer: Berlin, Germany, 2006. 
20. Kolomenskii, A.A.; Gershon, P.D.; Schuessler, H.A. Surface-plasmon resonance 
spectrometry and characterization of absorbing liquids. Appl. Opt. 2000, 39, 
3314–3320. 
21. Komatsu, H.; Miyachi, M.; Fujii, E.; Citterio, D.; Yamada, K.; Sato, Y.; Kurihara, 
K.; Kawaguchi, H.; Suzuki, K., Spr sensor signal amplification based on dye-doped 
polymer particles. Sci. Tech. Adv. Mat. 2006, 7, 150–155. 
 79 
22. Salamon, Z.; Macleod, H.A.; Tollin, G. Surface plasmon resonance spectroscopy as 
a tool for investigating the biochemical and biophysical properties of membrane 
protein systems. I: Theoretical principles. Biochim. Biophys. Acta 1997, 1331, 117–
129. 
23. Liedberg, B.; Lundström, I.; Stenberg, E. Principles of biosensing with an 
extended coupling matrix and surface plasmon resonance. Sens. Actuat. B 1993, 
11, 63–72. 
24. Esteban, Ó.; González-Cano, A.; Díaz-Herrera, N.; Navarrete, M.-C. Absorption as 
a selective mechanism in surface plasmon resonance fiber optic sensors. Opt. Lett. 
2006, 31, 3089–3091. 
25. Hanning, A.; Roeraade, J.; Delrow, J.J.; Jorgenson, R.C. Enhanced sensitivity of 
wavelength modulated surface plasmon resonance devices using dispersion from a 
dye solution. Sens. Actuat. B 1999, 54, 25–36. 
26. Nakkach, M.; Lecaruyer, P.; Bardin, F.; Sakly, J.; Lakhdar, Z.B.; Canva, M. 
Absorption and related optical dispersion effects on the spectral response of a 
surface plasmon resonance sensor. Appl. Opt. 2008, 47, 6177–6182. 
27. Löfås, S.; Johnsson, B. A novel hydrogel matrix on gold surfaces in surface 
plasmon resonance sensors for fast and efficient covalent immobilization of 
ligands. J. Chem. Soc. Chem. Commun. 1990, 21, 1526-1528 
28. Rich, R.; Myszka, D. Advances in surface plasmon resonance biosensor analysis. 
Curr. Opin. Biotech. 2000, 11, 54–61. 
29. Giannetti, A.M. From experimental design to validated hits: A comprehensive 
walk-through of fragment lead identification using surface plasmon resonance. 
Meth. Enzymol. 2011, 493, 169. 
30. Hämäläinen, M.; Zhukov, A.; Ivarsson, M.; Fex, T.; Gottfries, J.; Karlsson, R.; 
Björsne, M. Label-free primary screening and affinity ranking of fragment 
libraries using parallel analysis of protein panels. J. Biomol. Screen. 2008, 13, 
202–209. 
31. Masel, R.I. Principles of Adsorption and Reaction on Solid Surfaces; Wiley: New 
York, USA, 1996. 
32. Karlsson, R. Real-time competitive kinetic analysis of interactions between low-
molecular-weight ligands in solution and surface-immobilized receptors. Anal. 
Biochem. 1994, 221, 142–151. 
33. Karlsson, R.; Fält, A. Experimental design for kinetic analysis of protein-protein 
interactions with surface plasmon resonance biosensors. J. Immunol. Method. 
1997, 200, 121–133. 
34. Motulsky, H.J.; Mahan, L.C. The kinetics of competitive radioligand binding 
predicted by the law of mass action. Mol. Pharmacol. 1984, 25, 1–9. 
35. Huber, W.; Mueller, F. Biomolecular interaction analysis in drug discovery using 
surface plasmon resonance technology. Curr. Pharm. Des. 2006, 12, 3999–4021. 
36. Frostell-Karlsson, Å.; Remaeus, A.; Roos, H.; Andersson, K.; Borg, P.; 
Hämäläinen, M.; Karlsson, R. Biosensor analysis of the interaction between 
immobilized human serum albumin and drug compounds for prediction of human 
serum albumin binding levels. J. Med. Chem. 2000, 43, 1986–1992. 
37. Navratilova, I.; Myszka, D.G. Investigating Molecular Interactions and Binding. In 
Surface Plasmon Resonance Based Sensors; Homola, J., Ed.; Springer: Berlin, 
Germany, 2006. 
38.Daniel, M.-C.; Astruc, D. Gold nanoparticles: Assembly, supramolecular 
chemistry, quantum-size-related properties, and applications toward biology, 
catalysis, and nanotechnology. Chem. Rev. 2004, 104, 293–346. 
39. Kubitschko, S.; Spinke, J.; Brückner, T.; Pohl, S.; Oranth, N. Sensitivity 
enhancement of optical immunosensors with nanoparticles. Anal. Biochem. 1997, 
253, 112–122. 
II Label-Enhanced Surface Plasmon Resonance: A New Concept for Improved Performance in Optical 
Biosensor Analysis 
80 
40.Sato, Y.; Sato, Y.; Okumura, A.; Suzuki, K.; Kawaguchi, H. Flow-stress-induced 
discrimination of a k-ras point mutation by sandwiched polymer microsphere-
enhanced surface plasmon resonance. J. Biomat. Sci. Pol. Edit. 2004, 15, 297–310. 
41. Hermanson, G.T. Bioconjugate Techniques, 2nd ed.; Elsevier: Amsterdam, The 
Netherlands, 2008. 
42. Yu, F.; Persson, B.; Löfås, S.; Knoll, W. Attomolar sensitivity in bioassays based on 
surface plasmon fluorescence spectroscopy. J. Am. Chem. Soc. 2004, 126, 8902–
8903. 
 
 81 
6 III CHARACTERIZING ULTRATHIN AND THICK 
ORGANIC LAYERS BY SURFACE PLASMON 
RESONANCE THREE-WAVELENGTH AND 
WAVEGUIDE MODE ANALYSIS 
Abstract 
 
A three-wavelength angular-scanning surface plasmon resonance based analysis has 
been utilized for characterizing optical properties of organic nanometer-thick layers 
with a wide range of thicknesses. The thickness and refractive index were determined 
for sample layers with thicknesses ranging from subnanometer to hundreds of 
nanometers. The analysis approach allows for simultaneous determination of both 
the refractive index and thickness without prior knowledge of either the refractive 
index or the thickness of the sample layers and without the help of other instruments, 
as opposed to current methods and approaches for characterizing optical properties 
of organic nanometer-thick layers. The applicability of the three-wavelength angular-
scanning surface plasmon resonance approach for characterizing thin and thick 
organic layers was demonstrated by ex situ deposited mono- and multilayers of 
stearic acid and hydrogenated soy phosphatidylcholine and in situ layer-by-layer 
deposition of two different polyelectrolyte multilayer systems. In addition to the 
three-wavelength angular-scanning surface plasmon resonance approach, another 
surface plasmon resonance optical phenomenon, i.e., the surface plasmon resonance 
waveguide mode, was utilized to characterize organic sample layers whose 
thicknesses border the micrometer scale. This was demonstrated by characterizing 
both in situ layer-by-layer deposited polyelectrolyte multilayer systems and an ex situ 
deposited spin-coated polymer layer. 
 
 
 
 
 
 
 
 
 
 
 
 
*Reproduced with permission from: Granqvist N, Liang H, Laurila T, Sadowski J, 
Yliperttula M, Viitala T (2013) Characterizing ultrathin and thick organic layers by 
surface plasmon resonance three-wavelength and waveguide mode analysis. 
Langmuir 29 (27):8561-8571. (http://dx.doi.org/10.1021/la401084w). Copyright 
2013 American Chemical Society. 
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6.1 INTRODUCTION 
The determination of organic ultrathin film properties, i.e., thickness (d) and 
refractive index (n), in the range of 0.1–100 nm is still a challenging task, especially 
when reaching the lower end range of 0.1–10 nm. [1, 2] The lower end range is highly 
relevant for chemical sensing, organic optics, and electronics, as well as 
characterizing and measuring biological processes and biological barrier layers, such 
as cell walls, cell membranes, and lipid bilayers. [3, 4] Furthermore, relatively thick 
layers from 400 nm to a few micrometers are also relatively difficult to characterize, 
as they fall into a gap between nano- and macrocharacterization techniques. 
Examples of layer structures with a few micrometer thickness are, for instance, 
bacteria, certain cell types, such as red blood cell monolayers, [5] many natural 
structural components, such as cellulose cell walls in plants, [5, 6] and biologically 
relevant hydrogels and structural or fibrillar proteins such as actin, collagen, and 
keratin fibers. [5] There are several techniques that provide accurate information on 
organic thin film properties and are commonly used for thin film characterization, 
e.g. ellipsometry, [7] spectroscopic ellipsometry (SE), [1] surface plasmon resonance 
spectroscopy (SPR), [3] quartz crystal microbalance (QCM), [1] and atomic force 
microscopy (AFM). [8] However, in many cases several different techniques have to 
be simultaneously employed to obtain a reliable estimate of d and n of ultrathin and 
thick organic films. [1] 
Ellipsometry and SE utilize polarized light for determining d and n of thin organic 
layers. In the case of SE the dispersion coefficient for materials is also obtained. [1, 
7] However, when using monochromatic light for determining d and n for thin 
organic layers by ellipsometry, these two parameters are inseparable. Therefore, it is 
necessary to know, assume, or measure with some other techniques either d or n. 
Even with a known n, it is still difficult to obtain accurate values for organic layer 
thicknesses below 10 nm with ellipsometry. [9] With SE it is possible to 
independently determine both d and n for organic layers, but for organic ultrathin 
films where 2πdn/λ  1, the relative error of d becomes linked to the initial 
assumption of n for the layer, and a unique determination of both d and n becomes 
impossible. [1] When the thickness of the sample layers approaches the micrometer 
range, the output vector (Ψ, Δ) obtained from ellipsometry measurements will have a 
periodicity, which complicates the analysis of such sample layers with single-
wavelength ellipsometry. This is, however, not a major issue in SE due to multiple 
output vectors as a function of the wavelength. [7] Characterizing sample layers with 
ellipsometry or SE with samples immersed in liquid is also often challenging, because 
of the optical setup required. The incident light and reflected light need to travel 
through optical windows, as well as the surrounding medium and the sample layer. 
This creates challenges in engineering flow systems with low volume and good flow 
control and prevents the use of opaque liquids. [7] 
QCM on the other hand is a mechanical technique which makes use of an AT-cut 
quartz resonator oscillating at its resonance frequency. [10] It can be used to measure 
the amount (mass) and mechanical properties (viscoelasticity) of sample layers 
deposited on top of the quartz crystal resonator by measuring the change in 
frequency and dampening of the oscillation. If the change in frequency and the 
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dampening of oscillation are measured at several overtones, the thickness, density, 
and viscoelasticity of the sample layer can be obtained by theoretical modeling. 
[11] However, for accurate modeling in QCM also the density of the material should 
be known, which is practically never accurately known for ultrathin films but is often 
estimated from bulk properties. [1] Furthermore, the sensing depth of QCM in liquid 
media is approximately 300 nm, and highly viscoelastic layers with thicknesses in the 
range of 200–500 nm easily dampen the crystal oscillation completely. 
AFM is a mechanical technique where an oscillating or stationary cantilever probe 
is brought in close contact with the sample surface until van der Waals force 
repulsion starts to affect the oscillation amplitude or deflection of the cantilever. The 
oscillation amplitude and/or deflection of the cantilever can then be used to directly 
measure the topography, as well as the viscoelasticity and viscoelasticity distribution 
in the sample layers. With AFM it is also possible to measure interaction forces, 
nanoscale friction, conductivity, and other properties depending on what type of 
probes are used for the measurements. To accurately measure sample layer 
thicknesses with AFM, it is necessary to use a mask or some other method to create 
an internal reference within the sample layer. Additionally, the film thickness 
obtained by AFM will depend on the tip force or tapping strength used during the 
measurement, especially for soft and fluidlike films where the tip can penetrate 
through the sample layer. Another challenge with AFM is that performing in situ 
measurements, especially in liquid media, is not at all a trivial procedure. [8, 12, 13] 
SPR is an optical method where the free electron plasma on a metal surface is 
excited by using p-polarized visible light. The excitation of surface plasmons can be 
monitored as a function of the incoming light angle or a change in the wavelength of 
light. In the most common optical configuration for SPR, i.e., the Kretschmann 
configuration, the light is coupled to the metal layer through a glass prism from one 
side, while the sample and the outside medium in contact with the sample are located 
on the opposite side. This configuration enables signal detection which does not have 
any interference from the surrounding media as the incoming light is not passing 
through the media or sample layer as is the case with ellipsometry. [14] To 
obtain d andn information on a sample layer, a single-wavelength SPR angle versus 
light reflection intensity spectrum can be fitted using multilayer models in the same 
way as in ellipsometry. In the cases where the sample layer does not absorb light at 
the wavelengths used for detection, the same limitations also occur for SPR as for 
ellipsometry; i.e., d and n are not separable variables. [15, 16] However, it has 
previously been shown that if the SPR spectra are measured in two different media, 
[15, 17] or the SPR measurement is performed with two different wavelengths of light 
and the dispersion relation is known, then a unique d and n can be calculated for the 
sample layer. [17-20] Usually the limit of thickness determination of sample layers 
with SPR is taken to be around 300 nm on the basis of the fact that the plasmon 
evanescent field that decays exponentially penetrates approximately 1/2 wavelength of 
the incident light into the media. [21] However, when the sample layer thickness 
approaches and exceeds 1/2 times the wavelength of light used for detection, then a 
harmonic type of waveguide behavior of the SPR begins, which can be used to 
uniquely determine d and n of the sample layers. [22-24] 
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In this study we demonstrate how to utilize the SPR phenomenon for determining 
optical properties of ultrathin and relatively thick organic layers by using a three-
wavelength SPR approach for (a) determining the thickness and refractive index of 
ultrathin films and (b) determining the thickness and apparent refractive index of 
thick layers in the SPR waveguide mode. This has been achieved by investigating 
several model systems consisting of well-known ultrathin Langmuir–Blodgett (LB) 
films, thick polyelectrolyte multilayer films, and a thick spin-coated polymer film. 
6.2 MATERIALS AND METHODS 
6.2.1 MATERIALS 
Hydrogenated l-α-phosphatidylcholine (HSPC; >99%) was obtained from Avanti 
Polar Lipids, and stearic acid (SA; ≥98.5%), uranyl acetate dihydrate (UAc; ≥98%), 
poly(styrenesulfonate) sodium salt (PSS; Mw = 70 kDa), poly(allylamine 
hydrochloride) (PAH; Mw = 15 kDa), poly(ethyleneimine) (PEI; Mw = 750 kDa), 
poly(l-lysine) (PLL; Mw 300 = kDa), and hyaluronic acid (HA; Mw = 1500 kDA) were 
obtained from Sigma-Aldrich. NaCl, Tris, NH3OH (30%), and H2O2 (30%) were of 
analytical grade and obtained from Sigma-Aldrich. All chemicals were used as 
received. All water used was Milli-Q grade with a conductivity of 18 MΩ cm–1 and a 
total organic content of <4 ppm. 
6.2.2 THREE-WAVELENGTH SPR MEASUREMENTS 
Three-wavelength surface plasmon resonance measurements were performed with an 
SPR Navi 200-L instrument equipped with two light source pairs providing 655 and 
782 nm, as well as 670 and 783 nm, wavelengths and an autosampler accessory (Oy 
BioNavis Ltd., Tampere, Finland). SPR sensors were gold-coated sensors ( 50 nm) 
with a chromium adhesion layer ( 2 nm) and were obtained from BioNavis Ltd. SPR 
sensors were cleaned before use by boiling them for 15 min in an 
NH3 (30%)/H2O2 (30%)/H2O (1:1:5, v/v) oxidizing solution. 
All three-wavelength SPR experiments were processed using the BioNavis 
Dataviewer software. Multilayer models for sample layer analysis were done by using 
the Winspall 3.02 software. [25] The three-wavelength and two-medium cross point 
analyses were performed by using Microsoft Office Excel 2007. 
6.2.3 COMPRESSION ISOTHERMS AND LANGMUIR–BLODGETT FILM 
DEPOSITION 
A KSV Minitrough instrument (KSV-NIMA, Biolin Scientific Oy, Espoo, Finland) was 
used for all compression isotherms and Langmuir–Blodgett deposition experiments. 
The experiments were carried out at 23 °C using a thermostated Teflon trough (330 
mm × 75 mm) and 50 μM UAc in the subphase. The isothermal compressions were 
started 10 min after the monolayer substance was spread onto the subphase. A 
constant barrier compression speed of 7.5 cm2/min was used during the whole 
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monolayer compression. For LB depositions the monolayer was first left to stabilize 
for 10 min at the predetermined surface pressure before the deposition procedure 
was started. The speed for the deposition of mono- and multilayers of SA and HSPC 
was 5 mm/min. The deposited layers were allowed to dry in air for at least 15 min 
before the SPR spectra at different wavelengths of the sample layer were measured. 
After the SPR spectra were measured, the multilayer buildup was continued using the 
same sensor. SA monolayers were deposited at surface pressures of 15 and 45 mN/m 
and multilayers at a surface pressure of 45 mN/m. HSPC monolayers were deposited 
at surface pressures of 10 and 30 mN/m and multilayers at a surface pressure of 30 
mN/m. 
d and n of the deposited LB films were determined by three-wavelength SPR 
analysis from SPR spectra measured of 1, 3, 5, 7, 9, and 11 deposited layers of SA, and 
from SPR spectra of 1 and 3 deposited layers of HSPC. Additionally, d and n of 11 SA 
and 3 HSPC layers were determined by two-medium SPR analysis from SPR spectra 
measured in both air and water. 
6.2.4 PM-IRRAS MEASUREMENTS 
Polarization-modulated infrared reflection absorption spectroscopy (PM-IRRAS) is a 
reflection-based infrared tool where p- and s-polarized spectra are simultaneously 
measured for a sample deposited on an IR reflecting substrate, such as an air–metal 
interface. [26] If the substrate is a good electrical conductor (e.g., gold), there is an 
enhancement effect of molecular dipoles perpendicular to the surface and an 
elimination of dipoles parallel to the surface. This effect can be used to qualitatively 
determine the orientation and packing of molecules on the metal surface. 
PM-IRRAS measurements were performed with a KSV-NIMA PMI 550 
instrument (KSV-NIMA, Biolin Scientific Oy, Espoo, Finland). PM-IRRAS spectra of 
LB monolayers of SA and HSPC deposited on the SPR gold sensor at different surface 
pressures were recorded at an incident light angle of 80°, which gives the highest 
sensitivity for gold substrates. The maximum retardation wavelength was set to 3000 
cm–1 for all measurements. 
6.2.5 POLYELECTROLYTE MULTILAYER DEPOSITION 
The polyelectrolyte multilayer (PEM) depositions were performed and monitored in 
situ in the SPR Navi 200-L instrument. All PEM buildup experiments were 
performed in a 0.15 M NaCl, 20 mM Tris buffer with a pH of 7.4 and at a temperature 
of 20 °C. The flow rate used in the experiments was 50 μL/min, the sample contact 
time was 4 min, and the washing time between oppositely charged polyelectrolyte 
injections was 10 min. One layer of PEI (0.1 mg/mL) was first deposited on gold as an 
adhesion layer for all PEM experiments. After this, the PEMs were formed with 
sequential deposition of PSS and PAH (0.1 mg/mL) for PSS–PAH PEM formation or 
HA and PLL (0.1 mg/mL) for HA–PLL PEM formation. 
The PSS–PAH PEM formation was measured up to 20 bilayers using both SPR 
light source pairs and up to 120 bilayers using the 782 and 655 nm SPR light source 
pair. The measurement was paused, and all the fluidics were thoroughly cleaned with 
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pure water every 40 bilayers to avoid clogging of the samples in the microfluidics of 
the instrument. 
d and n of the forming PEM layers were determined by three-wavelength SPR 
analysis from SPR spectra measured for 3, 5, and 10 bilayers for PSS–PAH, for 2 and 
5 bilayers for HA–PLL, and for a relatively thick PSS–PAH multilayer consisting of 
120 bilayers. 
6.2.6 EX SITU PREPARED SPR WAVEGUIDES 
A waveguide was prepared on the SPR sensor by spin coating 5 wt % PS–PMMA in 
toluene solution at 1000 rpm. The spin-coated polymer layer was allowed to dry in 
ambient room temperature and humidity for 30 min before the SPR spectrum of the 
sample layer was measured. The PS–PMMA used was a random copolymer with a 
24% fraction of MMA determined by 1H NMR and an Mw of 500 kDa determined by 
size exclusion chromatography. The copolymer was a kind gift from the Laboratory of 
Polymer Chemistry, Department of Chemistry, Faculty of Science, University of 
Helsinki. The SPR spectrum of the spin-coated polymer layer was measured in air at 
ambient humidity and room temperature by using a wavelength of 670 nm. The 
analysis of the optical properties of the waveguide was performed with the Winspall 
3.02 software. 
6.3 THEORY 
6.3.1 SPR VECTOR FUNCTION 
Surface plasmons are particle waves of the free electron plasma on a metal 
surface, which can be excited by p-polarized light under the resonance condition 
(Figure S1, Supporting Information). A theoretical mathematical description for the 
resonance condition can be obtained by solving the Maxwell equations for a 
multilayer optical system. [15] A detailed mathematical description of the SPR 
phenomenon is available in the Supporting Information(section SI). A general 
solution for a multilayered system linked to measurable or controllable variables can 
be obtained by using a transfer matrix formalism of 2 × 2 matrices. The overall 
formalism has already been published several times, and it is not in the scope of this 
paper to discuss it in detail again. [15, 16] 
In practice, this matrix formalism is solved by mathematical fitting tools or by 
dedicated software tools developed for it, such as Winspall. [25] 
6.3.2 MULTIVARIABLE SPR EXPERIMENTS 
Multivariable SPR analysis has previously been described for two-variable 
systems. [18-20] These approaches have not been widely accepted, and the full 
analysis described in previous literature is mathematically quite complicated. 
However, with the ability today to accurately model and calculate multilayer optical 
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system responses from the SPR spectrum by using matrix formalism, we can simplify 
the overall process and mathematical analysis for solving the sample layer properties. 
As stated previously, the SPR spectrum measured in one set of conditions is in 
practice not sensitive to the unique differences in d and n, and only a continuum 
solution for the surface plasmon wave vector (ksp) proportional to d and n can be 
deducted: 
 
?? ? ? ? ?.     (1) 
 
In practical experiments we can assume that ksp contains all the information and 
constants that cause the differences in the experimental SPR spectra measured at 
several wavelengths or in two different media. Hence, we can simplify the 
relationship for mathematical purposes in the following way. If we measure the SPR 
spectrum in two different media with a large enough difference in n, then a unique 
solution for the final sample layer can be relatively easily calculated from the 
intersection of the two continuum solutions when d1 = d2 = d and n1 = n2 =n, i.e. 
 
?
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A similar but slightly more complex approach is to use a multiwavelength 
approach, as n also has a wavelength dependency, i.e., dn/dλ. However, for relatively 
small changes, this relationship can to a good approximation be assumed to be linear 
(Supporting Information, section SII, Figure S2). [27] Hence, this approximation 
allows us to find a unique solution for d and n by solving the following equation 
system: 
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where 
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If even more wavelengths are available, then in theory it should be possible to use 
a true Cauchy relation instead of the linear approximation of dn/dλ. It is worth 
mentioning that the discussion above is only valid for sample layers that do 
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not absorb light at the wavelengths used for SPR spectrum measurement, i.e., for k = 
0, which is often the case for organic sample layers. If k ≠ 0, then there is actually a 
unique solution for the sample layer in the ksp = d(n + ik) space, and the above 
approach would be unnecessary. 
6.3.3 SPR WAVEGUIDE 
A so-called SPR waveguide mode can be utilized in SPR sensing when relatively 
thick dielectric layers are deposited on the SPR sensor surface, i.e., when the 
thickness of the sample layer is >1/2λ of the incident light. When using the 
Kretschmann configuration, it is even possible to couple surface plasmons and optical 
waveguide modes so that the excitation light and the guided wave modes are phase 
matched. [23] The effect of matching these conditions has been discussed previously 
for thin and loose hydrogels [23] and for dense spin-coated polymers. [22] The SPR 
waveguide coupling can theoretically be investigated and analyzed by using the same 
mathematical models as for standard SPR as described above. 
6.3.4 RESULTS AND DISCUSSION 
6.3.5 COMPRESSION ISOTHERMS AND LANGMUIR–BLODGETT DEPOSITION 
The purpose of utilizing Langmuir and Langmuir–Blodgett methods in this study 
is shortly discussed in the Supporting Information (section SIII). Parts A and B of 
Figure S3 (Supporting Information, section SIII) show the compression isotherms of 
SA and HSPC measured on pure water and UAc-containing subphases. UAc was 
chosen as the subphase counterion as it has been shown to enable the deposition of 
more than one monolayer of phospholipids on a solid substrate. [28, 29] The 
compression isotherms reveal that the UAc expands the liquid state of both the SA 
and HSPC monolayers compared with the monolayers measured on a pure water 
subphase. This is an effect opposite what is usually encountered with multivalent 
counterions, such as Mn2+, Cd2+, and Tb3+. [30] Also, the area per molecule is slightly 
larger for both monolayers on a UAc-containing subphase compared with the pure 
water reference. These effects can be attributed to the complex state of uranium(IV), 
which forms (UO2(OH)2)22– or UO2(CO3)22– complexes at pH 5.6 used in the 
experiments shown in Figure S3. [31] The formation of these uranyl complexes 
consequently makes the counterion larger than simple multivalent ions. Therefore, 
the uranyl counterion complexes become the limiting factor in the packing of the 
monolayers instead of the hydrophobic lipid tail of the amphiphilic substances in the 
monolayer. [32, 33] However, the UAc counterion clearly stabilizes and rigidifies the 
monolayer similar to other multivalent counterions, which can be seen from the 
increase in the maximum pressure that can be achieved in the compression isotherm. 
The UAc counterions in the subphase thus enabled us to deposit mono- and 
multilayers of both SA and HSPC monolayers on SPR sensor slides for further optical 
characterization of ultrathin organic layers. The transfer ratios of all the LB 
depositions were close to 1 (data not shown), which indicates that the transfer of the 
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mono- and multilayers was complete and that the transferred layers were intact and 
of good quality. 
The PM-IRRAS (Supporting Information, section SIII, Figure S3C,D) and 
isotherm (Supporting Information, section SIII, Figure S3A,B) data show that the SA 
monolayer has a more ordered packing than the HSPC monolayer at higher surface 
pressures and that the order in the SA monolayer increases with increasing surface 
pressure. The difference in the SA and HSPC monolayer properties should clearly be 
reflected in the optical properties of the monolayers. Furthermore, the SA monolayer 
deposited from a UAc subphase is not as highly ordered as an SA monolayer 
deposited from a Cd2+-containing subphase, which exhibits a crystalline hexagonal 
packing. [33] For optical measurements such as SPR and ellipsometry, a slightly 
more random order makes comparison between the two different molecules more 
reliable. For example, crystalline hexagonal packing of SA with cadmium[27] has a 
relatively large effect on the optical properties of the layer, [17] which is reflected as 
an anomaly large dispersion coefficient for the Cd–stearate monolayer. 
6.3.6 THREE-WAVELENGTH AND TWO-MEDIUM SPR ANALYSIS OF 
ULTRATHIN FILMS 
The SPR full angle scans measured for SA and HSPC mono- and multilayers were 
separately fitted with a multilayer model in Winspall for each thickness, wavelength, 
and appropriate surrounding medium for the measurement to gather the d–
n continuum solutions for the layers. The procedure started with finding the 
optimized optical properties for the pure SPR sensor slide by accurately fitting the 
background SPR full angle scan measured for the same SPR sensor slide used for 
mono- and multilayer depositions. The optical properties of the pure SPR sensor slide 
were then kept constant and used as the starting point for finding the optical 
properties of the deposited sample layers. Parts A–C of Figure 1 show examples of the 
results of the Winspall fits to the SPR full angle scans measured in air with 655, 670, 
and 782 nm laser wavelengths for the pure SPR sensor slide and one SA monolayer 
deposited at 45 mN/m. Figure 1D on the other hand shows the SPR full angle scans 
measured in both air and water with a 783 nm laser wavelength for the pure SPR 
sensor slide and for 11 SA monolayers deposited at 45 mN/m. 
For the three-wavelength analysis, the d and n continuum solutions were plotted 
against each other, and the dn/dλ value was varied manually until a matching cross 
point between the wavelength pairs was found (Supporting Information, section SIV, 
Figure S4). In the case of the two-medium analysis the continuum solution was 
directly obtained by determining the cross point in the d–n plot obtained by 
analyzing the SPR full angle spectra of SA and HSPC multilayers measured in both air 
and water. The cross point determined through the two-medium analysis is also the 
unique solution for d and n of the corresponding multilayer. Tables 1 and 2 
summarize the results from the two-medium and three-wavelength analyses for these 
ultrathin films, respectively. 
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Figure 1 SPR full angle scans of the pure SPR sensor background (blue solid lines) and a single 
deposited SA monolayer (red solid lines) with corresponding Winspall fits (symbols and black 
dashed lines) measured with (A) 655 nm, (B) 670 nm, and (C) 783 nm laser wavelengths. (D) 
Measured SPR full angle scans of 11 SA layers measured with a 783 nm laser wavelength, 
both in air (solid lines) and in water (dashed lines). Inset tables show the optical parameters 
used for the Winspall fits (1 = prism, 2 = chromium, 3 = gold, 4 = sample layer, 5 = air) 
 
Figure 2 Example of finding the intersection points from thickness (d) versus refractive index (n) plots of 
(A) 1 monolayer of HSPC in air using the three-wavelength analysis and (B) 11 layers of SA 
with the two-medium analysis. The arrows emphasize the intersection point found in the 
graphs. 
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Table 1. Thickness (d), Refractive Index (n), Dispersion (dn/dλ), Thickness per Layer (d/Layer), and 
Error Estimates (“±”) Obtained from the Two-Medium Analysis for HSPC and SA Multilayer 
Films Deposited at 30 and 45 mN/m, Respectively 
HSPC d (nm) "" (nm) n(780nm) "" dn/dλcalculated d/layer 
3 LB 655 nm 8..86 0..01 1..506 0..001   2..95 
3 LB 670 nm 8..03 0..01 1..552 0..001   2..68 
3 LB 782 nm 8..65 0..01 1..525 0..001 0.00015 2.88 
3 LB 783 nm 7.65 0.01 1.599 0.001 0.00037 2.55 
AVG 8.30       0.00026 2.77 
STD 0.55         0.18 
              
SA d (nm) "+-" n(780nm) "+-" dn/dλ calculated d/layer 
11 LB 655 nm 28.76 0.01 1.512 0.001   2.61 
11 LB 670 nm 27.84 0.01 1.531 0.001   2.53 
11 LB 782 nm 29.26 0.01 1.509 0.001 2.6E-05 2.66 
11 LB 783 nm 28.60 0.01 1.520 0.001 9.0E-05 2.60 
AVG 28.62       0.00006 2.60 
STD 0.59         0.05 
 
 
Table 2. Table 2. Thickness (d), Refractive Index (n), Dispersion (dn/dλ), Thickness per Layer 
(d/Layer), and Error Estimates of the Cross Point Determination (“±”) Obtained from the 
Three-Wavelength Analysis in Air for HSPC and SA Monolayers Deposited at Two 
Different Surface Pressures and for SA Multilayers Deposited at 45 mN/m 
  d (nm) "" (nm) n(780nm) "" dn/dλ (1/nm)   
HSPC             
1 LB 10 mN/m 3.4 0.10 1.404 0.001 0.0002   
1 LB 30 mN/m 3.7 0.10 1.334 0.001 0.0002   
  
SA             
1 LB 15 mN/m 2.4 0.10 1.584 0.5 0.0002   
1 LB 45 mN/m 3.88 0.70 1.351 0.07 0.00015   
              
SA 45 mN/m d (nm) "" (nm) n(780nm) "" dn/dλ (1/nm) d/layer (nm) 
1 LB 3.88 0.70 1.351 0.07 0.00015 3.88 
3 LB 8.8 0.20 1.471 0.0099 0.00015 2.94 
5 LB 12.7 0.08 1.551 0.01 0.00015 2.54 
7 LB 17.9 0.29 1.536 0.0049 0.00015 2.56 
9 LB 21.9 0.09 1.571 0.00075 0.00015 2.43 
11 LB 26.4 0.34 1.573 0.0078 0.00015 2.40 
AVG ofLB 5-11   0.20 1.558 0.0057   2.48 
STD of LB 5-11   0.136 0.018 0.004   0.08 
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It is interesting to notice concerning the three-wavelength analysis (Table 2) that 
the thicknesses of the SA monolayers deposited at low and high surface pressures 
show large differences in their values, while the differences in the thicknesses 
obtained for the HSPC monolayers at low and high surface pressures are much 
smaller. This is in good agreement with the compression isotherms (Figure 
S3A,B, Supporting Information) and PM-IRRAS data (Figure S3C,D) of SA and HSPC 
monoalyers, which clearly indicated that the SA monolayer undergoes a structural 
ordering in the form of increased trans conformers along the hydrocarbon chain 
when the surface pressure is increased from 15 to 45 mN/m. On the other hand, the 
structural changes in the HSPC monolayer were merely due to a slight change in the 
tilt angle of the hydrocarbon chains with respect to the SPR sensor slide surface. 
As can be seen in Figure 2A, all the d–n continuum solutions obtained by the 
three-wavelength analysis in air did not necessarily cross perfectly as would be 
expected from a purely theoretical point of view. The reason for this was most 
probably the fact that the wavelength pairs in the SPR instrument used in this study 
actually measure the sample layers from two physically different spots. To take this 
uncertainty into account in the analysis, the parameter values were estimated 
graphically as the average of the two cross points in the d–n plots for different laser 
pairs (Supporting Information, section SIV), and the difference between the average 
of the cross points and the actual cross points has been given as an error estimate 
(“±”) in the values provided for each analysis in Tables 1 and 2. 
The three-wavelength analysis of single deposited monolayers of both HSPC and 
SA shows relatively high uncertainty in the obtained values, and it seems to 
overemphasize the thickness of the first layer compared with the two-medium 
analysis (Tables 1 and 2). However, the individual thicknesses obtained for SA mono- 
and multilayers plotted against the layer number in Figure 3A show an excellent 
linear dependency, as well as a transition of the intersection with the y axis at 1.7 nm. 
The transition is on the order of magnitude of the peak-to-peak roughness of 2 nm of 
the SPR sensor slide (Supporting Information, section SV, Figure S5). The linear 
trend of the individual analyses of the SA mono- and multilayers confirms that the 
three-wavelength analysis behaves as expected aside from the deviation in the first 
layer. The slope in the d-layer number plot of the SA mono- and multilayers gives a 
thickness of 2.24 nm/layer, while the three-wavelength analysis for SA multilayers 
with five or more deposited layers gives an average thickness of 2.48 ± 0.08 nm 
(Table 2). This is in good agreement with the value of 2.6 ± 0.05 nm obtained from 
the two-medium analysis (Table 1). The average layer thicknesses obtained from both 
the three-wavelength and two-medium analyses correspond well to the theoretical 
length of 2.5 nm of SA, [33] the thickness of 2.66 ± 0.05 nm reported for Cd–stearate 
monolayers, [17, 33] and the average thickness between 2.66 and 2.79 nm/layer 
obtained with ellipsometry for arachidic acid/uranyl acetate multilayers. [34] 
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Figure 3 Dependency of the (A) thickness (d) and (B) refractive index (n) on the deposition layer 
number for SA mono- and multilayers analyzed using the three-wavelength analysis. The 
thickness has an excellent linear dependency with a slope of 2.24 nm and a y intersection at 
1.7 nm. The refractive index increases for the first deposited layers and levels out after five 
deposited layers. The error bars portray the uncertainty in the graphical determination of the 
intersection from thed–n plots. 
The individually extracted refractive indices from the three-wavelength analysis 
for the SA mono- and multilayer films plotted against the layer number in Figure 3B 
show a nonlinear increasing trend in the refractive index values, which levels out 
after five deposited layers. This can be explained by a space-filling model where the 
first couple of deposited layers partially follow the roughness of the SPR sensor 
surface, and then the layers gradually bridge the gaps and finally start to deposit 
more smoothly with better organization and orientation when more layers are 
deposited. This probably also causes the slightly lower thickness of 2.24 nm/layer for 
the SA monolayers obtained from the slope in Figure 3A compared with the 
individually determined average thicknesses obtained from the three-wavelength and 
two-medium analyses. 
The results obtained from the three-wavelength analysis indicate that this 
approach detects the real thickness and the apparent (layer density dependent) 
refractive index of the ultrathin layers. The two-medium analysis, on the other hand, 
probes the real refractive index and the apparent thickness of the sample layers. This 
is surprising, as usually similar optical methods are thought to give an apparent 
thickness of a virtual full layer, which is of course always lower than the real layer 
thickness if there is any roughness present in the system. The three-wavelength SPR 
analysis on the other hand uses multiple and simultaneous probing wavelengths 
which interact with the system slightly differently. This means that, although the 
dispersion coefficient has to be empirically determined, or assumed if only two 
wavelengths are used, the three-wavelength analysis actually determines the real 
layer thickness more accurately than the single-wavelength analysis where the 
refractive index has to be completely assumed or is taken from literature sources for 
bulk materials. Regarding the dispersion coefficient, it is obvious that the uranyl 
acetate counterion clearly has a smaller effect on the refractive index of the 
condensed monolayers than the cadmium ions, which earlier showed a very large 
dn/dλ value of 0.00463 for Cd–stearate. [17] The dispersion coefficient values 
obtained for the ultrathin films in this study are close to those of other organic 
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compounds, such as palmitic acid (dn/dλ ≈ 0.00005) [35] and different polymers 
(0.00008–0.00003), [36] and those obtained for the polyelectrolyte multilayers (see 
the SPR analysis of polyelectrolyte multilayers section below). This difference is 
probably due to the fact that the Cd–stearate monolayer is arranged in a hexagonal 
crystalline lattice, while uranyl acetate and other complex counterions result in a less 
ordered packing in the monolayers, and therefore, the optical properties of the layer 
are not affected by the crystallization. 
6.3.7 THREE-WAVELENGTH SPR ANALYSIS OF POLYELECTROLYTE 
MULTILAYERS 
Two types of polyelectrolyte multilayers, i.e., PSS–PAH and HA–PLL, with 
different growth characteristics and properties were chosen for three-wavelength 
analysis. The thickness of the PSS–PAH polyelectrolyte multilayer is known to grow 
relatively slowly for each additional layer, but with quite dense layers. [37] The 
thickness of the HA–PLL polyelectrolyte multilayer grows very fast, forming 
relatively low density layers compared with the PSS–PAH multilayer. [38] As the 
PEM deposition can include tens or hundreds of layers, only a few layers close to the 
beginning of the depositions were characterized in detail. The actual three-
wavelength characterization of the polyelectrolyte multilayers followed the same 
procedure as described earlier for the LB deposited SA and HSPC mono- and 
multilayers, with the exception that the SPR full angle spectra for the polyelectrolyte 
multilayers were measured in liquid media and not in air as was the case for the LB 
films. Table 3 summarizes the results obtained for the thicknesses and refractive 
indices for 3, 5, and 10 bilayers of PSS–PAH and 2 and 5 bilayers of HA–PLL 
polyelectrolyte multilayers. 
 
Table 3. Thickness (d), Refractive Index (n), Dispersion (dn/dλ), Thickness per Layer (d/Layer), and 
Error Estimates (“±”) Obtained from the Three-Wavelength Analysis for PSS–/PAH and 
HA–PLL Polyelectrolyte Multilayer Films 
 No. of bilayers d (nm) "" (nm) n(780nm) "" dn/dλ (1/nm) d/layer (nm) 
PSS:PAH             
3 9.2 0.5 1.495 0.010 0.00003 3.07 
5 16.8 0.5 1.481 0.005 0.00003 3.36 
10 35.0 1 1.470 0.005 0.00002 3.50 
120  
(782 nm) 400.0   1.501     3.33 
120  
( 655 nm) 404.0   1.503     3.37 
              
HA:PLL             
2 25.2 3 1.356 0.001 0.00003 12.61 
5 67.1 3 1.351 0.001 0.00005 13.42 
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The characteristic behavior of the two different polyelectrolyte multilayers is very 
clear; i.e., the thickness per layer for the HA–PLL polyelectrolyte multilayer is always 
at least 4 times larger than the thickness per layer for the PSS–PAH polyelectrolyte 
multilayer and already reaches a thickness of 67 nm after five deposited bilayers. 
The thicknesses per layer for both polyelectrolyte multilayers also increase slightly 
with the number of layers, which is often the case because the first few layers during 
polyelectrolyte multilayer buildup usually grow in a nonlinear fashion. [37, 
38] Furthermore, the refractive indices obtained for the HA–PLL polyelectrolyte 
multilayers are clearly smaller than for the PSS–PAH polyelectrolyte multilayers. The 
results from the three-wavelength analysis of the polyelectrolyte multilayers are in 
good agreement with the facts that HA–PLL polyelectrolyte multilayers exhibit 
exponential growth characteristics, forming low-density layers. [38] PSS–PAH has 
been reported to exhibit a linear growth pattern with high–density layers. [37] The 
thickness values obtained from the three-wavelength analysis for the polyelectrolyte 
multilayers correlate very well with previously reported thickness values of 4 
nm/layer for PSS–PAH polyelectrolyte multilayers, especially when taking into 
account that the concentration used for the polyelectrolyte multilayer buildup in the 
present study was 1/10 of the concentration normally used. [37] 
The results obtained from the three-wavelength analysis for both the LB films and 
the polyelectrolyte multilayers indicate that the SPR technique can effectively be 
utilized for characterizing optical properties of ultrathin films without previous 
knowledge of the system. While the examples in this study still show some 
uncertainty in the results, the three-wavelength analysis approach is rather easy to 
perform, while the level of the uncertainties can be easily estimated and evaluated for 
acceptance. Critical assessment of the limits of detection and accuracy of the three-
wavelength SPR analysis presented in this study in comparison to established 
methods such as ellipsometry or SE have proven difficult because of insufficient 
literature available. However, a careful evaluation of published results on ultrathin 
film measurements indicates that the SPR three-wavelength analysis approach is able 
to characterize thinner layers with less uncertainty for the extracted thickness and 
refractive index values. Additionally, the ability of the three-wavelength SPR analysis 
to determine the real thickness instead of apparent thickness obtained from single-
wavelength and two-medium analysis could be extremely beneficial in the future 
when characterizing ultrathin films in the range of a few to tens of nanometers. 
Schoch and Lim recently published a study [39] where SPR was used for analyzing 
the layer thickness by utilizing a noninteracting sample which probes the excluded 
volume created by the layers on the sensor surface. Their study showed a capability of 
determining the real thickness and apparent (layer density dependent) refractive 
index of thin organic layers similar to that of the three-wavelength analysis approach 
presented in the current study. As stated by Schoch and Lim, self-assembly of 
polymers into loose solvated polymer brushes tends to occupy a space related to their 
hydrodynamic size, and use of the bulk material refractive index is clearly incorrect 
for such systems. Therefore, any approach that can take into account the material 
density related refractive index is always more correct than using bulk refractive 
indices. The benefit of their approach is that it does not need any knowledge about 
the underlying optical system (sensor structure), but it is a relative measurement, 
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unlike the analysis approach presented in the current study. However, the approach 
of Schoch and Lim requires a lot of knowledge about the sample layer properties, 
reference cells, and a noninteracting probe sample, which actually makes it quite a 
tedious measurement to perform in practice. The analysis approach presented in the 
current study does not need any of these. Furthermore, the molecular probes 
approach utilized by Schoch and Lim is suitable mostly for liquid-phase 
measurements, and there will always be an issue of finding completely noninteracting 
samples with sufficiently high refractive index. After all, most noninteracting 
samples, such as polysaccharides and polyethylene glycol, are materials with 
extremely low refractive index, which produce low signal responses in SPR. In 
addition, Schoch and Lim claim that their approach bypasses the refractive index 
constraint in SPR. However, one of the most important properties of organic layers is 
the real refractive index, which should not be neglected, especially for layer-related 
optical applications. From another point of view, the refractive index itself reflects the 
integrity of the deposited layers, because the refractive index is sensitive to the 
molecular packing density of the sample layers. 
6.3.8 SPR ANALYSIS OF RELATIVELY THICK FILMS 
It is possible to build very thick and dense layers with polyelectrolytes under 
proper experimental conditions and by the choice of the polyelectrolytes used for the 
layer buildup. It has been shown that the PSS–PAH polyelectrolyte pair can be used 
to prepare polyelectrolyte multilayers consisting of hundreds of layers, partly because 
of its ability to form densely packed layers with linear growth characteristics. 
[37] Figure 4A shows a time sensogram of the change in SPR minimum angle 
measured with a 655 nm laser wavelength for 110–120 PSS–PAH bilayers. Every 
single peak in the time sensogram represents an injection of an oppositely charged 
polyelectrolyte followed by a rinsing period. The time sensogram clearly shows that 
the signal from the growing PSS–PAH polyelectrolyte multilayer was still behaving in 
a linear fashion when the SPR waveguide mode minimum was monitored. It is also 
clear from the sensogram that the SPR waveguide mode is still sensitive enough to 
measure the addition of nanometer-scale layers on top of the waveguide layer, and 
not only for detecting changes in the layer density in the form of sample absorbing 
into the waveguide as shown earlier. [23, 24] 
Interestingly, the PSS–PAH polyelectrolyte multilayer induced an SPR waveguide 
when approximately 100 bilayers had been deposited, which could be seen as a 
dramatic decrease in the SPR peak intensity, as well as the appearance of an 
additional peak at lower angles compared with the main SPR peak (Figure 4B). The 
waveguide formed by the PSS–PAH polyelectrolyte multilayer also showed a 
significant wavelength dependency (Figure 4B,C). The SPR resonance peak in the 
SPR full angle scan measured with the 655 nm laser wavelength has progressed 
enough to higher angles to be clearly distinguishable from the additional waveguide 
peak appearing in the critical angle region of the SPR spectrum (Figure 4B). The SPR 
full angle spectrum measured with a 782 nm laser wavelength for the same layer 
thickness shows that the main SPR resonance peak and the waveguide peak in the 
critical angle region can still be detected as an overlapping optical phenomenon 
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(Figure 4C). However, an overlapping critical angle and the main SPR resonance peak 
can still be used to calculate the thickness of the layer. 
 
Figure 4 (A) Time sensogram of the change in SPR minimum angle measured with a 655 nm laser 
wavelength for 110–120 bilayers. SPR full angular scans (solid red lines) and corresponding 
Winspall fits (dashed black line) for 120 bilayers of PSS–PAH polyelectrolyte multilayers 
measured with (B) 655 nm and (C) 782 nm laser wavelengths. (D) SPR full angle scan of a 
spin-coated PS–PMMA copolymer layer measured in air with a 670 nm laser wavelength (red 
solid line) and the corresponding Winspall fit (black times signs, dashed black line) plotted 
together with a pure gold background (blue solid line). The inset table in (D) shows the optical 
parameters used for the Winspall fit (1 = prism, 2 = chromium, 3 = gold, 4 = PS–PMMA layer, 
5 = air). 
Actually, whenever a layer is thick enough to induce an SPR waveguide mode in 
the SPR full angle spectrum, then there is only one solution for the real thickness and 
the apparent (layer density dependent) refractive index, which means that there is no 
need to assume one or the other. The thicknesses and refractive indices obtained by 
fitting the SPR full angle spectrum measured for the 120 bilayer thick PSS–PAH 
polyelectrolyte multilayer with two different laser wavelengths of 655 and 782 nm 
were 404 and 400 nm and 1.503 and 1.501, respectively (Table 3). The thickness per 
layer is also in good agreement with the values obtained for the PSS–PAH 
polyelectrolyte multilayers consisting of 5 and 10 bilayers. The refractive index 
obtained for the thick PSS–PAH polyelectrolyte multilayers was on the other hand 
slightly larger than the refractive indices obtained for 5 and 10 bilayers. This is a 
consequence of the fact that polyelectrolyte multilayers that form dense layers tend to 
compact their structure with increasing layer number by excluding excess water from 
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the layer structure. [37] The resonant waveguide peaks actually retain the thickness 
development after its formation, which is evident from the waveguide node minimum 
shift (Figure 4A). This makes it possible to use them to characterize both the 
thickness and refractive index of thick organic layers or as a detection element in 
biosensor assays, which has also previously been shown in the literature. [22, 23] 
Finally, it was also possible to measure waveguides deposited ex situ in a fashion 
similar to that for the in situ prepared waveguides of PSS–PAH polyelectrolyte 
multilayers. This allows for the determination of the real thickness and apparent 
(layer density dependent) refractive index for other types of relatively thick layers as 
well. Figure 4D demonstrates this for a spin-coated PS–PMMA copolymer layer. The 
SPR full angle scan measured in air with a 670 nm laser wavelength now shows all 
together three distinct peaks caused by the thick spin-coated PS–PMMA layer. The 
thickness and the refractive index determined for the PS–PMMA layer were 765.7 nm 
and 1.554, respectively (inset table in Figure 4D). The refractive index of the PS–
PMMA layer is in very good agreement with the weighted average of the refractive 
indexes of pure PS (1.58425 at 670 nm) and PMMA (1.48741 at 670 nm) when 
considering that PS–PMMA contains 24% PMMA, i.e., 1.561. The slight nonzero 
imaginary part in the refractive index for the PS–PMMA layer indicates that there is 
some loss of light in the material, which may occur, for example, when light is 
reflected from an inhomogeneous surface or cracks in the spin-coated film. 
6.4 CONCLUSIONS 
 
A three-wavelength angular-scanning surface plasmon resonance based analysis has 
been demonstrated to be an efficient approach for determining ultrathin films 
thicknesses within the range that is difficult to access with other methods. The 
applicability of the multiparametric SPR (MP-SPR) for measuring the film thickness 
and optical property determination with relatively thick films using SPR waveguide 
modes was also demonstrated. These results can be utilized in characterizing and 
building different detection platforms for sensor development, life sciences, and drug 
development, as well as for obtaining fundamental information about the optical 
properties of different biological and organic systems. A one-instrument approach for 
accurately characterizing such layers without the help of any other instrument was 
successfully presented in this work. A critical assessment of the limits of detection 
and accuracy of the three-wavelength SPR analysis compared to the established 
ellipsometry or SE methods could not be done due to insufficient literature in the 
area. A careful evaluation of the few publications with results on ultrathin film 
measurements indicates, however, that the SPR three-wavelength analysis approach 
is able to characterize thin layers with good accuracy for the resulting thickness and 
refractive index values. 
The ability to perform SPR measurements at multiple wavelengths allows both for 
an accurate characterization of ultrathin films and also for characterizing relatively 
thick organic layers in the micrometer range. By proper wavelength selection in the 
future, it should also be possible to almost completely cover the SPR “blind spot”, in 
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which the SPR angle is too high to be modeled, but the waveguide resonance mode 
has not yet been reached. 
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6.6 APPENDIX: SUPPORTING INFORMATION 
6.6.1 SI THEORY OF SPR 
Surface plasmons are particle waves of the free electron plasma on a metal surface, 
which can be excited by p-polarized light under the resonance condition (Figure S1). 
A theoretical mathematical description for the resonance condition can be obtained 
by solving the Maxwell equations for a multilayer optical system [1], which provides 
the following mathematical solution for the resonance condition:  
 
?
? ??????? ? ???????
????
?????
 ,   (S1) 
 
where ω is the angular frequency of light, c is speed of light in vacuum, and ε0, ε1 
and ε2 are the permittivities of the prism, SPR metal layer and the adjacent medium, 
respectively. 
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Figure S1. Schematic representation of the Kretschmann configuration of the SPR used in the 
study. A) When the projected wave vector of the incident light do not match the wave vector of 
surface plasmons no excitation occurs. B) At a certain incident light angle the projected wave 
vector of the incident light matches the wave vector of surface plasmons, which is dependent 
on the wavelength of light used and the dielectric properties of the prism (0), metal layer (2) 
and the surrounding medium (1). 
 
The permittivity and refractive index of materials can be used in their complex 
forms: 
 
? ? ? ?? ? ????     (S2) 
? ? ? ? ????? ??? ? ??.     (S3) 
 
Where ε, ε' and ε" are the complex permittivity, real- and imaginary part of the 
complex permittivity, respectively. ñ, n and k are the complex refractive index, real- 
and imaginary part of the complex refractive index, respectively. Permittivity and 
refractive index have the following relationship: 
 
? ? ??      (S4) 
? ? ?? ? ???.     (S5) 
 
A general answer for a multilayered system linked to measurable or controllable 
variables can be solved using a transfer matrix formalism of 22 matrices. The overall 
formalism has already been published several times, and it is not in the scope of this 
article to discuss it in detail again. [1,2] 
 In practice this matrix formalism is solved by mathematical fitting tools, or by 
dedicated software tools developed for this, such as Winspall [3]. 
6.6.2 SII REFRACTIVE INDEX LINEARITY APPROXIMATION 
So called Cauchy materials, such as most polymers and metal oxides, have a non-
linear dependency between wavelength and the refractive index. However, in a 
relatively small wavelength region this dependency can be approximated as linear, 
which is apparent from Figures S2. The refractive index (n) obtained from Kasarova 
et al. [4] has been fitted with a linear regression in Figure S2. The separately marked 
triangles emphasize the measurement wavelengths used in the SPR analysis in the 
current study. It can be seen from Figure S2 that the red-visible region refractive 
index dependency on wavelength can be approximated as the residual of the linear fit 
which is approximately 2% (R-value), and visually one can see that the linear fit also 
describe the relevant region with good correlation. 
 
 103 
 
 
Figure S2. Wavelength dependency of the refractive index for three different polymers 
(plastics). The Red lines are linear fits to the data in the wavelength region between 0.6 – 0.8 
µm. The colored triangles emphasize the wavelengths used in the SPR analysis in the current 
study. 
6.6.3 SIII LANGMUIR AND LANGMUIR-BLODGETT TECHNIQUE AND PM-
IRRAS CHARACTERIZATION OF MONOLAYERS 
In this study we utilized the Langmuir-Blodgett technique for preparing well defined 
thin organic films with controlled number of layers in order to clarify how well a 
multi-wavelength SPR detection could be used for simultaneous determination of the 
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thickness and refractive index of ultrathin films in the thickness range 1-10 nm. The 
Langmuir-Blodgett (LB) technique is a well established method that enables 
controlled depositions of mono- and multilayers of a water insoluble organic 
amphiphilic substance floating on an air-water interface [5]. Deposition takes place 
by single or repeated immersions of a solid substrate through the floating monolayer 
at a controlled molecular packing density. Thus, the LB technique allows to precisely 
controlling the number of deposited layers and consequently the thickness of thin 
organic amphiphilic sample layers on solid substrates. Often multivalent counter ions 
are used in the subphase beneath the floating monolayer in order to facilitate the 
deposition of good quality mono- and multilayers [6-9]. 
 
 
Figure S3. A) Compression isotherms for SA and HSPC monolayers on pure water (blue solid 
lines) and 10-5 UAc subphases (red solid lines). PM-IRRAS spectra of the CH-region of B) SA 
and C) HSPC monolayers deposited on the SPR sensor slide at different surface pressures; 
low surface pressure (blue solid lines) and high surface pressure (red solid lines). 
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6.6.3.1 PM-IRRAS measurements 
PM-IRRAS spectra measured for organic ultrathin films deposited on IR reflective 
substrates have proven to provide valuable information about the orientation, 
conformation and structural order of the molecules in the sample layer, even for 
single monolayers [10-11]. These properties on the other hand have an influence on 
the thickness and optical properties of ultrathin organic layers determined by optical 
techniques, such as SPR, especially in the case of the first deposited layers. In order to 
detect any clear differences in orientation or structural order in the deposited 
monolayers of SA or HSPC we collected PM-IRRAS spectra for monolayers deposited 
onto SPR sensor slides from UAc containing subphases at two different surface 
pressures (Figure S3B and S3C). 
 The PM-IRRAS spectra for the C-H stretching mode region measured for both SA 
and HSPC monolayers show bands at 2965 cm-1, 2920 cm-1, 2880 cm-1 and 2850 cm-1, 
which are assigned to the CH3 asymmetric stretch, CH2 asymmetric stretch, CH3 
symmetric stretch and CH2 symmetric stretch vibrations, respectively [12-13]. For the 
SA monolayer an increase in the surface pressure, i.e. an increase in packing density, 
shifts the IR band at 2920 cm-1 slightly towards lower wavenumbers, whereas the 
band at 2880 cm-1 grew more discrete and shifted to slightly higher wavenumbers. 
These changes in the PM-IRRAS spectra indicates that the SA monolayer possess an 
increasing number of trans conformers along the hydrocarbon chain for the 
monolayer deposited at higher surface pressure [14]. This correlates with an 
increasing order in the SA monolayer at higher surface pressure, which should be 
reflected in the optical properties of the monolayer. In the case of the HSPC 
monolayer the PM-IRRAS spectra did not show any shift for the band at 2920 cm-1, 
whereas the bands at 2965 cm-1, 2880 cm-1 and 2850 cm-1 shifted to slightly higher 
wavenumbers. This indicates that the molecules in the HSPC monolayer obtain a 
slightly more perpendicular orientation against the SPR sensor slide surface without 
an increase in order when deposited at higher surface pressure. The isotherm 
behavior of the HSPC and SA monolayers also supports this, as no clear liquid-solid 
transformation can be seen for the HSPC monolayer, while the SA monolayer exhibits 
this transition at 40 mN/m. 
6.6.4 SIV THREE WAVELENGTH ANALYSIS METHOD  
The thickness (d) versus refractive index (n) continuum solutions for the sample 
layer deposited on the SPR sensor slide were obtained by using Winspall [3] to fit the 
SPR full angle scan measured at a specific laser wavelength. The optical properties of 
the sample layer were then fitted by fixing the previously optimized optical properties 
for the pure SPR sensor slide, and then keeping n constant while fitting d for the 
sample layer. This was then repeated for n-values between 1.2-1.6 with an increment 
of 0.2. The d-n continuum solutions obtained by this procedure for a HSPC 
monolayer are shown in Figure S4A for the three different wavelengths used in this 
study. Hereafter, the d-n curve for 655 nm was kept in place and the d-n curves for all 
the other wavelengths were shifted by varying the dn/dλ value manually so that the 
two cross-points for the different laser pairs were as close as possible to each other, 
both in the d and n direction (Figure S4B). The positions of cross-point #1 and cross-
III Characterizing Ultrathin and Thick Organic Layers by Surface Plasmon Resonance Three-Wavelength 
and Waveguide Mode Analysis 
106 
point #2 were then used to calculate the average cross-point, which then provided d 
and n for the sample layer in question. The difference between the average cross 
point and the actual cross points (i.e. cross-point #1 and cross-point #2) was then 
taken as the error estimate (“±”) in the values provided for each analysis. 
 
Figure S4. A) The d-n continuum solutions obtained at different SPR laser wavelengths for a 
HSPC monolayer deposited at 30 mN/m. B) Illustration of the optimal cross-points found after 
shifting the d-n continuum solutions for 670 nm, 783 nm and 782 nm by dn/dλ = 0.0002   
with respect to d-n continuum solution for 655 nm. The circle in B) represents the error 
estimate form the cross-point analysis. 
6.6.5 SV SPR SENSOR ROUGHNESS 
The information about the roughness of the SPR sensors slide has been kindly 
provided by the sensor manufacturer. The roughness has been measured using AFM 
analysis. Rq average of 5 independent measurements was 0.890 nm. It is apparent 
from the Gaussian-shaped thickness population in Figure S5 that approximately 70-
90% of the thickness is within +-1 nm from the average thickness. 
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Figure S5. AFM image and height histogram of a pure SPR sensor slide surface.  
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6.7 APPENDIX: ADDITIONAL INFORMATION 
The multiple wavelength SPR analysis presented in section 5.3.2 can also be 
expanded from the three-wavelength into a general solution with N-possible 
wavelengths. In such case, it is also possible to use a true Cauchy dispersion relation 
instead of the linear approximation of dn/dλ. The previous considerations would be 
transferred into a general solution with N wavelengths: 
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where 
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that can be in most cases simplified into the first two terms: 
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 The three wavelength solution has been empirically tested in this dissertation, 
and was found to function well in both liquid and gaseous media down to single 
molecular monolayer thicknesses. The general Cauchy dispersion is currently only a 
theoretical consideration at the moment due to limitations in current 
instrumentation. But as it seems to be clearly beneficial to add additional probing 
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wavelengths, it is quite probable that a commercial instrument manufacturer will 
soon come up with systems capable of carrying such measurements. The evaluation 
of the above general theory will need to wait for such situation.  
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7 IV CONTROL OF THE MORPHOLOGY OF LIPID 
LAYERS BY SUBSTRATE SURFACE 
CHEMISTRY 
Abstract 
 
In this study, surface coatings were used to control the morphology of the deposited 
lipid layers during vesicle spreading, i.e. to control if liposomes self-assemble on a 
surface into a supported lipid bilayer or a supported vesicular layer. The influence of 
the properties of the surface coating on the formation of the deposited lipid layer was 
studied with quartz crystal microbalance and two-wavelength multi-parametric 
surface plasmon resonance techniques. The control of the lipid self-assembly on the 
surface was achieved by two different types of soft substrate materials, i.e. dextran 
and thiolated polyethylene glycol, functionalized with hydrophobic linkers for 
capturing the lipid layer. The low-molecular-weight dextran-based surface promoted 
a formation of supported lipid bilayers, while the thiolated polyethylene glycol-based 
surface promoted a supported vesicular layer formation. A silicon dioxide surface was 
used as a reference surface in both measurement techniques. In addition to 
promoting the supported lipid bilayer formation of known lipid mixtures, the dextran 
surface also promoted a supported lipid bilayer formation of vesicles containing the 
cell membrane extract of human hepatoblastoma cells. The new dextran-based 
surface was also capable of protecting the supported lipid bilayer against dehydration 
when exposed to a constant flow of air. The well established quartz crystal 
microbalance technique was effective in determining the morphology of the formed 
lipid layer, while the two-wavelength surface plasmon resonance analysis enabled a 
characterization of the adsorbed supported lipid bilayers and supported vesicular 
layers. 
 
 
 
 
 
 
 
 
 
 
*Reproduced with permission from: Granqvist N, Yliperttula M, Välimäki S, 
Pulkkinen P, Tenhu H, Viitala T (2014) Control of the morphology of lipid layers by 
substrate surface chemistry. Langmuir (ASAP 24.2.2014 web) 
(http://dx.doi.org/10.1021/la4046622). Copyright 2014 American Chemical Society. 
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7.1 INTRODUCTION 
The understanding of different biochemical interactions present in human physiology 
is one of the primary goals of modern biochemistry and pharmaceutical research. 
Many of the methods and approaches for studying biochemical interactions use full 
systemic experiments on either human or animal physiology. Human or animal 
experiments are difficult to perform both from an experimental and an ethical point 
of view. Especially analyzing in vivo results as well as evaluating different causalities 
is often very complicated. Therefore, both the study of biochemical interactions and 
the current pharmaceutical development relies heavily on different in vitro 
experimentations[1,2]. Most of these in vitro methods are either relatively simple and 
do not mimic the in vivo situation very well, such as the parallel artificial membrane 
permeation assay (PAMPA)[2,3], or are quite complicated, making the control of the 
system difficult, as is the case with most cell screening assays[4,5]. Furthermore, 
these in vitro methods often use fluorescently labeled compounds, do not enable 
measurements in real-time and rely on secondary detection techniques. The overall 
efficiency (cost per new drug entering the market) is decreasing constantly, partly 
because an effective transfer of new formulations from laboratory scale to the clinic is 
very slow[6]. Hence, there is a clear need for new, more efficient and/or cost-effective 
methods for screening biochemical interactions that could provide complementary 
information to already existing in vitro methodologies, as well as reduce the need of 
ethically questionable in vivo studies. 
Supported lipid membrane structures, i.e. supported lipid bilayers (SLBs) and 
supported vesicle layers (SVLs), are excellent biomimetic systems because they 
closely resemble cell membranes and other biological barriers consisting mostly of 
phospholipids.. It is possible to incorporate membrane proteins, receptors and other 
biologically relevant molecules into these lipid membrane structures to mimic 
biological membranes with specific functionalities[7]. For example, it is possible to 
prepare asymmetrical SLBs so that the mobility of the lipids and other components is 
very near to that of the membranes found in the nature. The biological similarity of 
such cell membrane models can be excellent in the context of interaction research[8]. 
Traditionally SLBs and SVLs are prepared directly on a solid support by vesicle fusion 
or vesicle adsorption, respectively[9]. This method is often used in combination with 
several label-free detection techniques, such as quartz crystal microbalance (QCM), 
dual polarization interferometry (DPI) and surface plasmon resonance (SPR).   
The common applications of cell membrane model systems are in membrane 
biophysics for SLBs[9] and in studying biochemical interactions between soluble 
compounds and lipids or membrane proteins for SVLs[10]. The SLBs and SVLs have 
also been introduced for pharmaceutical research[8,11,12]. But there are still several 
challenges such as control of the morphology between SLB and SVL, incorporation of 
membrane proteins and other membrane components of interest, as well as the 
method robustness and the lack of assays showing all these three properties together. 
The control of morphology has been extensively studied on inorganic supports, for 
example SLBs are readily formed on SiO2 substrate and SVLs on Au and TiO2[9,13]. 
Also specific linking chemistry, such as biotin-avidin, HisTag, nucleotides and ionic 
interactions between polyelectrolytes and charged lipids have been used to bind lipid 
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bilayers on solid support[14,15].  However, often the challenge with both SLBs and 
SVLs is that the formed lipid layers are unstable and sensitive for irreversible 
denaturation of the membrane structure upon transition through the air-water 
interface[16]. Improvements in the stability of SLBs against this denaturation have 
recently been demonstrated by using cholesteryl functionalized hydrated polymer 
supports[17], strongly-interacting metal chelated SLBs[18] and by “sandwiching” 
SLBs between the support and proteins[16] or PEG[19]. In the case of using linking 
chemistry in formation of SLBs or SVLs one of the counterpart is also left on top of 
the final lipid layer[14], which can influence the surface properties and interactions of 
the lipid layer. The advantage of using hydrophobic linkers such as alkane chains or 
cholesterol immobilized on the support is that they do not introduce unwanted 
counterparts on top of the lipid layer[14,17]. 
In this study we have focused on improving the control of the morphology of the 
supported layer (SLB vs. SVL) as well as the air stability of supported lipid 
membranes using polymeric supports. Furthermore, our aim was to enable an SLB 
formation of vesicles composed of known lipid mixtures, or a mixture of cell 
membrane extract of human hepatoblastoma cells (HepG2) and known lipid mixture 
in order to prepare SLBs with high biological relevance for biochemical and 
pharmaceutical applications. The support materials for anchoring either SLBs or 
SVLs were loose networks of hydrated polymers functionalized with hydrophobic 
linkers acting as a cushion between the supported lipid membrane structure and the 
substrate. The surfaces were prepared from commercially available dextran and a 
custom-synthesized thiol containing polyelthylene glycol–polymer (PEG-SAM). 
Silicon dioxide (SiO2) surface was used as a reference support due to its well-known 
ability to promote SLB formation by vesicle spreading[9]. Three different known lipid 
mixtures and one cell membrane extract composition were used to study the type of 
lipid structure that was promoted by the different supports. 
7.2 MATERIALS AND METHODS 
7.2.1 MATERIALS  
Sodium chloride, sodium hydroxide, calcium chloride, 50% hydrogen peroxide, 
concentrated ammonia, HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid), 11-mercaptoundecanol, epichlorohydrin, bromoacetic acid, decylamine, EDC 
(1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride), NHS (N-
Hydroxysuccinimide), ethanolamine, PBS (phosphate buffered saline, tablet P4417)  
and Dextran (Mr = 6kDa from Leuconostoc spp.) were obtained from Sigma-Aldrich 
(Helsinki, Finland). B-03 labeled biotin was obtained from Episentec Ab (Sollentuna, 
Sweden). EggPC (Egg phosphatidylcholine), POPS (palmitoyl-oleyl-
phophatidylserine), cholesterol (from lamb wool) and CHAPS (3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate) were obtained from Avanti 
Polar Lipids (Alabama, USA). Ethanol (95%) was obtained from Altia Corporation 
(Rajamäki, Finland). Hellmanex II was obtained from VWR Finland (Helsinki, 
Finland). All water used in the experiments had a resistivity of 18.2 MΩ/cm.  
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The PEG-SAM was synthesized from a commercial PEG45–polymer with OH-end 
groups and a molecular weight of 2 kD, obtained from Polysciences Inc 
(Pennsylvania, USA). The synthesized PEG-SAM had the general structure of 
H2C=CH-(CH2)9-PEG-(CH2)10-SH, or an analogous disulfide dimer. The reagents 
and methods used in the synthesis of the PEG-SAM are described in detail in the 
Supporting information section S1.  
Gold and SiO2-coated SPR sensors were obtained from BioNavis (Ylöjärvi, 
Finland), and similarly coated 5 MHz QCM crystals were obtained from Q-Sense 
Inc./BiolinScientific (Västra Frölunda, Sweden). 
7.2.2 SURFACE SYNTHESIS 
Two different lipid-binding surface coatings were synthesized on gold coated sensors 
for SPR and QCM measurements. The surface coatings on both the SPR and QCM 
sensors were simultaneously prepared in the same reaction vessels in order to have as 
identical coatings as possible for both sensors. The dextran based surface was 
selected because the polysaccharide structure is close to the natural polysaccharides 
found in the cell membranes. The small 6 kDa size should make relatively thin and 
dense layers upon grafting to a surface and there are suitable chemical pathways to 
post modify it into a lipid anchoring surface[20,21]. The PEG-SAM was selected 
because PEG is well known for its biocompatibility and low interaction with SLBs and 
there are suitable chemical pathways which allow end-group modification of the PEG 
prior to grafting it to the support surface (see Supporting information S1). Both of 
these polymers have been shown to work well with SLB and SVL layers in previous 
literature[8]. 
The dextran coated (Dex6kDa) surface in this study was synthesized with slight 
modifications as described by Summanen et al.[20], which is a modification of the 
method by Löfås and Johnsson[21], i.e. 6kDa Dextran at a concentration of 300 g/L 
was used instead of 500 kDa Dextran at a concentration of 30 g/L, and 2 M 
bromoacetic acid was used instead of 0.5 M bromoacetic acid. The sensors were first 
cleaned by keeping them in a boiling H2O2:NH3:H2O (1:1:5)-solution for 10 minutes 
and then washed thoroughly with ultrapure H2O. Hereafter, the sensors were 
immersed in a solution of 5 mM mercaptoundecanol in an 8:2 ethanol:water-solution 
for 24 hours. The sensors were then allowed to react for 3 h with epichlorohydrin (2% 
v/v) in 0.1 M NaOH rinsed with water, transferred to a 300 g/L solution of dextran in 
0.1 M NaOH and left to react for 24 h. After this the sensors were washed thoroughly 
with ultrapure H2O and immersed in 2.0 M bromoacetic acid in 2 M NaOH for 24 h, 
after which the sensors were thoroughly washed with ultrapure H2O and stored at 
+4°C. The surface immobilized carboxylated dextran was then functionalized with 
decylamine by utilizing EDC/NHS activation chemistry. The carboxylated dextran 
surface was first activated by treating it for 10 minutes with a 80 mg/mL:20 mg/mL 
EDC/NHS in PBS buffer. Immediately after this, the activated dextran surface was 
treated with a 30 mg/mL decylamine suspension in PBS for 10 minutes. The surface 
was finally deactivated with a 1 M ethanolamine solution, washed thoroughly with 
ultrapure H2O and ethanol, dried and stored dry in +4 °C for later use. 
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   The PEG-SAM surface coating was prepared on gold coated sensors by using a 
simple self-assembly protocol. The sensors were first cleaned by keeping them in a 
boiling H2O2:NH3:H2O (1:1:5)-solution for 10 minutes, then washed thoroughly 
with ultrapure H2O and dried with nitrogen gas. The sensors were then immersed in 
a 2 mg/mL ethanol solution of the PEG-SAM for 24 h. After the formation of the self-
assembled PEG-SAM layer the sensors were finally washed thoroughly with ethanol, 
dried carefully with nitrogen and stored dry in +4 °C for later use. 
7.2.3 CELL MEMBRANE EXTRACT PREPARATION 
Cell membrane extract was produced from human hepatoblastoma cells (HepG2) 
derived from the liver tissue of a fifteen year old male (HB-8065, ATCC-LGC 
Promochem, USA). The cells were cultured in high glucose Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 μg/ml 
penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine and 100 mM sodium pyruvate 
in a humidified atmosphere containing 5% CO2 at 37° C. About 0.86 g HepG2 cells 
were allowed to melt on an ice well. Cell pellets were suspended into a harvest buffer 
(50 mM Tris-HCl /300mM mannitol, pH7). The cell suspension was centrifuged at 
800 x g for 5 min at 4 °C and the supernatant was thrown away. This step was 
repeated twice. The residue was suspended in a membrane buffer (50 mM Tris-
HCl/50mM mannitol and 2mM EGTA, pH7). Cells were then homogenized by using a 
cell homogenizer by 40 strokes and incubated on ice for 1 h. The solution was 
centrifuged at 800 x g for 10 min at 4 °C, and the supernatant was taken and further 
centrifuged at 15 000 x g for 1 h at 4 °C. Again, the supernatant was taken and 
centrifuged at 100 000 x g for 75 min at 4 °C. Finally, the supernatant was removed 
and the pellets were weighed and stored at -75 °C until used. Qualitative test for the 
presence of proteins in the extracted cell membranes was performed by using a Bio-
Rad Protein Assay Reagent kit (Cat.#500-0006), which verified that the cell 
membrane extract contained a substantial amount of protein. 
7.2.4 LIPOSOME PREPARATION 
Three different lipid compositions were used for the liposomes for the SPR and QCM 
studies. The EggPC was chosen as the majority of the lipids in prokaryotic cell 
membranes are phosphatidylcholines[22], and it offers a good combination of 
saturated and non-saturated lipids that are physiologically relevant. The POPS was 
added to the lipid mixture to simulate the natural negative charge that is exhibited in 
natural prokaryotic cell membranes. The cholesterol was added to the lipid mixture 
in order to mimic the natural cell membranes even further as it is one of the major 
components controlling the rigidity of cell membranes.  Liposomes were prepared 
with the sonication method[23]. The lipid compositions were 100 % EggPC, 75:25 % 
EggPC:POPS and 70:25:5 % EggPC:POPS:Cholesterol by molar ratio. A labeled 
liposome containing 100% EggPC (EggPC+Label) liposome and 1 μg/mL of B-03 
labeled biotin in the hydration buffer was also prepared for SPR experiments. 
Shortly, the liposomes were prepared by first drying the lipid mixture with a 
nitrogen flow, and rehydrated to a total lipid concentration of 1 mg/mL with a 
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HBS+Ca2+ buffer (20 mM HEPES, 150 mM NaCl, 3 mM CaCl2, pH 7.4). Hydration 
was allowed to take place for one hour with mixing every 15 minutes. After the 
hydration, the liposomes were sonicated with a Vibra-Cell VCX 750 sonicator (Sonics 
& Materials Inc., Newtown, CT, USA) in an ice-water bath until the solution became 
clear, which typically took 5-15 minutes depending on the lipid mixure. The quality of 
the prepared liposome solution was always checked with a Malvern Zetasizer 
3000HSA dynamic light scattering (DLS) instrument (Malvern Ltd., Malvern, UK). A 
hydrodynamic radius below 50 nm and a monomodal size distribution for the 
liposomes were required in order to accept the prepared batch for later use. The 
number averaged size of the liposomes obtained from DLS measurements were 27 
nm for EggPC, 27 nm for EggPC+PS, 39 nm for EggPC+PS+Chol and 27 nm for the 
EggPC+Label, respectively. The CONTIN analysis of the size distributions are 
presented in the supporting information (Figure S3). The liposome stock solutions 
were stored at +4 °C and used within 5 days. 
Labeled EggPC liposomes were prepared exactly as the other liposomes, except 
that 1 μL of 1 mg/mL B-03 labeled biotin in pure water solution was added to the 
HBS+Ca2+ hydration buffer during the hydration step.  
The lipsomes containing the HepG2 membrane extract were prepared with a 
method adapted from the work of Dodd et al.[24]. The HepG2 membrane extract 
from the centrifugation pellet was dispersed in a HBS+Ca2+ buffer to form a 10 
mg/mL stock solution, and then sonicated for 20 minutes in the same conditions as 
the other liposomes in this study This extract was then mixed with a 10 mg/mL pre-
sonicated stock solution of EggPC liposomes with a mass ratio of 4:10 extract:EggPC 
forming a total lipid concentration of 0.14 mg/mL. This solution was then sonicated 
for 5 minutes at the same conditions as described before for other liposomes in this 
study in order to mix the different liposome populations. The sonicated membrane 
extract mixture was always used for the QCM and SPR measurements within the 
same day of preparation. DLS measurements of the resulting HepG2-EggPC 
liposomes gave a number averaged size of 63 nm. The HepG2 cell membrane extract 
was mixed with EggPC because in general natural total extractsdo not fuse into SLBs 
due to the stability of natural extracts, but addition of more unstable lipid such as 
EggPC can results in a bilayer formation, as described by Dodd et al. 
7.2.5 QCM MEASUREMENTS  
The QCM measurements were performed with a KSV QCM-Z500 instrument (KSV 
Instruments, Helsinki Finland) at 20 °C. The flow rate used for the measurements 
was 250 μL/min and the running buffer was HBS (20 mM HEPES, 150 mM NaCl, pH 
7.4). The frequency and dissipation changes for the 3rd, 5th, 7th and 9th overtones 
(marked from here on as F3, F5, F7 and F9) were recorded during all experiments. 
The results were analyzed by using the KSV QCM-Z500 software (version 3.4). 
The silicon dioxide QCM sensors were washed in situ in the flow channel with 
sequential 5 min injections of 20 mM CHAPS, 2% Hellmanex II, 95 % ethanol and 
ultrapure H2O[25]. The experiments were performed by first measuring a baseline 
with the running buffer for approximately 10 minutes, then injecting a 0.1 mg/mL 
liposome solution for 8 minutes followed by a 10-minute rinse period with the 
IV Control of the morphology of lipid layers by substrate surface chemistry 
116 
running buffer. Samples were measured consecutively with a wash sequence between 
the samples. 
The Dex6kDa and PEG-SAM surfaces were washed in situ in the flow channel 
before the measurements by injecting 20 mM CHAPS for 5 minutes followed by 
rinsing with ultrapure H2O. The measurement sequence was the same as for the SiO2-
coated QCM sensors, with the exception that a 5-minute ultrapure H2O injection was 
added after the flush period with the running buffer, followed by a second flush 
period with the running buffer. 
The QCM thickness analysis of the lipid layers was performed by using either the 
Sauerbrey- or a viscoelastic model (equivalent circuit analysis) for the deposited lipid 
layers[26]. It was necessary to use two different models for QCM analysis, because 
the Sauerbrey model describes the thickness of a rigid layer (such as an SLB), and the 
equivalent circuit analysis provides the thickness and mechanical properties of a 
viscoelastic layer. Constant parameters used in the modeling were: density of 
lipid/liposome layer 1.0 g/mL, density of buffer 0.9986 g/mL and viscosity of buffer 
0.890 mPa s. 
7.2.6 SPR MEASUREMENTS 
The SPR measurements were simultaneously performed at wavelengths of 670 and 
785 nm with an MP-SPR instrument SPR Navi 200-L (BioNavis, Ylöjärvi, Finland). 
The measurements were performed at 20 °C and with a flow rate of 30 μL/min. The 
flow rate for the SPR measurements was selected so that the hydrodynamic flow 
conditions in the SPR flow channel matched the flow conditions in the QCM flow 
channel[27]. Theoretically, the SPR flow channel used in this study would have a 9 
times higher surface shear stress than the QCM flow channel if the same flow rate 
were used in both flow channels. 
SiO2 SPR sensors were washed in situ in the flow channel with sequential 3-min 
injections of 20 mM CHAPS, 2% Hellmanex II, 95 % ethanol and ultrapure H2O. The 
experiments were performed by first measuring the baseline with the running buffer 
for approximately 10 minutes, then injecting a 0.1 mg/mL liposome solution for 8 
minutes, followed by a 10-minute rinse/flush period with the running buffer. Samples 
were measured consecutively with a wash sequence in between the samples. 
The Dex6kDa and PEG-SAM surfaces were washed in situ in the flow channel before 
the measurements by injecting 20 mM CHAPS for 5 minutes. The SPR measurements 
did not need the same ultrapure H2O rinsing treatments as the QCM measurements. 
The air stability of the EggPC+PS+Chol lipid bilayers on Dex6kDa was measured by 
running air for 10 min at a flow rate of 200 μL/min over the SPR surface. After 
exposing the lipid bilayer to air, the surface was rewetted with the same HBS buffer, 
and the return of the baseline was recorded. The full SPR angular range was 
continuously monitored during this period, and the change to air and back to the 
buffer was confirmed in real-time from the critical angle (total internal reflection 
angle, TIR from now on) shift induced in the SPR angular spectrum when going from 
water-based buffer to air and back to the buffer. 
The thickness (d) and the real refractive index (RI) of the lipid layer structures 
were calculated by using the SPR Navi LayerSolver software v. 0.16 (BioNavis Ltd, 
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Ylöjärvi, Finland). The software uses the well-known Fresnel equation formalism for 
calculations[28], but allows to simultaneously process multiple SPR spectra in a 
single calculation which has earlier been performed in several calculation 
steps[29,30]. In this work the optical modeling was performed by using SPR angular 
spectra measured at 670 and 785 nm at the same time point, and by linking all the 
thicknesses as common variables, while the complex refractive index was put either 
as an independent variable (for background) or as a linearly dependent variable 
between the two wavelengths used[30].   
7.3 RESULTS AND DISCUSSION 
7.3.1 QCM MEASUREMENTS 
The QCM measurements in Figure 1 shows that the liposomes of the three known 
lipid compositions spread as a bilayer on the SiO2 sensor surface. The three lipid 
compositions exhibited the typical adsorption-bursting behavior often seen in QCM 
experiments during vesicle spreading when SLBs are formed[9,31]. The overlap of the 
normalized overtones (or more precisely, the lack of any difference between the 
overtones), the normalized frequency level of 25 Hz and the fact that the changes in 
dissipation values  are less than 210-6 (supporting information, Figure S4) indicates 
that good quality lipid bilayers were formed[9]. The QCM measurements also 
revealed that the simple in situ wash cycle of CHAPS, Hellmanex II, ethanol and 
ultrapure H2O used between consecutive measurements in this study was sufficient to 
clean the sensor completely, and it was not necessary to wash the sensors with 
piranha (conc. H2SO4:H2O2 3:1) as is commonly suggested[9]. This enables a faster 
repetition of measurements and improves the safety of the preparative steps for 
vesicle spreading studies on SiO2 surfaces. 
A similar initial adsorption-bursting behavior seen on the SiO2 surface was also 
clearly seen for the vesicles composed of known lipids, when they interact with the 
Dex6kDa surface (Figure 2; red, black and blue lines). On the other hand, the 
normalized frequency level and the overlap of the overtone frequencies clearly show 
that complete lipid bilayers were not spontaneously formed on the Dex6kDa surface, 
and the deposited lipid layers remain as mixtures of SLBs and SLVs (Figure 2). 
However, treating the lipid layers deposited on the Dex6kDa surface with H2O 
triggers a process which results in the formation of almost perfect lipid bilayers, 
which is indicated by the normalized frequency levels of approximately 25 Hz and the 
overlap of the normalized overtone frequencies. The dissipation results also support 
these findings (Supporting information, Section S3, Figure S5). The mechanism of 
the triggered SLB formation caused by the H2O injection is not clear, and it seems to 
be specific for the lipid composition. It is probable that the mechanism is due to 
osmotic stress induced by the ionic strength gradient over the liposome membrane. 
[32,33]. 
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Figure 1 QCM Δf/N vs. time sensograms at F3, F5, F7 and F9 for the three known lipid formulations 
deposited on SiO2 sensor. Left to Right: Red – EggPC ; Black – EggPC+PS ; Blue 
EggPC+PS+Chol. The horizontal line marks the position where Δf/N = 25 Hz. The arrows 
indicate events in the sensogram: a) injection of liposomes b) end of injection of liposomes. 
The final frequency change (25 Hz) and the overlap of the overtones indicate that the 
liposomes rupture and form lipid bilayers on the SiO2 sensor surface. 
The H2O triggered SLB formation could also be used to prepare an SLB from the 
vesicles composed of a mixture of the HepG2 cell membrane extract and EggPC (green 
lines in Figure 2). The higher level and the poorer ovelap of the normalized overtone 
frequencies for the SLB of the HepG2-extract compared to the known lipids could be 
expected. This, because the HepG2 cell membrane extract contains intact cell 
membrane proteins, saccharides and other components, which increase the size and 
viscoelasticity of the SLB of the HepG2-extract compared to the SLBs with known 
lipids. A similar approach of including cell membrane extract in an SLB (i.e. natural 
extract from Escheria Coli bacteria mixed with fluid EggPC) has been previously 
demonstrated by Dodd et al.[24]. However, even though Dodd et al. managed  to 
immobilize some kind of a supported lipid bilayer on SiO2, surface it was not a good 
quality SLB according to their QCM-D results. However, it was  possible to use 
similar approach with small modifications in this study in order to spread the 
HepG2-extract mixed with EggPC into a bilayer. 
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Figure 2 QCM Δf/N vs. time sensograms at F3, F5, F7 and F9 for all the four vesicle formulations used 
in this study during interaction with the Dex6kDa surface. (Left to Right: Red – EgPC ; Black – 
EgPC+PS ; Blue EgPC+PS+Chol ; Green – HepG2-extract). The horizontal line marks the 
position where Δf/N = 25 Hz. The arrows indicate events in the sensogram: a) injection of 
liposomes b) end of injection of liposomes c) injection of water d) end of injection of water. The 
bilayer formation was triggered by treating the deposited lipid layers with H2O. The final 
frequency change (25 Hz) and the overlap of the overtones indicate that the liposomes rupture 
and form lipid bilayers on the Dex6kDa surface.  
When interacting with the PEG-SAM surface, all the vesicles in this study behaved 
completely differently than with the two previous surfaces. The PEG-SAM surface 
clearly promoted the formation of SVLs, which can be seen from the significantly 
larger normalized overtone frequency changes compared to the typical 25 Hz for an 
SLB as well as from the fact that the normalized overtone frequencies do not overlap 
at all (Figure 3). This indicates that the deposited lipid layer was a visco-elastic layer 
composed of adsorbed vesicles. Furthermore, the H2O treatment that was capable of 
transforming the (partial) SVLs adsorbed on the Dex6kDa surface did not result in 
the formation of SLBs with the PEG-SAM surface. The dissipation results for the 
PEG-SAM surface also shows a completely different behavior compared with the 
Dex6kDa or SiO2 surfaces (Supporting information, Section S3, Figure S6) further 
indicating that the PEG-SAM surface promotes SVL formation and not SLB 
formation. 
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Figure 3 QCM Δf/N vs. time sensograms at F3, F5, F7 and F9 for all the three known vesicle 
formulations used in this study during interaction with the PEG-SAM surface. (Left to Right: 
Red – EgPC ; Black – EgPC+PS ; Blue EgPC+PS+Chol). The horizontal line marks the 
position where Δf/N = 25 Hz. The arrows indicate events in the sensogram: a) injection of 
liposomes b) end of injection of liposomes c) injection of water d) end of injection of water.  
H2O treatment could not trigger bilayer formation, unlike with the Dex6kDa surface. The 
surface clearly does not allow for bilayer formation, as the final frequency is far from the 
typical bilayer frequency (25 Hz) and the overtones do not overlap, which is a typical indication 
of a loose visco-elastic layer, such as a SVL. 
It should be noted that in order to properly prove SLB formation with the QCM, more 
than one measured overtone should be analyzed and compared, and the difference 
between the normalized overtones should be as small as possible. Apart from 
reaching a final frequence level of 25 Hz and negligible dissipation changes[31], the 
overlap of the normalized overtones is also an important indicator for showing the 
absense of liposomes, The sensitivity of a single overtone frequency for differentiating 
between an SLB and an SVL becomes smaller as the overtone frequency gets higher. 
At the 9th or the 11th overtones the frequency changes for a 5 MHz crystal is nearly 
identical for an SLB and an SVL due to the shear wave penetration depth of the 
higher overtone frequencies compared to the lower ones[26]. For example, the shear 
wave penetration depth for the 3rd overtone for a 5 MHz crystal in pure water at 25 °C 
is 138 nm compared to 79 nm for the 9th overtone. 
The QCM thickness analysis of the SLBs formed on the SiO2 and and on Dex6kDa 
surfaces was performed by using the Sauerbray equation. Additionally, the thickness 
of the SLB/SVL formed both before and after water treatment on both the Dex6kDa 
and PEG-SAM surfaces was analyzed by using the visco-elastic model. The results of 
the analysis, i.e. thickness from Sauerbray analysis, and the thickness, the elastic 
modulus () and viscous modulus () from the viscoelastic analysis, are presented in 
Table 1. 
These Sauerbrey QCM thickness analysis show that approximately equal SLBs 
from all the known lipid compositions were readily formed on the SiO2 surfaceas, 
whereas SLB formation on the Dex6kDa surface only takes place after ultrapure 
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water treatment. Applying the visco-elastic modeling to the lipid layers on the 
Dex6kDa surface after water treatment produced systematically slightly larger 
thicknesses compared to the Sauerbrey analysis. The thickness and elastic moduli of 
the SLBs on the Dex6kDa surface were generally significantly higher than those of the 
SVL layers on Dex6kDa before water treatment, which supports the conclusion that 
SLBs are formed on the Dex6kDa surface after the water treatment. The thickness of 
the HepG2 extract mixture on the Dex6kDa surface after ultrapure water treatment is 
slightly higher while the elasticity is lower compared to the thickness of the known 
lipid mixtures. However, the thickness for the HepG2 extract mixture after ultrpure 
water treatment is still significantly smaller than any of the lipid mixtures before 
water treatment. The HepG2 results are reasonable when considering that there is 
membrane potruding proteins present in the SLB formed from the HepG2 mixture 
which easily could contribute to a thickness increase of 1-2 nm and a higher 
viscoelasticity due to protruding proteins incorporated in the bilayer which traps 
water. The PEG-SAM surface clearly retains the SVL morphology both before and 
after water treatment according to the QCM modeling results. However,  decrease in 
thickness and an increase in elasticity indicates that some fraction of the liposomes 
on the PEG-SAM surface actually are fused into an SLB, but a significant portion of 
the adsorbed liposomes still retains the SVL morphology. 
It is also worth noting that the thicknesses of the SVLs on the Dex6kDa surface 
before ultapure water treatment are clearly smaller compared to the SVLs on the 
PEG-SAM surface. This is a strong indication that the liposomes deform to a larger 
extent on the Dex6kDa surface than on the PEG-SAM surface, thus inducing larger 
stresses to the liposomes on the Dex6kDa surface and therefore facilitating SLB 
formation when changing the osmotic conditions during ultrapure water treatment. 
One of the explanations for a larger deformation of liposomes on the Dex6kDa 
surface compared to the PEG-SAM surface could be that there is a difference in the 
density and availability of the hydrophobic chains which causes differences in the 
interaction strength between the surfaces and the adsorbed liposomes.  
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Table 1. Result from the QCM thickness modeling. Sau = Sauerbray equation and V-E= visco-
elastic modeling (equivalence circuit modeling). *) The Sauerbray equation produces false 
values because it assumes a rigid film, but as shown as shown from the viscoelastic 
modeling, the HepG2 extract seems to behave as an SLB with protruding proteins.   
d (nm /Sau) d (nm /V-E)  (MPa)  (Pa s) 
SiO2 EggPC 4.7 
EggPC+PS 4.5 
EggPC+Chol 4.7 
Dex6kDa EggPC 7.5 0.85 0.0025 
Bef H2O EggPC+PS 8.3 0.56 0.0014 
EggPC+Chol 10 0.55 0.00235 
HepG2 16 0.72 0.00365 
Dex6kDa EggPC 4.9 5.7 1.75 0.0039 
Aft H2O EggPC+PS 5.3 5.8 1.20 0.0040 
EggPC+Chol 4.4 4.5 1.55 0.0056 
HepG2 2* 6.1 0.66 0.0028 
PEG-
SAM  EggPC  14.5 0.73 0.00285 
Bef H2O EggPC+PS 17.0 0.69 0.00265 
EggPC+Chol 16.0 0.63 0.00247 
PEG-
SAM 
EggPC 
 
11.8 0.79 0.00260 
Aft H2O EggPC+PS 11.8 0.71 0.00240 
EggPC+Chol 9.8 0.80 0.00245 
7.3.1.1 Promotion of SLB or SVL formation by the substrate 
The QCM results showed that there was a large difference between the Dex6kDa and 
PEG-SAM surfaces in promoting either SLB or SVL formation, even though both 
surfaces are relatively thin hydrogel supports with a thickness in the range of a few 
nanometers.The Dex6kDa clearly promoted the formation of SLBs and the PEG-SAM 
promoted SVL formation. The most probable explanation for this is the type of 
surface morphology the polymers form on the sensor surface, and the effect of 
different synthesis routes causing the lipid anchoring groups to be distributed 
differently in the Dex6kDa and PEG-SAM layers. The measurement conditions used 
in this work were selected so that they would promote SLB formation on the SiO2 
surface[9]. The measurement protocols were also kept constant during all 
measurements and it is unlikely that these would have a significant effect on the 
morphology control in this work. Furthermore, the Dex6kDa and PEG-SAM surfaces 
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should be non-charged due to the way they are produced, whereas the wettability of 
the surfaces show a clear difference, i.e. contact angle of ultrapure water for the 
surfaces were 56° for PEG-SAM and 71° Dex6kDa. Therefore, the surface charge 
cannot have a large role in the promotion of either SLBs or SVLs on the different 
polymer surfaces synthesized in this study, while the wettability originating from the 
different distribution of hydrophobic linker chains in the polymer surfaces probably 
is more significant.  
The Dex6kDa was formed from a highly concentrated solution, where the 
polymers are in a semi-entagled conformation and should also form a similar 
network upon surface linking[34]. Furthermore, the hydroicarbon chains (i.e. decyl 
chains) were also post-synthesized into the formed dextran hydrogel, which most 
probably modifies mainly the outer surface portion of the hydrogel. Thus, the overall 
synthesis process should lead to a relatively dense and flat dextran surface with easily 
accessible hydrocarbon chains. The higher contact angle of Dex6kDa compared to the 
PEG-SAM and the change in the contact angle as a result of the decyl binding to the 
Dex6kDa also indicate that the decyl-chains are more exposed in the Dex6kDa than 
in the PEG-SAM surface.  
The PEG-SAM was formed by a self-assembly reaction with a custom synthesized 
PEG polymer having pre-modified end groups. While the dominant species in the 
PEG polymer mixture were thiol- and analogous disulfides of the PEG-polymer with 
one hydrocarbon chain (i.e. un-10-decene), the PEG polymer mixture also contained 
di-thiols and unthiolated polymers. The concentration of the PEG polymer mixture 
was relatively high during the PEG-SAM formation, but was still within a range where 
polymers behave mostly as individual coils rather than as an entangled network[34]. 
Due to steric interactions the self-assembly of polymers under such conditions should 
form a more “mushroom” like surface with individual polymer coils rather than a 
dense polymer brush structure[35]. This kind of behavior is also supported by an 
other study where similar PEG self-assembly were studied with SPR for PEG 
thickness and density as a function of molecular weight, which is also proportional to 
polymer coil dimensions[36]. 
Taken together the promotion of SLB formation on the Dex6kDa and SVL 
formation on the PEG-SAM surface is quite reasonable. The brushlike Dex6kDa 
hydrogel most probably forms a rather homogeneous and smooth surface with a 
sufficient amount of easily accessible hydrocarbon chains, which promotes SLB 
formation, whereas the mushroomlike PEG-SAM surface is probably not so 
homogeneous and smooth with less accessible hydrocarbon chains, thus promoting 
the vesicles to retain their shape on the surface. 
7.3.2 SPR MEASUREMENTS 
TThe SPR measurements did not show as pronounced bursting behavior for any of 
the surface/lipid compositions as was seen in the QCM measurements (Figure 4). 
This is reasonable, as the QCM technique is sensitive to the water content in the 
adsorbed layer while SPR is not, and SVLs carry a significant amount of water 
trapped in the liposomes. Despite of this, a small bursting behavior which follows the 
general shape of the SLB-formation steps in QCM measurements was detectable in 
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the SPR measurements. The level of the SPR signal acquired during the deposition of 
the vesicles corresponds well with the expected values for a lipid bilayer when 
evaluated with an optical model of the systems (Supporting information, Section S4, 
Table S2)[22]. The difference between the signal level of SiO2 and Dex6kDa SLBs can 
be explained by the effect caused by the support structure on the optical signal of the 
SLB. In an optical model an SLB adsorbed on a spacer hydrogel support structure 
gives approximately 15% less signal compared with an SLB adsorbed on a dense SiO2 
surface (Supporting information, Section S4, Table S2). This was approximately also 
the difference observed in the actual SPR measurements (Figure 4).  
The SPR measurements with the vesicles containing the dye-label did not largely 
differ from the pure EggPC lipid composition on the surfaces that were expected to 
promote the SLB formation (i.e. SiO2 and Dex6kDa – EggPC red trace and 
label+EggPC orange trace in Figure 4). However, the difference in the SPR signal 
between the EggPC and the label+EggPC lipid compositions during adsorption to the 
PEG-SAM surface was large. This is expected in the case of SVLs, because when a 
compound that absorbs light is trapped in the vesicles this will appear as a much 
higher RI index compared to vesicles without the light-absorbing compound. This is 
due to the anomalous behavior of the refractive index when compounds that absorb 
light in the same wavelength region used for the SPR measurements are present.[37-
39].This further confirms the earlier findings from QCM measurements, i.e. that the 
SiO2 and Dex6kDa coatings promote SLB formation and the PEG-SAM coating 
promotes SVL formation. The small difference between the SPR signal levels of the 
Dex6kDa and SiO2 surface for the EggPC and label+EggPC lipid formulations is 
probably due to the extra space provided by the hydrogel under the SLB, which traps 
a small amount of the labeled material in the hydrogel. On the other hand, in the case 
of the SiO2 surface the SLB is formed on a rigid surface with a minimal space between 
the surface and the SLB, which does not allow any labeled material to be trapped 
between the surface and the SLB. 
The label+EggPC SPR measurements also show that it was not necessary to use 
the water triggering step used in the QCM measurements for SPR measurements in 
order to form SLBs of the known lipid compositions on the Dex6kDa surface. This is 
probably due to the fact that the shear stress in the SPR flow channel is actually 
higher compared to the QCM flow channel, because the heights of the two flow 
channels used in the calculations for synchronizing the flow conditions are in reality 
not as well defined and precise as assumed. On the other hand, the HepG2-extract 
lipid composition still required a water triggering step in the SPR measurements in 
order to form an SLB on the Dex6kDa surface. Furthermore, there was a clear 
difference in the absolute SPR signal level measured for the SLB of the HepG2-extract 
lipid composition (green line in Figure 4) compared to the other lipid compositions. 
The reason for this is that the HepG2-extract lipid composition contains more 
cholesterol, as well as membrane proteins and other cell membrane components 
which are not present in the known lipid compositions. This also makes the vesicles 
prepared from the HepG2-extract lipid composition more stable and visco-
elastic[40], which consequently requires some triggering step such as the water 
treatment to induce SLB formation. 
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Figure 4 SPR angle vs. time sensograms measured with a wavelength of 670 nm during interaction of 
all the five lipid vesicle formulations with the three different surfaces used in this study. From 
left to right – SiO2 surface, PEG-SAM, Dex6kDa and HepG2 membrane extract on Dex6kDa. 
The different lipid compositions are marked with colors as follows: EggPC – Red ; EggPC+PS 
– Black ; EggPC+PS+Chol – Blue ; EggPC + Label – Orange and HepG2-extact – Green. The 
arrows indicate events in the sensogram: a) injection of liposomes b) end of injection of 
liposomes c) injection of water d) end of injection of water. The SPR is sensitive to the 
refractive index of the lipids (density and packing), as well as to the effect of the supporting 
surface structure on the evanescent field (Supporting information, Section S4, Table S2). This 
makes it relatively difficult to determine if a bilayer is formed or not. However, the 
measurements with the label clearly show a large difference between the PEG-SAM and the 
other two surfaces, which correlates with the QCM measurements (Fig1-3). The HepG2-
extract has a higher SPR signal than the other lipid compositions on the Dex6kDa surface 
because it also contains a higher amount of cholesterol, as well as membrane proteins and 
other cell membrane components that are not present in the known lipid compositions.  
 
7.3.2.1 Two-wavelength SPR analysis 
A two-wavelength analysis for determining the thickness (d) and refractive index (RI) 
of the adsorbed lipid structures was performed with the LayerSolver software for all 
the known lipid compositions. Background parameters were calculated from the 
spectra taken 1 minute before the vesicle injection, and the sample spectra were taken 
10 minutes after the vesicle injection was ended. The optical parameters obtained 
from the background spectra and examples of the optical fits to the background 
spectra can be found in the supporting information Table S1 and Figure S7. It was not 
possible to accurately determine or separate the optical properties of the Dex6kDa 
and PEG-SAM layers in the background spectra, because their contribution to the 
overall background spectra was very small. Hence, the optical parameters for the 
background spectra in the case of Dex6kD and PEG-SAM surfaces should be 
considered as “apparent” parameters, which means that they are not physically 
correct but they are still accurate enough for the analysis purpose in this study. This 
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in combination with the effect caused by the support structure on the optical signal 
discussed above (Supporting information, Section S4, Table S2) means that the 
results from the two-wavelength SPR analysis for the lipid layer structure formed on 
the Dex6kDa and PEG-SAM surfaces should only be considered as qualitative and 
reflect only the differences inside the same series. The results from the two-
wavelength SPR analysis for the lipid layer structures formed on the SiO2 surface do 
not suffer from this drawback, and can be viewed as accurate. The results of the two-
wavelength SPR analysis for the different lipid compositions and support surfaces are 
presented in Table 2. 
The d and RI values obtained for the SLBs on SiO2 in this study correlate well with 
results obtained with a similar surface in dual polarization interferometry by Lee et 
al. [22], especially when taking into account the difference in the lipids used. The 
lipid mixtures used in this study were natural extracts (EggPC) which are mixtures of 
many components with a high amount of unsaturated fatty acid chains, while the 
work of Lee et al. was performed with fully-saturated di-myristoyl 
phosphatidylcholine (DMPC) as the main component. It should also be noted that 
while the reference in the work by Lee et al. also relies on results obtained from a 
secondary technique (i.e. neutron scattering for thickness determination) for 
analyzing both the refractive index and thickness for their lipid mixtures, we have 
obtained similar results in this study without a need for similar references. Both the 
current study and literature show that the cholesterol-containing lipid mixture has a 
higher thickness, which can be explained by the condensing effect of cholesterol in 
the SLB. The cholesterol situates between the fatty acid tails of the phospholipids in 
the SLB, and forces them to stand up straighter than they would without the presence 
of cholesterol[41]. This effect was more pronounced with the longer unsaturated 
chains in this work compared with saturated alkane chains used by Lee et al. 
As discussed above, the d and RI values obtained for the actual Dex6kDa and 
PEG-SAM surfaces have to be taken as qualitative rather than quantitative. Even so, 
the d and RI values obtained for the lipid layers on the Dex6kDa surface support the 
fact that an SLB was formed with all the different lipid compositions used in this 
study, which is further supported by the QCM results. The d and RI values for the 
SLBs on the Dex6kDa surface were slightly higher but within a reasonable range 
when compared to the values obtained for the SiO2 surface. This might depend on the 
influence of the background during optical modeling as discussed above, or 
alternatively the SLBs might ripple on the Dex6kDa surface consequently displaying a 
slightly larger thickness compared to the SiO2 surface. It might also be possible that 
the higher RI obtained for the SLBs on the Dex6kDa surface compared to the SiO2 
surface indicates that the lipids can pack more tightly on the Dex6kDa surface than 
on the SiO2. However, this can only be speculated, as the results obtained from the 
optical modeling were too uncertain for drawing stronger conclusions, because of the 
issues related to the background uncertainty and the spacing layer sensitivity 
(Supporting information, section S4).  
The lipid layers on the PEG-SAM surface clearly shows higher d and lower RI 
compared to the two other surfaces, which was expected on the basis of the QCM 
results. This supports the earlier findings that the PEG-SAM surface rather promotes 
SVL than SLB formation. However, the d:s were quite small compared to the vesicle 
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sizes. This can be explained either by the uncertainty in the background used during 
optical modeling, or most probably because the SVLs deform into disc-like vesicles 
upon absorption on the PEG-SAM surface which consequently is reflected as a much 
smaller thickness than would be expected for full non-deformed vesicles. 
The results from the two-wavelength SPR analysis correlate very well with the 
results obtained from the QCM thickness analysis. Hence, these SPR results support 
the conclusions drawn from the QCM results on the SLB and SVL formation on the 
different surfaces used in this study. The results are also supported well by earlier 
studies with similar experiments reported in the literature [22]. While the QCM was 
an easier method for detecting the SLB formation as such, it is quite apparent that the 
two-wavelength SPR analysis approach was more sensitive to slight changes in the 
lipid layer thickness and density than the QCM experiments even though the SPR 
analysis was performed in a qualitative intra-series manner. However, together these 
two methods seem to offer an excellent combination for studying the biophysical 
properties of different membranes and other adsorbed or layered materials. 
Table 2. Lipid layer parameters obtained from optical modeling of SPR measurements.   
Surface Lipid d n (670nm) n (785nm) dn/dL (-1/nm) 
SiO2 EggPC 4,70 1,4421 1,4381 0,000035 
SiO2 EggPC+PS 4,63 1,4431 1,4387 0,000038 
SiO2 EggPC+Chol 5,61 1,4236 1,4191 0,000039 
Dex6kDa EggPC 5,11 1,4735 1,4680 0,000048 
Dex6kDa EggPC+PS 5,16 1,4729 1,4673 0,000049 
Dex6kDa EggPC+Chol 6,38 1,4401 1,4371 0,000026 
PEG-SAM EggPC 10,79 1,3977 1,3975 0,000002 
PEG-SAM EggPC+PS 13,84 1,3813 1,3804 0,000008 
PEG-SAM EggPC+Chol 8,69 1,3928 1,3882 0,000040 
PEG-SAM EggPC+Label 10,55 1,4031 1,4013 0,000016 
  
7.3.2.2 Air stability of the SLB 
The air stability for the EggPC-PS-Chol lipid mixture on the Dex6kDa surface was 
tested in triplicate by flowing air through the SPR microfluidic system at a nominal 
speed of 200 μL/min. The SPR flow channels have an internal volume of 1 μL, 
meaning that the gas content in the flow channel was replenished 3.33 times per 
second. Other lipid mixtures or surfaces used in this study were not tested, because 
SLBs formed on the SiO2 surface are known to be unstable during transition through 
the air-water interface[16]. The air-stability of the SVLs adsorbed on the PEG-SAM 
surface was not studied because SLBs are often more desirable biomimetic surfaces 
than SVLs for use with surface-sensitive detection techniques because of their well 
defined structures, which consequently makes the analysis of the signal responses 
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with SLBs much easier compared to SVLs. The less complex lipid mixtures were also 
left out from the air-stability studies because the main challenge in preparing 
biomimetic surfaces by vesicle adsorption is to form air-stable SLBs with cholesterol 
containing vesicles, as well as for vesicles with lipid compositions resembling natural 
cell membranes as close as possible. 
 When the SPR flow channel was filled with air this caused a large transition in the 
SPR angular spectra, where the SPR peak typical for water was transformed into a 
multimodal mixed angular spectrum. During this time it was not possible to track the 
SPR peak minimum. However, the crossing of the air-water interface was clearly 
indicated by the shift of the critical angle of the SPR peak to the range typical for 
water. Due to the difficulty in tracking the SPR peak during air exposure, the time 
period for the air flow in the measurements was cut from the SPR sensograms (Figure 
6). Figure 6 clearly shows that the SPR signal levels returned close to the original 
signal level after the air treatment of the EggPC+PS+Chol SLB. An air-stability of 
86% was obtained for the EggPC+PS+Chol SLB by comparing the averaged SPR 
signal level before the air injection to the averaged SPR signal level after the air 
treatment. The measurements were performed with a constant flow of air through the 
flow channel for 10 minutes, which means that the EggPC+PS+Chol SLB was also 
continuously drying during the experiment. This indicates that the EggPC+PS+Chol 
SLB on the Dex6kDa surface had an excellent resistance against drying upon 
exposure to air and upon thransition through the air-water interface. 
 
Figure 5 Normalized SPR minimum angle vs. time sensorgrams of air stability measurements of the 
EggPC+PS+Chol lipid mixture adsorbed on the Dex6kDA surface. The three repetition 
sensorgrams have been normalized to the deposition plateau (interval starting at 20-25 
minutes), and the air stability in percentage has been characterized from the magnitude of the 
returning signal (interval at 45-50 minutes). The air treatment was also recorded on line, but 
was cut out of the sensogram for clarity. The presence of air in the flow channel was 
confirmed by the shift in the TIR angle during the measurement (not shown). The three 
repetitions gave an average of 86% stability of the deposited EggPC+PS+Chol SLB.  
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7.3.3 COMPARISON OF SURFACES 
The QCM and SPR results indicate, that the Dex6kDa surface offers a platform for 
SLB deposition similar to the SiO2 surface, which was utilized as a reference surface 
in this study. The PEG-SAM surface however promotes SVL deposition. While both 
the Dex6kDa and the PEG-SAM surfaces are hydrophilic and highly hydrated, the 
difference in promoting different lipid morphology was most probably due to the 
differences in the inherent structure, density and location of the hydrophobic groups 
of the hydrogels. 
 Both of the hydrogel-based sensor surface coatings could be regenerated by a 
simple CHAPS detergent washing cycle, while the SiO2 surface needed a much 
harsher and complex washing procedure before reuse. This is also a beneficial 
property for the screening of interactions, as it allows a faster experimental cycle and 
increases the throughput of the assay. The throughput, along with a simpler 
automation caused by the less-complicated wash cycle, makes the new Dex6kDa and 
PEG-SAM surfaces viable candidates for wide applications in the screening of 
biochemical interactions and in pharmaceutical research. This kind of a reusable 
sensor structure offers even greater benefits in several application areas when 
compared to non-regenerable sensor structures, e.g. biotin-avidin based sensors.  
The air stability exhibited by the SLBs on the Dex6kDa surface was found to be 
good. This property is important in a wider application of SLBs within interaction 
research and pharmaceutical development, as it allows resistance to sampling 
mistakes (i.e. dissolved gases out-gassing in microfluidics), more advanced samples 
(air-bubble trapped samples) or even a pre-deposition of SLBs and a storage of them. 
A similar air stability has also been shown for supports containing Langmuir-Blodgett 
deposited monolayer with a Zr2+-ion top-layer, which actually required that 
palmitoyl-oleyl phosphatic acid is included into the SLB mixture[18]. The benefits of 
the SLB supported with Dex6kDa over the Zr2+-ion approach are a wider lipid 
functionality, a regenerability and a simpler synthesis. Another similar approach has 
been introduced by using cholesterols in a PEG matrix as linking groups[17]. This 
approach was similar to the Dex6kDa approach in this study, but the air stability was 
performed in much milder conditions (i.e. a careful transfer of the substrate and SLB 
through air-water interface), while in this study the stability was demonstrated under 
a constant air flow.  An approach where SLBs have been “sandwiched” between 
proteins or PEG has shown good results for the SLB air stability. However, the 
approach often requires certain groups or macromolecules to be added to the SLB 
formulation[16,19]. This can cause interference in measuring the interactions or 
other properties of the SLBs, which further makes the Dex6kDa surface developed in 
this study a more viable approach for preparing SLBs for any applications studying 
these properties.   
7.4 CONCLUSIONS 
This work describes the synthesis of two new surface coatings that promotes different 
lipid layer morphologies during vesicle spreading on the supporting surface. The low-
molecular-weight dextran-based Dex6kDa surface showed good performance in 
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promoting SLB formation with both known lipids, as well as with a mixture 
containing the natural membrane extract of HepG2 cells. The low-molecular-weight 
self-assembled PEG-SAM surface promoted SVL formation on the surface with all 
lipid compositions tested in this study. It was also possible to demonstrate that the 
Dex6kDa surface effectively protects the SLB layer from dehydration after deposition. 
The air-stability allows to develop more robust SLB based experimental assays, 
thereby increasing the probability to further develop SLBs as useful platforms for a 
wide range of applications. The simple synthesis procedures of a surface combined 
with air-stability for the deposited lipid layers makes it possible to achieve more 
flexible and robust SLBs for applications in areas such as drug discovery and 
development, biosensing and biophysics. 
In addition, this study further demonstrates the utilization of the relatively rare 
multiple-wavelength SPR method. The two-wavelength SPR analysis used provided 
results which correlated with the well established QCM technique, as well as with 
other optical techniques used for SLB characterization. This study also shows that the 
combination of both SPR and QCM methodologies provides high quality data with a 
large amount of information for characterizing nanometer-scale systems. It is 
apparent that the use of both techniques is especially beneficial in biophysics and 
similar applications, due to the quality and magnitude of the information required for 
these applications. 
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7.7 SUPPORTING INFORMATION 
7.7.1 S1 – END GROUP MODIFICATION OF PEG POLYMER 
Materials 
All chemicals used in the synthesis were obtained from Sigma-Aldrich (Helsinki, 
Finland), if not stated otherwise. PEG45, Mw = 2 kDa and –OH end groups at both 
end, was obtained from Polysciences Inc (Pennsylvania, USA) and ethanol was 
obtained from Altia (Rajamäki, Finland). The water used was of 18.2 MΩ/cm 
resistivity. Solvents were distilled over molecular sieves and chemicals were dried in 
vacuum dessicator before use. 
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Synthesis of 1-tosyloxyundec-10-ene 
1-tosyloxyundec-10-ene was synthesized using a known method from literature [1]. 
Briefly, 10-undecen-1-ol  (40 mmol), 4-toluenesulfonylchloride (125 mmol) and 
triethylamine (250 mmol) were dissolved in 300 mL of dichloromethane (DCM). The 
dichloromethane was purged with nitrogen before addition of the reactants, and the 
reaction mixture was purged with nitrogen all through the reaction. The mixture was 
allowed to react 4 hours at room temperature (RT).  
The solvent was removed using a rotary evaporator. DCM was added, and the 
mixture was extracted twice with 1 M HCl2. The organic phase was separated and 
dried with sodium sulphate (anhydrous). The solids were filtered out and the organic 
phase was evaporated in a rotary evaporator and the residue was dried overnight in a 
vacuum dessicator.  Further purification was performed using column 
chromatography (silica, DCM:cyclohexane 75:25, Rf 60%.) The colorless final product 
(1-tosyloxyundek-10-ene) was dried overnight in a vacuum. 
The purity of the product was checked with 1H NMR, and was determined to be 
close to 100%. The yield was determined to be 58%. 
Synthesis of PEG-SAM 
The synthesis protocols were adapted from literature [1,2]. 
First the end-groups of PEG45 were modified to form an intermediate product 
carrying double bonds in both ends. PEG45 (0.5 mmol) and 1-tosyloxyundec-10-ene 
(3 mmol) were dissolved into 25 mL of distilled and nitrogen purged DMF. Five 
mmol of NaH was then carefully added to the mixture (Note! Reacts violently with 
water, handle with care). The reaction mixture was stirred for one hour at RT, then 
the temperature was raised to 90 °C and the reaction was carried out for 3 days. The 
reaction was stopped by lowering the temperature back to RT, and carefully 
neutralizing the remaining NaH with a small amount of methanol. 
The raw product was dissolved in a small amount of THF and precipitated twice 
into ice cold diethyl ether. The product was then dried in a vacuum. The purity of the 
intermediate product was checked with 1H NMR, and it was calculated that 
approximately 88% of all end groups were converted with the double bond in the 
reaction. Yield was determined to be 50%. 
The intermediate product (0.28 mmol) and thioacetic acid (35 mmol) were 
dissolved into 15 mL of distilled and nitrogen purged THF. The mixture was stirred 
under nitrogen flow for 30 minutes, after which a catalytic amount of 
azobisisobutyronitrile (AIBN) was added to the mixture. The reaction mixture was 
heated to 70°C and allowed to react overnight.  
The residue was precipitated in diethyl ether and collected by centrifugation at +8 
°C. A clear solid intermediate product was collected and dried. This intermediate 
product was dissolved into 15 mL of ethanol, and 15 mL of saturated sodium 
methoxide in methanol was added to the mixture. The reaction mixture was allowed 
to react overnight at RT with vigorous stirring.  
The solvent was evaporated and the crude product was dissolved in THF and the 
solids were removed by filtering. The liquid was evaporated and the product was 
finally purified by passing it through a plug of silica (Chloroform:methanol 80:20). 
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Finally, the product was dried in a vacuum. The yield of the product was 70% by 
mass. 
The final product was characterized with 1H NMR, size exclusion chromatography 
(SEC, in THF and against polystyrene standards), and matrix assisted laser 
desorption-ionization time of flight mass spectromenty (MALDI TOF MS) using 
sodium fluoroacetate and dihydroxybenzoic acid as the matrix. The NMR results 
confirm that both thiol- and double-bonds existed in the product, but also that some 
of the product was dimerized with disulfide bridges (Figure S1). The dimerization was 
also confirmed by SEC, which showed two separate peaks. Treatment with 
sodiumborohydrate could remove the disulfide shift in the 1H NMR, confirming the 
first impression on partial dimerization to disulfide. The MALDI TOF MS did not 
show the dimerization, but as the MALDI TOF method involves a relatively large 
energy transfer, it probably broke the disulfide during the measurement. The MALDI 
TOF MS was used to characterize the product, and yielded a Mn = 2174 Da and a Mw 
= 2275 Da and a PDI = 1.05 (Figure S2). The MALDI TOF MS also showed that the 
most common molecular weight (highest intensity of the distribution) was 2341 Da, 
which was the theoretical molecular weight for the desired PEG product with 
unsymmetric end-groups (i.e. thiol and double bond).  
 
 
Figure S1. 1H NMR spectrum of the synthesized PEG-SAM polymer.  
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Figure S2. MALDI TOF MS spectrum of the synthesized PEG-SAM polymer. 
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7.7.2 S2 - DLS SIZE DISTRIBUTION. 
 
Figure S3. The number-average size distribution results for CONTIN analysis. Red – EggPC, 
Blue EggPC+PS, Green EggPC+PS+Chol and Purple HepG2:EggPC. 
7.7.3 S3 IMPEDANCE BASED QCM: DISSIPATION RESULTS 
 
The KSV QCM-Z500 utilizes impedance based analysis for measuring dissipation of 
samples [3], unlike the patent-protected dissipation technology of QCM-D from Q-
Sense. While both can measure viscoelastic properties of the samples, the 
measurements are physically quite different and they cannot be assumed to be 100% 
comparable. Still, relative information of the degree of viscoelasticity should be 
comparable and valid between the different technologies, and this was how they have 
been compared in this work. Comparing the similarities and differences of the 
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different QCM technologies in detail are not in the scope of this article, and therefore 
not discussed further. 
The dissipation results support the findings of the QCM-frequency in terms of SLB 
or SVL formation on the surface. The 9th and 11th overtones for the measured 
dissipation were discarded from the figures, because they were so noisy that they 
interfered with the visualization of the other overtones. However, the dissipation 
measured at the 9th and 11th overtones also showed the same trends and dissipation 
levels as the overtones shown. The dissipation changes measured for the SiO2 (Figure 
S3) and the Dex6kDa (Figure S4) surfaces that the morphology of the lipid layer was 
an SLB at the end of each deposition experiment. The dissipation changes measured 
for the PEG-SAM surface (Figure S5), on the other hand, indicate that the 
morphology of the lipid layer was an SVL layer. These results correlate with the 
dissipation responses for SLB and SVL layer formation in the literature.  
 
Figure S4. Dissipation changes during vesicle spreading on the SiO2 surface for EggPC (red) 
EggPC+PS (black) and EggPC+PS+Chol (blue) for the 3rd, 5th and 7th overtones. Figure1 in 
the original article corresponds to this dissipation figure. The vertical lines have been drawn to 
response level 0 and 5 to help in visualizing the response level between the dissipation graphs 
(Figures S3-S5). 
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Figure S5. Dissipation changes during vesicle spreading on the Dex6kDa surface for EggPC 
(red) EggPC+PS (black),  EggPC+PS+Chol (blue) and HepG2-extract (green) for the 3rd, 5th 
and 7th overtones. Figure2 in the original article corresponds to this dissipation figure. The 
vertical have been drawn to response level 0 and 5 to help in visualizing the response level 
between the dissipation graphs (Figures S3-S5). 
 
Figure S6. Dissipation changes during vesicle spreading on the PEG-SAM surface for EggPC (red) 
EggPC+PS (black) and EggPC+PS+Chol (blue) for the 3rd, 5th and 7th overtones. Figure 3 in the original 
article corresponds to this dissipation figure. The vertical lines have been drawn to response level 0 and 5 
to help in visualizing the response level between the dissipation graphs (Figures S3-S5). 
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7.7.4 S4 – THE INFLUENCE OF THE COATING MATERIAL ON THE SPR 
SIGNAL 
 
As the penetration depth of the SPR field and the SPR sensitivity both depend on the 
distance between the surface and the dielectric constant of the coating [4], a rough 
estimate of the effect on SPR signal magnitude was performed by optical simulations 
of the layer. The optical model used for simulations consisted of an SPR sensor with 
optical parameters obtained from optical modeling of an actual SPR sensor 
(Glass/Adhesion/Gold layers in TableS1). The surface coating was assumed to be 
either 10 nm of SiO2 (n = 1.56, d = 10 nm), or a loose dextran hydrogel (n = 1.34, d = 
10 nm). A hypothetical lipid bilayer was included in the model on top of this, with an 
assumed n = 1.50 and thickness of either 4 nm or 5 nm [5]. The SPR measurement 
wavelength was set to 670 nm, which is the wavelength of the standard laser in the 
SPR instrument used in this study. The modeling was performed by using the 
Winspall 3.02 software [6]. The theoretical SPR signal changes obtained in this way 
for the different surfaces and lipid bilayer thicknesses are shown in Table S2. 
The results of the simulations shown in Table S2 reveal that a “spacing” hydrogel 
produces approximately 75% less signal in an SPR measurement under the assumed 
conditions when compared with a rigid SiO2 surface. As the model is relatively rough, 
it does not perfectly reflect the real experimental situation. For example, the Dextran 
hydrogel thickness and RI are only rough assumptions. Despite of this, it is possible 
to conclude from the results that the hydrogel support surface most probably will 
produce a visibly smaller SPR signal change than the SiO2 surface during SLB 
formation.  
 
Table S1. Optical parameters used in the SPR models. A is the surface support layer (10 
nm of SiO2 with n = 1.56 or 10 nm of hydrogel with n = 1.34). The SLB layer thickness (B 
in the table) used was either 4 nm or 5 nm. 
Layer d n k 
Glass Inf 1.5202 0 
Adhesion 1.62 3.098 1.734 
Gold 48.76 0.227 3.775 
Support A A 0 
SLB B 1.50 0 
Buffer Inf 1.334 0 
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Table S2. Theoretical changes in the SPR angle during SLB formation on the SiO2 surface 
or on the dextran hydrogel surface, and the signal ratio as a function of thickness. The 
simulations were performed with two different thicknesses of the SLB in order to see if it 
had any effect on the signal ratio. 
SLB 
thickness SiO2 Dextran 
Ratio 
(Dex6kDa/SiO2) 
5nm 1,021 0,759 0,744 
4nm 0,816 0,602 0,738 
AVG 74 % 
7.7.5 S5 – OPTICAL CONSTANTS OF THE TWO-WAVELENGTH SPR 
ANALYSIS 
 
The optical parameters obtained for the backgrounds in the two-wavelength 
calculations are shown in Table S3. An example of the fitting results for the two-
wavelength SPR analysis is presented in Figure S6. 
 
Table S3. The optical constants obtained for the background fits and used for the following 
lipid layer characterization with two-wavelength SPR analysis. “A” denotes the variable 
parameter during lipid layer characterization. 
SiO2 Dex6kDa 
d n(670) n(785) k(670) k(785) d n(670) n(785) k(670) k(785) 
Glass Inf 1,5202 1,5612 0,0000 0,0000 Inf 1,5202 1,5612 0,0000 0,0000 
Cr 2,59 3,8648 4,9861 1,1051 0,9994 2,60 5,0014 5,0064 0,9983 1,0282 
Au 49,65 0,2695 0,3005 3,7381 4,8012 49,65 0,2426 0,2600 3,8559 4,9096 
SiO2 6,96 1,5773 1,5900 0,0000 0,0000 5,00 1,3367 1,3392 0,0000 0,0000 
Lipid A A A 0,0000 0,0000 A A A 0,0000 0,0000 
Buffer Inf 1,3340 1,3324 0,0000 0,0000 Inf 1,3340 1,3324 0,0000 0,0000 
PEG-SAM 
d n(670) n(785) k(670) k(785) 
Glass Inf 1,5202 1,5612 0,0000 0,0000 
Cr 2,60 5,0009 5,0016 1,0141 1,0563 
Au 50,80 0,2268 0,2388 3,8164 4,8342 
SiO2 2,98 1,3876 1,3554 0,0000 0,0000 
Lipid A A A 0,0000 0,0000 
Buffer Inf 1,3340 1,3324 0,0000 0,0000 
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Figure S7.  Measurd data and typical fitting results obtained for background (red and blue) 
and lipid layer (orange and green) when fitted with simultaneous two-wavelength SPR 
analysis. The example is for a SiO2 surface with EggPC lipid bilayer. 
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8 V ELUCIDATING THE SIGNAL RESPONSES OF 
MULTI-PARAMETRIC SURFACE PLASMON 
RESONANCE LIVING CELL SENSING: A 
COMPARISON BETWEEN OPTICAL MODELING 
AND DRUG–MDCKII CELL INTERACTION 
MEASUREMENTS 
Abstract 
 
In vitro cell-based assays are widely used during the drug discovery and development 
process to test the biological activity of new drugs. Most of the commonly used cell-
based assays, however, lack the ability to measure in real-time or under dynamic 
conditions (e.g. constant flow). In this study a multi-parameter surface plasmon 
resonance approach in combination with living cell sensing has been utilized for 
monitoring drug-cell interactions in real-time, under constant flow and without 
labels. The multi-parameter surface plasmon resonance approach, i.e. surface 
plasmon resonance angle versus intensity plots, provided fully specific signal patterns 
for various cell behaviors when stimulating cells with drugs that use para- and 
transcellular absorption routes. Simulated full surface plasmon resonance angular 
spectra of cell monolayers were compared with actual surface plasmon resonance 
measurements performed with MDCKII cell monolayers in order to better 
understand the origin of the surface plasmon resonance signal responses during drug 
stimulation of cells. The comparison of the simulated and measured surface plasmon 
resonance responses allowed to better understand and provide plausible explanations 
for the type of cellular changes, e.g. morphological or mass redistribution in cells, 
that were induced in the MDCKII cell monolayers during drug stimulation, and 
consequently to differentiate between the type and modes of drug actions. The multi-
parameter surface plasmon resonance approach presented in this study lays the 
foundation for developing new types of cell-based tools for life science research, 
which should contribute to an improved mechanistic understanding of the type and 
contribution of different drug transport.  
 
 
 
 
 
 
 
*Adapted from (License CC BY 3.0): Viitala T, Granqvist N, Hallila S, Raviña M, 
Yliperttula M (2013) Elucidating the Signal Responses of Multi-Parametric Surface 
Plasmon Resonance Living Cell Sensing: A Comparison between Optical Modeling 
and Drug–MDCKII Cell Interaction Measurements. PLoS ONE 8 (8):e72192. 
doi:10.1371/journal.pone.0072192 
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8.1 INTRODUCTION 
Current drug discovery paradigms are slowly shifting from the reductionism thinking 
approach towards a more holistic approach [1,2]. The ability to examine living cells in 
physiologically relevant environments, to monitor drug induced cell stimuli, and 
differentiating between different drug delivery routes are of utmost importance for 
improving our mechanistic understanding during the drug discovery and 
development processes [2–5]. Therefore, cell-based assays have gained increased 
popularity compared to biochemical assays in drug discovery and development. 
Although cell-based assays are more complex and less specific than biochemical 
assays, they facilitate the measurements of mode of action, pathway activation, 
toxicity, and phenotypic responses of cells mediated by exogenous stimuli. However, 
established in vitro cell-based assays are static and laborious and cannot measure 
real-time interactions on the cellular level. They often rely on labelled materials for 
imaging or detection purposes, and they require a secondary detection technique 
where the final quantification is based on UV- or fluorescence spectroscopy, mass 
spectrometry, radiometry or chromatographic techniques. Thus, a development of 
new in vitro cell-based assay methodologies and approaches which enable direct 
detection, and real-time, non-invasive, label-free and continuous high sensitivity 
monitoring of cell responses to exogenous stimuli, would be desirable. 
Several label-free techniques have recently been developed for studying cell-
substrate adhesion, cell-cell interactions, cell migration and volume changes in 
cells [6–14], as well as for monitoring living cell activity (e.g. cellular metabolism, 
toxicity, receptor mediated signaling and endocytic vesicle formation) [15–26]. 
Among the label-free techniques developed for probing the activities and interactions 
of living cells, optical techniques that utilizes evanescent waves, i.e. surface plasmon 
resonance (SPR) and resonant waveguide grating (RWG), have attracted a great deal 
of interest. This is probably because they are widely spread and have established 
themselves as powerful techniques for biosensing applications. However, the 
evanescent wave measuring techniques generally penetrate approximately ½ of the 
incident light wavelength into the surrounding medium. Thus, for a visible light 
source, a 300 nm penetration depth with an exponential decay of sensitivity as a 
function of distance from the sensor surface is commonly achieved [27]. This means 
that in living cell sensing, the evanescent wave technique only probes the bottom part 
of the cell layer. Attempts to improve the penetration depth have been made by 
utilizing near infrared (NIR) SPR [12, 24], but despite of this the active scanning 
range is still well below the common cell diameter. 
An advantage of SPR compared to RWG is that SPR systems are capable of 
measuring in constant and controlled flow conditions, and depending on the optical 
setup of the SPR instrument, it is even possible to extract thickness and refractive 
index information on the (cell) layers through optical modeling of the full SPR 
spectrum [27, 28]. SPR has established itself as a powerful technique for providing 
affinity and kinetic information of target-based biomolecular interactions [29, 30]. 
However, several studies have demonstrated that SPR is also a powerful tool for real-
time monitoring of living cell interactions, and for studying different cellular 
processes without the use of labeling agents [15, 16, 18, 19–22, 24, 26]., So far all SPR 
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interaction studies with living cells are performed by measuring and analyzing only 
changes either in the main SPR peak angular position or in the reflection intensity at 
a fixed angle near the main SPR peak minimum. This probably origins from one or 
both of the following reasons: 1) Traditionally SPR has almost solely been used for 
routine biomolecular interaction analysis based on reflectance or angular changes, 
and the living cell sensing is therefore forced into the same thinking patterns, and/or 
2) the SPR instruments used for living cell studies do not provide any other 
information than reflection intensity at fixed angle or angular change information, 
which does not allow for any other type of analysis. 
The full SPR angular spectra have successfully been used in modeling optical 
properties and thicknesses of both thin organic and inorganic layers [27, 28, 31]. 
However, a highly unexploited approach of SPR is to measure the full SPR angular 
spectra in real-time in order to fully utilize its shape or key parameters (i.e. SPR peak 
angular position, SPR peak minimum intensity and the changes in the total internal 
reflection region) for studying drug interaction processes with cellular targets. This 
might not be critical when considering traditional biomolecular interactions, but it 
should play a significant role in living cell sensing. Therefore, analyzing multiple 
parameters from the full SPR angular spectra would be of interest in order to try to 
obtain a better quantitative or even qualitative understanding of how SPR could be 
utilized for living cell sensing. No studies have so far made use of real-time 
monitoring of the full SPR angular spectra and utilized it for analyzing real-time 
drug-cell interactions. 
Herein, changes in simulated full SPR angular spectra induced by varying 
different optical parameters are compared with actual SPR measurements of drug-
MDCK II cell interactions in order to elucidate the signal responses in living cell 
sensing with SPR. An understanding of cell-analyte responses is established through 
optical modeling of different sections of the cell monolayer, and by examining the 
changes taking place in the full SPR angular spectra caused by the introduction of an 
analyte. The simulated SPR angular spectra responses from a cell monolayer are then 
compared with the measured full SPR angular spectra of an actual cell monolayer 
composed of MDCKII cells. Finally, a new qualitative analysis method demonstrating 
how the multi-parameter SPR approach enables to distinguish between passive 
(trans- and paracellular) drug absorption processes during drug-cell interactions is 
presented. 
8.2 EXPERIMENTAL SECTION 
8.2.1 SPR THEORY 
The working principle of the SPR technique is based on utilizing visible light to excite 
free electrons on a surface of a metal, which in turn causes surface plasmons to travel 
along the metal surface also creating an evanescent field to the adjacent medium in 
contact with the metal. The surface plasmon excitation takes place when certain 
conditions regarding the optical properties of the system and incident light angular 
frequency are matched, resulting in a high absorption of the incident light. The most 
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common way of fulfilling these conditions is to use the so-called Kretchmann 
configuration (Figure 1A), which enables the detection of plasmon excitation from a 
sharp dip in the refracted light intensity (Figure 1B). The total internal reflection 
(TIR) region is sensitive to the optical properties of the media outside the evanescent 
field (εbulk), whereas the main SPR peak angular position and intensity are highly 
sensitive to the optical properties of the media within the evanescent field 
(ε1) [27, 28]. 
 
Figure 1 Kretschmann configuration and key parameters obtained from the full SPR angular 
spectra. 
A) A simplified chart of the Kretschmann configuration enabling plasmon excitations and SPR 
measurements. The intensity of the reflected light from a monochromatic light source is 
measured as a function of incident light angle (θ). The light passes from a high refractive index 
medium (glass, ε0) to a low refractive index medium (air or liquid, ε1+εbulk). In between, the light 
is reflected from an interface containing a metal with a high density of free electrons and an 
optimal thickness for plasmon excitation (gold 50 nm, ε2) to a photodetector. The surface 
plasmons on the metal surface are excited at a certain incident light angle (θ) and the 
evanescent field created by the plasmon extends to the adjacent low refractive index medium 
(ε1) where samples are introduced to the system. B) A schematic full SPR angular spectrum 
showing the positions of the TIR region, the main SPR peak angular position and the main 
SPR peak minimum intensity. 
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A theoretical mathematical description for the surface plasmon resonance 
condition for a multilayer optical system can be obtained by solving the Maxwell 
equations. This results in the following solution for the resonance condition: 
 
    (1) 
 
where ω is the angular frequency of light, c is the speed of light, θ is the angle of the 
incident light and ε0, ε1 and ε2 are the permittivity of the prism, of the SPR metal 
layer and of the adjacent medium, respectively (Figure 1). The permittivity (ε) and 
refractive index (ñ) of the materials can be written in their complex forms as 
following: 
 
     (2a) 
    (2b) 
 
and the permittivity and the complex refractive index also have the following 
relationship: 
 
      (3a) 
     (3b) 
 
A general answer for the Maxwell equations for multilayered systems linked to 
measurable or controllable variables can be solved by using the transfer matrix 
formalism of 2×2 matrices. The overall mathematical formalism has been published 
several times, and it is not in the scope of this article to discuss it in detail [28, 31]. In 
practice, this matrix formalism is solved by mathematical calculations and fitting 
tools, or by taking advantage of dedicated software tools developed for this (e.g. 
Winspall) [32]. Fitting the full SPR angular spectra then provides information that 
can be used to characterize sample properties, such as the real refractive index, the 
thickness and the light absorbance properties of different analyst materials at the 
surface [28, 33, 34]. 
8.2.2 SIMULATION OF FULL SPR ANGULAR SPECTRA 
The Winspall software (version 3.02) [32] was used throughout this study to simulate 
the full SPR angular spectra. The optical parameters for the fixed components in the 
simulations were as following: Glass prism, n = 1.5294, k = 0 and thickness = ∞; 
Chromium adhesion layer, n = 3.1085, k = 3.4873 and thickness = 1.53 nm, Gold 
layer, n = 0.2262, k = 3.7639 and thickness = 50.59 nm. The optical parameters for 
the chromium adhesion and the gold layer were extracted from a Winspall fit to a 
measured full SPR angular spectrum of a real and thoroughly cleaned gold-coated 
SPR sensor slide immersed in water. All simulations were done with the sample layer 
immersed in a bulk medium resembling water with n = 1.3299 and k = 0. The 
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incident light wavelength used in the simulations was 670 nm, which is the same 
wavelength as in the SPR device used in this study. 
8.2.3 CELL CULTURE 
Madin-Darby canine kidney (MDCKII) cells were cultured in Dulbecco's Modified 
Eagle Medium (D-MEM) (Gibco) supplemented with 10% heat-inactivated FBS and 
1% penicillin-streptomycin. Cells were maintained at 37°C in a 5% CO2 incubator. 
Immobilization of cells on surface plasmon resonance sensor 
Gold-coated SPR sensor slides were obtained from Bionavis Ltd. (Tampere, 
Finland). Before the experiments the sensors were first cleaned by boiling them for 5 
min in a solution containing 1 part of 30% ammonia hydroxide solution (Sigma), 1 
part of 30% hydrogen peroxide (Sigma) in 5 parts of Milli-Q-water. Hereafter, the 
sensors were rinsed thoroughly with Milli-Q-water and dried with nitrogen. Finally, 
the SPR sensor slides were autoclaved before cell immobilization. 
The immobilization of MDCKII cells on the SPR sensor slides were performed by 
first treating confluent cell layers in cell culture flasks with 0.25% trypsin/EDTA in 
DPBS, followed by a re-suspension of the cells in the cell culture medium. The SPR 
sensor slide was then placed in a cell culturing polystyrene petri dish with a cell 
growth area of 8.8 cm2 and 3 ml of the cell suspension was pipetted on top of the SPR 
sensor slide. Cells were then allowed to attach and grow on the SPR sensor slide in an 
incubator in a controlled environment until they were confluent. 
8.2.4 VIABILITY OF CELLS ON SPR SENSOR SLIDES 
The trypan blue test was performed on cells cultured both in tissue culture treated 
polystyrene wells as a reference, and on cells cultured directly on SPR sensor slides. 
After 24 h of culturing the medium was carefully removed, and the cells were washed 
with DPBS before detaching them with a 0,25% trypsin/EDTA solution. Cells were 
then resuspended in cell culture medium and a Trypan blue solution (Gibco) was 
added to the cell suspension in a ratio of 1:1 (v:v) in order to stain the dead cells blue. 
The non-colored cells (viable cells) were counted with a Cedex XS cell counter (Roche 
Diagnostics Oy). 
8.2.5 TEST COMPOUNDS IN LIVING CELL SURFACE PLASMON RESONANCE 
ANALYSIS 
Propranolol hydrochloride (Sigma-Aldrich) and D-mannitol (Fluka) were used as test 
compounds in the SPR interaction studies with living cells. Each test compound was 
diluted in a buffer composed of Hank's Balanced Salt Solution (HBSS, Gibco) 
supplemented with 10 mM Hepes (Sigma) and adjusted to pH 7.4 with 1 M NaOH 
(running buffer). 
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8.2.6 SURFACE PLASMON RESONANCE ANALYSIS 
Interaction experiments between test compounds and immobilized MDCKII cells 
were performed using a multiparameter SPR device (MP-SPR Navi 200, BioNavis 
Ltd, Tampere, Finland). The cells were cultured on the SPR sensor slide for 3–4 days 
before analysis. Just before the measurements, the whole flow path of the SPR device 
was filled with the running buffer. Once the cells had reached confluency on the SPR 
sensor slide, they were once washed with the running buffer. After this, the sensor 
slide was quickly inserted into the instrument before the cell layer could dry. The 
experiments were performed under a constant flow rate of 10 μl/min, which was 
controlled by a syringe pump accessory. The interaction between cells and test 
compounds were measured by injecting the compound of interest for 6 to 10 min 
followed by a rinsing period of 10–20 minutes with pure running buffer. All the 
experiments were performed at 20 °C by using the angular scan mode. The angular 
scan range during the experiments was between 60–78°. With this scan range the 
angular scan mode provided a full SPR angular spectrum every four seconds. At the 
end of each experiment, the SPR sensor slide was examined under an optical 
microscope in order to evaluate the cell monolayer integrity after the interaction 
experiments. 
8.3 RESULTS 
8.3.1 IMMOBILIZATION OF MDCKII CELL MONOLAYERS ON SPR SENSOR 
SLIDES 
Real-time drug-cell interactions were monitored with SPR by immobilizing a 
monolayer of MDCKII cells on the SPR sensor slide while continuously measuring the 
full SPR angular spectrum during cell stimulation with propranolol and D-mannitol. 
For this purpose, it was of utmost importance to optimize the cell immobilization 
protocol, because the surface coverage of cells on the SPR sensor slide has a dramatic 
influence on the shape of the full SPR angular spectra [12, 16, 24]. The morphology of 
MDCKII cells seeded directly on SPR sensor slides and polystyrene surfaces (used as 
a reference) was found to be the same (Fig. 2A–D). Different cell seeding densities 
from 5×104 cells/cm2 to 1×105 cells/cm2 on the SPR sensor slide revealed the 
following: 1) The lowest cell seeding density of 5×104 cells/cm2 was not sufficient to 
form a fully confluent cell monolayer and large cell free areas could be seen in the 
microscopy image (Fig. 2B), 2) the highest cell seeding density of 
1×105 cells/cm2 showed some cell-condensed clusters (Fig. 2D), and 3) an 
intermediate cell seeding density of 7×104cells/cm2 was optimal for immobilizing a 
uniform, almost cluster-free and fully confluent cell monolayer on the SPR sensor 
slide (Fig. 2C). The optimum cell seeding time for achieving confluent MDCKII cell 
monolayers on SPR sensor slides was also determined to be 3–4 days. 
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Figure 2  MDCKII cell morphology and viability on polystyrene and gold coated SPR sensor 
slide. 
Light microscopy images of MDCKII cells cultured on A) polystyrene with a cell seeding 
density of 1×105 cells/cm2, B) SPR sensor slide with a cell seeding density of 5×104cells/cm2 , 
C) SPR sensor slide with a cell seeding density of 7×104 cells/cm2 , D) SPR sensor slide with 
a cell seeding density of 1×105 cells/cm2, E) SPR sensor slide with a cell seeding density of 
7×104 cells/cm2 after exposing the cell monolayer to increasing concentration (2.5 μM, 25 µM 
and 250 µM) of propranolol during 1 hour at a flow rate of 10 μl/min in the SPR flow channel, 
F) cell viability of MDCKII cells grown on polystyrene reference and gold coated SPR sensor 
slides. The cell seeding time used for the cell monolayers in A)–F) was 3 days. The scale bar 
in all images is 100 µm. 
Stimulation experiments with drugs showed that the MDCKII cell monolayers on 
the SPR sensor slides remained confluent with hardly any changes in morphology 
after being exposed to the drug at a flow rate of 10 μl/min in the SPR flow channel 
(Fig. 2E). The flow experiments clearly demonstrated that there is no need to use any 
adhesion promoter in order to successfully immobilize and retain a confluent 
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MDCKII cell monolayer on the SPR sensor slide for SPR interaction measurements. 
The trypan blue cell viability test showed that the MDCKII cells remained viable on 
the SPR sensor slides after 24 h of cell culturing (Fig. 2F). 
Thus, the optimized cell seeding conditions allowed to consistently preparing 
uniform, fully confluent and viable MDCKII cell monolayers on the SPR sensor slides. 
This ensures that no significant contributions to the SPR signal will be caused by cell 
spreading, cell division, cluster formation or overgrown cell monolayers. 
8.3.2 SIMULATED FULL SPR ANGULAR SPECTRA OF CELL MONOLAYERS 
In the majority of biomolecular or biosensing interaction studies with SPR, the 
sample layer thickness is well below the penetration depth of the evanescent field. In 
such a case, changes in the real part of the refractive index (n) will to a good 
approximation reflect the mass of the analyte within the sample layer. This is 
exemplified with the simulated full SPR angular spectra in Figure 3A. This figure 
shows that the main SPR peak angular position will shift to higher angles when the 
refractive index (n) of a sample layer increases from 1.45 to 1.5. On the other hand, if 
n would have been kept constant in the simulation in Figure 3A, then an increase in 
the sample layer thickness would have caused a corresponding increase in the main 
SPR peak angular position angle. This is the case, as long as the layer thickness is 
smaller than the penetration depth of the evanescent field. A much less frequently 
characterized property when using SPR is the imaginary part of the refractive index 
(k), which is linked to the absorbance or scattering of light by the sample layer. Figure 
3B shows the changes in simulated full SPR angular spectra caused by an increase in 
k from 0 to 0.05 in the sample layer. It is clear that the change in k induces an 
increase in the main SPR peak minimum intensity, which means that less of the light 
used to excite surface plasmons actually can do so. The reason for this is that the 
sample absorbs or scatters light, which consequently changes the conditions for 
exciting surface plasmons. In such a case the optical properties of the system start to 
deviate from the optimum conditions for surface plasmon excitation described 
by equation (1). This in turn leads to a situation where an increasing amount of light 
is reflected back instead of exciting the surface plasmons. 
Figure 3C shows another exotic optical behavior of the simulated full SPR angular 
spectra. When the sample layer thickness reaches the corresponding thickness of the 
penetration depth of the SPR evanescent field, then the main SPR peak angular 
position is shifted to very high angles and a second peak starts to appear in the 
vicinity of the total internal reflection (TIR) angle. After this a further increase in the 
sample layer thickness does not induce any major changes in the main SPR peak 
angular position, but the second peak in the vicinity of the TIR angle will become 
more pronounced. This behavior of the full SPR angular spectra is due to the 
formation of a waveguide on the SPR sensor slide [34, 35]. Figure 3C also reveals that 
the waveguide peak grows stronger when the layer thickness approaches the 
wavelength of the light used in the simulation (i.e. 670 nm), or when the sample layer 
thickness is close to twice the penetration depth of the evanescent field. 
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Figure 3 Simulated full SPR spectra for optical changes within the evanescent field and thick 
sample layers. 
Behavior of simulated full SPR angular spectra when A) changing the real and B) changing 
the imaginary parts of the refractive index components, and C) for very thick (waveguide) 
sample layers. The following parameters were used for simulations: A) sample layer 
thickness: 10 nm, k = 0 and n varied from 1.45–1.5, B) sample layer thickness: 10 nm, n = 
1.45 and k varied from 0.00–0.05, and C) n = 1.38, k = 0 and sample layer thickness varied 
from 400–700 nm. 
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When a cell monolayer is taken as the sample layer in SPR it is expected that the 
behavior of the full SPR angular spectra should differ dramatically compared to a 
sample layer with a thickness well below the penetration depth of the evanescent 
field. The cell monolayer is a very thick water rich layer with a thickness of a few to 
tens of micrometers, and with a refractive index very close to water. Thus, the 
thickness of the cell monolayer is much larger than the penetration depth of the 
evanescent field. Figure 4A shows a schematic representation for the sample layer 
used in simulating full SPR angular spectra of cell monolayers. In order to clarify the 
effect of changing different optical properties in a cell monolayer, the cell monolayer 
is theoretically split into three sections, i.e. a thin section in the magnitude of 
evanescent field close to the sensor surface (ñef, 500 nm), a thick section consisting of 
the rest of the cell (ñcell, 3000 nm), and an infinite bulk medium layer (ñbulk, buffer). 
When the full SPR angular spectra of a cell monolayer based on the layer structure 
in Figure 3A was simulated, it was found that a cell monolayer should form a weak 
waveguide on the SPR sensor slide (Fig. 4B–E). This is indicated by the small peaks 
and wavy curves in the TIR region (see Figure 3). An increase in the real part of the 
refractive index of a cell monolayer (nef) within the evanescent field (region III in Fig. 
4A) resulted in an increase in the main SPR peak angular position (Fig. 4B), with 
negligible changes in the main SPR peak minimum intensity and TIR region (inset 
in Fig. 4B). Similarly, an increase in the complex part of the refractive index (kef) 
induces an increase in the main SPR peak minimum intensity and a decrease in the 
intensity around the TIR angle, but no changes in the main SPR peak angular 
position (Fig. 4C and 4D). It is worth noting that 10 times smaller refractive index 
changes are needed for the cell monolayer compared to a thin sample layer 
(see Figure 3) in order to induce the corresponding changes in the main SPR peak 
angular position or main SPR peak minimum intensity. 
If the ncell for the cell monolayer outside the evanescent field (region II in Fig. 4A) 
was increased in the simulations, then no changes were seen in the main SPR peak 
angular position, but the TIR angle increased slightly (Fig. 4D). Correspondingly, 
when kcell was increased in the same region, then no changes were seen in the main 
SPR peak minimum intensity (Fig. 4E). The intensity changes in the TIR region also 
showed a rather complex behavior with several inflection points at which the 
intensity changes reversed direction. However, the intensity changes around the TIR 
angle (~62°) became negligible when kcellreached 0.002–0.003 (inset in Fig. 4E) 
when compared to the intensity changes induced by changes in kef within the 
evanescent field (inset of Figure 4C). Additionally, no changes in the main SPR peak 
angular position or the SPR peak minimum intensity were found in cases where the 
complete cell monolayer thickness (def + dcell) was varied between 2000–6000 nm or 
when only nbulk of the bulk medium layer was varied between 1.330–1.355 (Figure 
S1 and S2). In these cases there were also only negligible changes in the TIR region 
when the cell layer thickness was larger than 3000 nm, which is still much smaller 
than the actual thickness of a cell. 
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Figure 4 Simulated full SPR spectra for optical changes within different regions of a cell 
monolayer. 
A) Schematic representation of the sample layer used in simulating full SPR angular spectra 
of cell monolayers. The cell monolayer was theoretically split into three sections in order to 
clarify the effect of changing different optical properties in it: 1) a thin section in the magnitude 
of evanescent field close to the sensor surface (ñef, def = 500 nm), 2) a thick section consisting 
of the rest of the cell (ñcell, dcell = 3000 nm), and 3) an infinite bulk medium layer (ñbulk, dbulk = 
∞). Simulated full SPR angular spectra when changing; B) the real (nef) and C) the imaginary 
(kef) parts of the refractive index for a cell monolayer within the evanescent field, D) the real 
part of the refractive index (ncell) for a cell monolayer not within the evanescent field and E) the 
imaginary part of the refractive index (kcell) for a cell monolayer not within the evanescent field. 
Insets in B-E are more detailed views of the TIR regions. The following parameters were used 
for simulations: B) dcell = 3000 nm, kcell = 0.002, ncell varied from 1.340–1.345, def = 500 
nm, nef = 1.34 and kef = 0.002, C) dcell = 3000 nm with ncell = 1.340, kcell varied from 0–
0.005, def = 500 nm, nef = 1.34 and kef = 0.002, D) dcell = 3000 nm, kcell = 0.002,ncell = 1.34, def = 
500 nm, kef = 0.002 and nef varied from 1.340–1.345, and E) dcell = 3000 nm, kcell = 
0.002, ncell = 1.34, def = 500 nm, nef = 1.34 and kef varied from 0–0.005. 
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8.3.3 DRUG-CELL INTERACTION ANALYSIS WITH SURFACE PLASMON 
RESONANCE 
The successful immobilization of MDCKII cell monolayers on the SPR sensor slides 
was verified before each interaction measurement with drug compounds by first 
measuring the full SPR angular spectrum of the cell monolayer. Figure 5A shows a 
typical full SPR angular spectrum measured for a MDCKII cell monolayer. The full 
SPR angular spectrum for an MDCKII cell monolayer shows large shifts in the main 
SPR peak angular position, in the main SPR peak minimum intensity and in the 
shape of the TIR region compared to a pure SPR sensor slide. This confirmed the 
presence of a MDCKII cell monolayer on the SPR sensor slide. The main SPR peak 
angular position for the MDCKII cell monolayer was at 71.35° and the TIR region had 
a smooth shape located at ~64°. These were very close to the main SPR peak angular 
position of 71.85° and the TIR region location of ~62° for a simulated full SPR 
angular spectrum for a cell monolayer (see Fig. 4). This actually implicates that the 
MDCKII cell monolayer forms a low density waveguide on the SPR sensor slide. The 
differences in the angular position of the TIR region between measured and 
simulated full SPR angular spectra is a direct consequence of the fact that the 
simulated spectrum for a cell monolayer assumes a completely homogenous layer 
with a uniform thickness, whereas these assumptions are not necessarily valid for an 
actual living cell monolayer. 
After verifying the quality of the MDCKII cell monolayer the MDCKII cells were 
stimulated with the test compounds and the actual full SPR angular spectra were 
measured as a function of time. Figure 5B shows a typical sensogram of the main SPR 
peak angular position for an experiment with confluent MDCKII cell monolayer when 
cells were exposed to increasing concentrations of propranolol and D-mannitol. The 
main SPR peak angular position for both compounds was displaced to lower angles 
during stimulation. However, when the cells were rinsed with pure running buffer the 
SPR angle started to increase and it took approximately 5 minutes for the baseline to 
stabilize. The main SPR peak angular position remained at higher values after 
stimulating the MDCKII cells with propranolol, whereas it returned to the baseline 
level after stimulation with D-mannitol. This suggests that a certain fraction of the 
propranolol remains in the cell monolayer after each stimulation, and that D-
mannitol is almost completely removed from the cell monolayer after stimulation, 
regardless of the concentration used. The changes in the main SPR peak angular 
position were clearly concentration dependent for propranolol, but not for D-
mannitol, for which the changes in the main SPR peak angular position were almost 
constant for all tested concentrations. These results indicate that propranolol and D-
mannitol have different modes of interaction with the MDCKII cells which is reflected 
in the changes in the main SPR peak angular position. No significant changes in the 
main SPR peak angular position were measured when propranolol or D-mannitol was 
allowed to interact with a pure gold SPR sensor slide. This verifies that the main SPR 
peak angular position changes measured during interaction of the test compounds 
with the MDCKII cells actually reflect real drug-cell interactions and not drug-gold 
interactions. 
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Figure 5 SPR signal responses during drug stimulation of MDCKII cells. 
A) Measured full SPR angular spectra of a pure gold coated SPR sensor slide (grey line) and 
MDCKII cell monolayer immobilized on the SPR sensor slide (black line). B) Measured 
changes in the angular position of the SPR peak minimum as a function of time when a 
MDCKII cell monolayer was stimulated with propranolol (blue line) and D-mannitol (red line). 
C) Focused part of full SPR angular spectra showing the main SPR peak curves measured 
before (black line), during (red line) and after (blue line) stimulating a MDCKII cell monolayer 
with 25 µM propranolol. D) Measured changes in the SPR peak minimum intensity as a 
function of time when a MDCKII cell monolayer was stimulated with propranolol (blue line) and 
D-mannitol (red line). In figure C) and D) the downward arrows represent the time of sample 
injections, and upwards arrows represent the injection of buffer without sample. 
The changes in the main SPR peak angular position when stimulating the MDCKII 
monolayer with propranolol and D-mannitol are surprisingly large, especially when 
considering the molecular weight of these compounds (i.e. 259.34 g/mol for 
propranolol and 182.17 g/mol for D-mannitol). This is in accordance with the 
simulated full SPR angular spectra for cell monolayers in Figure 4, where it was 
shown that very small changes in n or k in the cell monolayer induced rather large 
variations in the main SPR peak angular position and the main SPR peak minimum 
intensity. 
Interestingly, when MDCKII cells were stimulated with propranolol it was found 
that not only the main SPR peak angular position changed during stimulation, but 
also the main SPR peak minimum intensity changed significantly (Fig. 5C–D). In the 
case of D-mannitol only slight or no changes were observed in the main SPR peak 
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minimum intensity during the MDCKII cell stimulation (Fig. 5D), even though the 
main SPR peak angular position during cell stimulation with D-mannitol still showed 
a negative shift (Fig. 5B). These results further indicate that propranolol and D-
mannitol have different modes of interaction with the MDCKII cells, which is 
reflected not only in the main SPR peak angular position but also in the main SPR 
peak minimum intensity. Thus, instead of analyzing only the main SPR peak angular 
position changes during drug-cell interactions it would be more useful to analyze 
both the main SPR peak angular position and the main SPR peak minimum intensity 
and plot these against each other in order to better understand and distinguish 
between the mode of interaction between different drugs during cell stimulation. 
Figure 6 shows a series of plots of changes in the main SPR peak angular position 
versus main SPR peak minimum intensity from at least three repetitions and for 
several concentrations when MDCKII cells were stimulated with propranolol and D-
mannitol. The difference between the behavior of the two compounds in terms of 
angle and intensity is very clear. Propranolol shows large changes in both angle and 
intensity which result in curves with significant slopes. D-mannitol on the other hand 
shows in most cases very small changes in intensity, leading to curves with a more 
horizontal appearance in these plots. The same trend in the intensity versus angle 
plots is repeated in the same way for each compound at all the concentrations tested. 
The simulated full SPR angular spectra for a cell monolayer suggest that the TIR 
region should also reflect changes in the cell monolayer during drug stimulation 
(see Fig. 4C–E). When examining the TIR region in more detail during drug 
stimulation of MDCKII cells we found that the TIR angular position followed the 
same trend as the main SPR peak angular position when stimulating the MDCKII 
cells with propranolol or D-mannitol, i.e. larger changes for propranolol compared to 
D-mannitol (Figures S3 and Figure S4A). On the contrary, the reflection intensity of 
the TIR angular position (~64°) showed a reverse trend compared to the main SPR 
peak minimum intensity, i.e. significant positive changes for propranolol and very 
small positive changes for D-mannitol (Figures S3 and Figure S4). These results are 
in sound accordance with the behavior of a cell monolayer described by the simulated 
full SPR angular spectra in Figure 4, where it was shown that the TIR angle and the 
main SPR peak angular position changes in the same direction with changes in n, and 
the reflection intensity in the TIR region changes in the opposite direction than the 
main SPR peak minimum with changes in k. Finally, when the TIR angular position 
was plotted against the reflection intensity of the TIR angular position, we found that 
the curves displayed similar slopes for both propranolol and D-mannitol, but the 
magnitude of the curve was clearly larger for propranolol than for D-mannitol (Figure 
S4C). 
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Figure 6  Change in SPR peak angular position versus minimum intensity during drug 
stimulation of MDCKII cells. 
Individual repetitions of the SPR measurements in a concentration series from three 
repetitions when MDCKII cell monolayers were stimulated with propranolol and D-mannitol, 
respectively: 2.5 nM (A: propranolol, F: D-mannitol), 250 nM (B: propranolol, G: D-mannitol), 
2.5 μM (C: propranolol, H: D-mannitol), 25 μM (D: propranolol, I: D-mannitol) and 250 μM (E: 
propranolol, J: D-mannitol). 
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8.4 DISCUSSION 
In this study, there were several reasons for using MDCKII cells and the two passively 
absorbing drugs utilizing different absorption routes. We anticipated at the beginning 
of our studies that the SPR signal responses with cells would be very complex if all 
kinds of drug transport processes were present. Therefore, the aim was to simplify 
the experimental design as much as possible by choosing a combination of cells and 
drugs which are already widely used specifically for passive (para- and transcellular) 
drug permeation studies. The choice of MDCKII cells was mainly based on the fact 
that they have low expression of drug transporters and little metabolic activity, which 
makes it a valuable cell line, especially for studying passive drug transport 
processes [36, 37]. D-mannitol and propranolol were chosen as model drugs because 
they are known to utilize different passive drug absorption routes, i.e. propranolol 
uses the transcellular and D-mannitol uses the paracellular absorption route [38, 39]. 
With this we could ensure that no other competing drug absorption processes, i.e. 
active transport and efflux of drugs, were present during our studies. In this way we 
could concentrate on studying and distinguishing the differences in the SPR signal 
responses which were solely due to passive drug absorption processes, without the 
interference from multiple competing processes. 
Several studies have shown that the surface coverage of cells on the gold SPR 
sensor slide has a dramatic influence of the shape of the full SPR angle 
curve [12, 16, 24]. Therefore, in order to obtain repeatable SPR analyses and avoid 
unspecific interactions of the test compounds, not originating from cell interactions; 
it is of utmost importance to find a cell immobilization protocol that enables a 
repeatable preparation of confluent monolayers on the SPR sensor slide. In this study 
we found that MDCKII cells adhered and proliferated on gold and formed a confluent 
cell monolayer on the bare gold SPR sensor slide (Figure 2). We also found that no 
cell adhesion promoter was needed to form confluent monolayers of MDCKII cells on 
gold. Furthermore, Trypan blue tests showed that the gold SPR sensor slide surface is 
not cytotoxic for MDCKII cells (Figure 2F). 
After reaching confluency, the MDCKII cells started to form clusters on the 
smooth gold SPR sensor slide surface. By examining the microscopy images it seemed 
that liquid had gathered under the cells at the clustering points. Cells are generally 
attached to surfaces in focal, close, and extracellular matrix contacts, each with its 
own characteristic separation distance from the surface [40]. As a result, cell plasma 
membranes are normally 10–100 nm away from the substrate surface depending on 
cell types and culturing conditions. However, due to the cluster formation in the case 
of MDCKII cells in this study the plasma membranes could have been even further 
away in those zones, which probably have a small effect on the quality of the 
measured full SPR angle spectrum of the MDCKII cell layer. This could explain why 
the small waveguide node appearing in the simulated full SPR angle spectra for a cell 
monolayer (Figure 4) is not properly visible in the measured full SPR angle spectrum 
of the MDCK II cells (Figure 5A). 
Other cells than MDCKII have previously also been cultured on bare gold for SPR 
cell studies. These studies include cell lines such as human melanoma [22], human 
basophilic KU812 [41], RBL-2H3 rat mast and PAM212 mouse keratinocyte cells [19]. 
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Moreover, Robelek and Weger[13] have grown MDCKII cells directly on SPR sensor 
surfaces as a confluent monolayer to study volume changes of cells. Based on the 
literature and the results in this study it seems that there is no general coating 
procedure or protocol for cell adhesion and preparation of confluent cell monolayers 
on gold coated SPR sensor slides, and therefore it is necessary to optimize these 
conditions for each cell line separately before performing SPR interaction 
measurements. 
According to the full SPR angular spectra simulations a cell monolayer should 
form a low density waveguide with the main fundamental SPR peak minimum visible 
at relatively small angles compared to the thickness of the system (Figure 4). 
Additionally, the next node(s) remain close to the total internal reflection region, 
never progressing far from there. The actual full SPR angular spectrum measured for 
a confluent MDCKII cell layer (Figure 5A) resembled the simulated spectrum for a 
cell monolayer surprisingly well (Figure 4). This suggests that a monitoring of the 
shape of the full SPR angular spectrum thus provides a means to verify cell 
monolayer integrity during SPR interaction measurements. The full SPR angular 
spectra simulations also revealed that the sensitivity towards optical changes in a cell 
monolayer is enhanced by the fact that the cell covers the complete SPR evanescent 
field region, which enables the detection of extremely small changes in the living cell 
monolayer during cell stimulation. This has already been experimentally shown and 
indicated by other studies [15, 19, 20], but no studies have so far attempted to give an 
explanation of the implications of this on the full SPR angular spectra and how this 
could possibly be further utilized for living cell sensing with SPR. 
The literature of SPR interaction measurements involving immobilized cells on 
the sensor surface are quite contradictory – in some cases the injection of the analyte 
results in positive SPR responses [15, 19, 20, 24, 26] and in other cases in negative 
SPR responses[18–21]. A widely accepted simplification for the measured SPR signal 
is that the main SPR peak angular position (or the intensity change at a fixed angle) is 
linearly proportional to the mass change in the evanescent field. This is also evident 
from the basic physics of the SPR phenomena [27] and the simulations in Figures 
3A and 4B. Based on this it has been suggested that the SPR responses with cells 
based on measuring the changes in the main SPR peak angular position (or the 
intensity change at a fixed angle) originates from mass redistribution within the 
cells [19]. While possible and even probable, such a mass redistribution in cells 
should lead into changes both in the refractive index, and in the apparent light 
absorption of cell layers as different cell organelles and structures shift within the 
cell. This mass distribution could indeed induce either negative or positive changes in 
the SPR responses measured by monitoring only the main SPR peak angular position 
(or the intensity change at a fixed angle), depending on if the cytoskeletal mass 
migration in the cells is in the direction away from or towards the SPR evanescent 
field region during cell stimulation. This is also actually implicated by the simulations 
in Figure 3 and 4, and supported by the studies by Cuerrier et al., Chabot et 
al. [18, 21] and Yashunsky et al. [12]. Cuerrier et al. and Chabot et al. showed that 
morphological changes in cells, i.e. contraction of cells, induce a negative SPR shift in 
the reflection intensity measured at a fixed angle, while Yashunsky et al. showed that 
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cell spreading induces an increase in the reflection intensity measured at a fixed angle 
with mid infra-red SPR. 
However, none of the studies mentioned above have considered the changes in the 
main SPR peak angular position together with changes in the main SPR peak 
minimum intensity. It is clear from the simulated spectra in this study that 
changes both in the main SPR peak angular position and in the main SPR peak 
minimum intensity, and preferably also changes in the TIR region should be 
simultaneously monitored in order to fully understand the origin of the SPR 
responses caused by changes in the whole cell monolayer during drug stimulation of 
cells. This is because an increase/decrease in n will increase/decrease the main SPR 
peak angular position (Figure 4B) about twice as much as the TIR angle position 
(Figure 4D). Furthermore, an increase/decrease in k will be reflected in an 
increase/decrease in the main SPR peak minimum intensity and mainly a 
decrease/increase in the intensity around the TIR (Figure 4C and Figure 4E). 
Often small molecular drugs or other compounds used for stimulating cells do not 
have significant absorptive properties in the wavelengths used in SPR devices and 
should generally cause a positive SPR response when measuring only the main SPR 
peak angular position (or the intensity change at a fixed angle). Thus, the simulations 
in Figure 4 suggest that a utilization of multiple parameters extracted from the full 
SPR angular spectra measured in real-time during cell stimulation would provide a 
means to determine the origin of the SPR response. In other words, this could 
provide a way to distinguish whether the SPR response 1) originates only from the 
accumulation of the stimulant in the cell layer, 2) is due to morphological changes of 
the cells or cytoskeleton mass redistribution within the cells, or 3) is a combined 
effect of 1) and 2). The plots of the main SPR peak minimum intensity versus the 
main SPR peak angular position in Figure 6 and the changes in the TIR region 
(Figures S3 andFigure S4) actually highlight that there is a clear difference in the 
interaction modes of propranolol and D-mannitol with the MDCKII cells. It is known 
that propranolol utilizes the transcellular pathway and D-mannitol utilizes the 
paracellular pathway when absorbed through a cell monolayer [38, 39]. The graphical 
representation in Figure 6 in combination with the changes in the TIR region (Figure 
S4C) thus provides the means to differentiate between the modes of action of drugs 
with cells. 
When examining Figure 5B, Figure 5D and Figure 6A–E in more detail it is 
obvious that there is a clear negative shift in both the SPR peak angular position and 
the SPR peak minimum intensity during cell stimulation with propranolol when 
examining each concentration separately. After stimulation, both the main SPR peak 
angular position and the main SPR peak minimum intensity return to a higher level 
than before stimulation. This indicates that some propranolol accumulates in the 
cells as expected because of its ability to diffuse transcellularly into cells. It is 
worthwhile to note from Figure 5B, Figure 5D and Figure 6E that the change in both 
the main SPR peak angular position and the main SPR peak minimum intensity 
quickly becomes positive during stimulation of the MDCKII cell with the highest 
concentration for propranolol (i.e. 250 μM). These results for propranolol indicate 
that a stimulation of the cells with a low concentration of propranolol first induces a 
cell contraction accompanied by a mass redistribution away from the evanescent field 
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region leading to a negative shift in both of the SPR responses. Hence, the SPR 
responses for low concentrations of propranolol probably originate from 
morphological and mass distribution changes of the cells, rather than from 
propranolol absorbed into the cell, since the amount of absorbed propranolol is not 
sufficient to render the SPR signals positive. A stimulation of the MDCKII cells with 
the highest concentration of propranolol causes an initial negative shift in both SPR 
responses. This suggests that a stimulation with propranolol first induces cell 
contraction accompanied by a mass redistribution away from the evanescent field 
region. Hereafter, both SPR responses become positive, which is probably a 
consequence of a cell spreading accompanied by a mass redistribution towards the 
evanescent field region and an accumulation of propranolol in the cells. Similar 
behavior has been shown for HEK-293 cells stimulated with angiotensin II by 
correlating the change in the SPR intensity at a fixed angle with phase-contrast 
microscopy imaging [18]. 
In the case of D-mannitol (Figure 5B, Figure 5D and Figure 6F–J), a clear negative 
shift is only seen in the angular position of the SPR peak minimum during cell 
stimulation, while the SPR peak minimum intensity only changes very little or not at 
all. After cell stimulation, the main SPR peak angular position returns to the same 
level as before stimulation. This could be expected because D-mannitol diffuses 
through cell layers by the paracellular pathway, and no accumulation of D-mannitol 
is expected in the cell monolayer or within the cells. However, it was surprising to see 
that the SPR peak angular position during cell stimulation with D-mannitol showed a 
negative shift even though there was no change in the main SPR peak minimum 
intensity. This could indicate that D-mannitol indeed induces a cell contraction in 
order to utilize the paracellular pathway, but the contraction is not sufficiently large 
to induce any cell mass redistribution within the cell. This perception is also 
supported by the fact that the changes in the main SPR peak angular position are 
basically constant for all concentrations and much smaller in the case of D-mannitol 
compared to propranolol (Figure 5B and Figure 6). Furthermore, the smaller changes 
in the TIR region (Figure S3 and Figure S4) indicate a smaller mass redistribution 
within the cells in the case of D-mannitol compared to propranolol. This is also 
supported by the simulations in Figure 4C–E, which suggest that the contribution to 
the TIR region origins mainly from the cell monolayer outside the evanescent field 
and does not have any significant contributions from morphological changes of the 
cells. This could mean that the TIR region merely reflects the mass redistribution 
within the cell monolayer. 
The results from our study presented here convinced us that the change in the 
main SPR peak angular position reflects both drug accumulation and morphological 
changes in the cell monolayer, and that the change in the main SPR peak minimum 
intensity is mainly due to mass redistribution within the cells. Thus, based on the 
results in this work, we suggest the following two possible scenarios for the SPR 
responses in living cell sensing: 1) An accumulation of a drug, e.g. D-mannitol, in the 
cell layer which induces only a slight contraction of the cells but no mass 
redistribution in the cells, would result in a negative change in the SPR peak angular 
position, but it would not result in a change in the SPR peak minimum intensity. 2) 
An accumulation of a drug, e.g. propranolol, in the cell layer which induces a 
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contraction of the cell layer and a mass redistribution in the cells, would result in a 
negative change in both the SPR peak angular position and the SPR peak minimum 
intensity. If taking into account all other possible options, there could be two 
additional scenarios for the SPR responses in living cell sensing which could not be 
addressed by the experimental design in this work. Namely, 1) a simple accumulation 
of a drug in the cell layer which does not induce any morphological changes in the cell 
layer, would result in a positive change in the SPR peak angular position, but no 
change in the SPR peak minimum intensity, and 2) an accumulation of a drug in the 
cell layer which induces a spreading of the cell layer, and a mass redistribution in the 
cells would result in a positive change in both the SPR peak angular position and the 
SPR peak minimum intensity. 
Conclusively, it is rather obvious that the origins of the SPR responses are very 
complex when combining SPR with living cells. In this work we have presented an 
attempt to better understand the SPR responses in living cell sensing by comparing 
optical modeling of cell monolayers with multiple parameters extracted from full 
angular SPR spectra recorded in real-time during cell stimulation with two model 
drugs. Simulated full SPR angular spectra in combination with changes in the main 
SPR peak angular position, the main SPR peak minimum intensity, and changes in 
the TIR region indicated that the change in the main SPR peak angular position, 
traditionally used in SPR studies, does probably not only reflect simple mass 
accumulation or mass redistribution within the cells. Instead, it probably also reflects 
morphological changes in the cell layer, which actually could dominate the main SPR 
peak angular position response. The change in the main SPR peak minimum 
intensity, on the other hand, is suggested to reflect which type of change in the cell 
layer (morphological and/or mass redistribution) causes the changes in the main SPR 
peak angular position. 
Finally, plotting the main SPR peak angular position versus the main SPR peak 
minimum intensity showed specific signal patterns. These signal patterns are 
suggested to reflect the type of drug absorption route utilized by the drug. We believe 
that the results in this study provide a step forward to an improved understanding of 
the signal responses in living cell sensing with SPR. This can open up new 
opportunities for utilizing the SPR technology in a broader context in the field of life 
sciences, for example as a tool for providing real-time complementary information 
for traditional in vitro cell assays in order to obtain a better mechanistic 
understanding of drug-cell interactions on a cellular level. 
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8.5 SUPPORTING INFORMATION 
 
FigureS1. Simulated full SPR angular spectra demonstrating that very large changes in 
the complete cell monolayer thickness (def + dcell) do not affect the main SPR peak 
position. It is worth noting that the complete cell monolayer thickness has to change 
dramatically before it induces any significant changes in the shape of the TIR region. The 
following parameters were used for simulations: nef = ncell = 1.34, kef = kcell = 0.002 and nbulk= 
1.3299, kbulk = 0. 
 
FigureS2. Simulated full SPR angular spectra demonstrating that changes in nbulk of the 
bulk medium layer above the cell monolayer do not affect the main SPR peak and induce only 
very small changes in the shape of the TIR region. The following parameters were used for 
simulations: nef = ncell = 1.34, kef = kcell = 0.002 and kbulk = 0. 
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FigureS3. Measured full SPR angular spectra at selected time points after starting the 
stimulation of a MDCKII cell monolayer with A) 25 μM D-mannitol and B) 25 μM 
propranolol. Th time points for recording the full SPR angular spectra in A) were t = 0 min 
(black solid line), t = 2 min (red solid line), t = 4 min (blue solid line), t = 13 min (black dashed 
line), and in B) t = 0 min (black solid line), t = 2 min (red solid line), t = 5 min (blue solid line), t 
= 17 min (black dashed line). 
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FigureS4. A) Change in the TIR angle position measured as a function of time during 
stimulation of a MDCKII cell monolayer with 25 μM Propranolol (blue line) or D-mannitol (red 
line). These results suggest that there is a much higher mass redistribution away from the cell 
monolayer region within the evanescent field (Fig. 4A, region III) for propranolol than for D-
mannitol. B) Change in the intensity at TIR angle position measured as a function of time 
during a stimulation of a MDCKII cell monolayer with 25 μM Propranolol (blue line) or D-
mannitol (red line). These results indicate that there is a much higher analyte accumulation 
and mass redistribution towards the cell monolayer region outside the evanescent field (Fig. 
4A, region II) for propranolol than for D-mannitol. C) Change in the intensity at TIR angle 
position versus change in TIR angle position for 25 μM Propranolol (blue line) or D-mannitol 
(red line) during stimulation of a MDCKII cell monolayer. Note that the slopes of these curves 
are the same, while the magnitude is clearly different indicating that an overall larger mass 
redistribution within the cell monolayer takes place during stimulation with propranolol than 
with D-mannitol. The same slope of these curves strongly suggests that the TIR region of the 
full SPR angular spectrum actually merely reflects accumulation of analytes and mass 
redistribution within the cell monolayer, but does probably not have any contribution from the 
adhesion and contact area of the cells. 
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9 CONCLUSIONS AND FUTURE PERSPECTIVES 
The label-free biosensor technologies have during the last decades established 
themselves as relatively common tools for biochemical interaction studies. While the 
label-free methods become more standardized, there still remain partially unexplored 
areas that could allow the methods to be utilized even better. The purpose of this 
thesis was to address several challenges of label-free methods that have not been 
widely studied, and to add new tools into the toolbox of biological and 
pharmaceutical scientists. 
While detection of simple biochemical interactions has been well established, 
especially for SPR-based biochemical assays, there are still several challenges in the 
experimental design and most notably in the immobilization chemistry for 
functionalizing the sensor surfaces. Publication I in this thesis presents a solution to 
the issue where the general protein immobilization protocols to CMD hydrogels did 
not allow to determining the affinity between protein kinase C ε and single-chain 
antibodies due to a steric hindrance or a denaturation of the immobilized protein. 
Thus, an uncommon alternative protein binding solution, where the dextran hydrogel 
was functionalized with and amine instead of carboxylic acid, was utilized in order to 
avoid the steric not to modify the immobilized protein structure which consequently 
allowed to determine the affinity. 
Another challenge in various interaction measurements where label-free detection 
is used is the assay sensitivity, as well as the fact that label-free detection methods are 
sensitive to changes in the surrounding environment. Publication II in this thesis 
presents a new hybrid-labelled method which can be used in tandem with label-free 
SPR detection, and which allows for significant improvements in the sensitivity and 
more importantly in the specificity of the detection. This enables simpler sensor 
structures for biosensing applications with SPR, and the use of difficult samples with 
non-optimal binding or optical properties. 
Biomaterials, like most other material science and engineering fields, are 
constantly moving towards the utilization of nanoscale layers. The use of the SPR 
phenomenon as an analysis tool for ultrathin film has largely been overlooked. 
Publication III in this thesis establishes the basis for using the SPR technique an 
analysis tool for nanoscale layers through theoretical considerations and empirically 
proving the effectiveness with several different nanotechnological layered systems. 
SLBs have been established as synthetic biomimetic models for biological 
membranes, but the current assay methodologies lack the control and robustness of 
the lipid membrane. In publication IV a new surface chemistry is presented that is 
capable of promoting formation of SLBs of complex lipid compositions which offers a 
platform for preparing more robust SLB assays with partial air-stability.  
The biomimetic detection assays are approached from another direction in 
publication V, i.e. established pharmaceutical cell-based assays are adapted to a flow-
through label-free detection technology for drug-cell interactions studies. While 
combining cell assays and a label-free technology is not a completely new idea, there 
have been a lot of uncertainties and unexplained differences in interpreting the signal 
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responses measured during cell stimulation. Publication V adds knowledge for better 
understanding the optical SPR signal behaviour when cells are stimulated with drugs, 
thus explaining a lot of the interpretation differences in the literature. The new 
analysis approach of the SPR signal also provided the mean for differentiating 
between the passive permeation routes of model drug compounds. 
The use of surface-sensitive label-free detection technologies in combination with 
various biomimetic sensing surfaces clearly indicated that these platforms are 
promising approaches as new type of in vitro drug development tools that could 
provide additional information to traditional assays for improving our mechanistic 
understanding when developing new drugs. These platforms may also enable a more 
ethical, efficient and cheaper drug development process in the future, consequently 
resulting in more effective and safer drugs. The new knowledge obtained in this thesis 
for a better understanding of the behaviour of the optical evanescent field detection 
system with different biomimetic surfaces, the analysis approaches developed for thin 
film characterization and the new surface chemistry protocols for creating 
biomimetic assays was not aimed for any specific application. However, the new 
knowledge will hopefully promote further development and utilization of non-
labelled detection techniques as new and more efficient research tools for 
biotechnological and pharmaceutical scientists.  
The technologies and analysis approaches presented in the literature survey and 
the individual research publications in this dissertation are not yet ready for 
commercialization. While the basic physics and chemistry are founded for a given 
methodology, there is still a lot of work to be done for optimizing, integrating and 
validating these technologies into widely accepted methodologies. Despite of this, this 
dissertation acts as a valuable addition to the existing knowledge, and provides the 
basic knowledge and hints for further development of surface-sensitive label-free and 
real-time research methods for life sciences. This could in general benefit the human 
society through a better understanding of our own physiology, and through improved 
medical care. 
